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The ability of motor cortex to plan, execute, and refine different movements
depends on the coordinated activity of many neurons found across its laminar structure.
Layer 5b (L5b), a deep cortical layer that drives output signals from the cortex, contains
excitatory pyramidal neurons that innervate many subcortical areas of the brain. In the
motor cortex, L5b is thicker and contains more pyramidal neurons than L5b of other
cortical areas. Electrophysiological, anatomical, and RNA-Seq profiling of neurons in the
motor cortex suggests there are diverse pyramidal neuron types within L5b. However, the
precise identities of these distinct populations and their defining traits have been difficult
to assess. Determining the cell type-specific properties of distinct L5b pyramidal neurons
will not only help in understanding how the motor cortex is able to execute its varied
functions, but may also reveal how selective vulnerability is established in
neurodegenerative diseases that affect the motor cortex, such as Amyotrophic Lateral
Sclerosis (ALS). Despite being expressed in all cells of the body, mutations associated
with ALS lead to specific loss of LMNs in the brainstem and the ventral horn of the spinal
cord, and UMNs in L5b of the motor cortex. For this reason, it is important to characterize
the unique molecular profiles that may underlie an increased vulnerability of these cell

types to the ubiquitously expressed mutations. In the motor cortex, this requires us to
determine the characteristics that differentiate vulnerable L5b cells from other resistant
cell types in the same area, and understand how these features may contribute to their
death in ALS. This study aims to understand how anatomical traits and molecular
properties, defined at the level of gene expression, vary across subpopulations of L5b
pyramidal neurons in the motor cortex. We show that there are two distinct, but closely
related, pyramidal neuron subtypes in mouse primary motor cortex which occupy discrete
sublayers of L5b. In the SOD1-G93A mouse model of ALS, we observe loss of only one
of these cell types, establishing the other as an analogous resistant L5b population. Using
TRAP (Translating Ribosome Affinity Purification) with RNA-Seq, we show that these
cells have important baseline differences in gene expression in healthy tissues, and that
they display differential molecular responses to SOD1-G93A expression. Together, these
findings reveal that the gene expression differences between the distinct L5b populations
not only reflect their diverse cortical and subcortical anatomy, but may also establish
selective vulnerability in ALS.
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CHAPTER 1:
Study Introduction and Objectives

The function of the central nervous system (CNS) fundamentally relies on
communication between many unique cell types. The myriad functions that are carried
out by the brain via these connections reflect the diverse anatomy, morphology, and
physiology of these CNS populations. Underlying this diversity are unique patterns of
gene expression that provide the necessary elements for constructing each distinct cell
type, both during development and in adulthood. For the mammalian neocortex, a hub
for cognition and integrative processing in the brain, this means defining the laminar
distribution of neuron populations that makes up its cytoarchitecture. The adult cortex is
classically organized into 6 anatomically and functionally distinctive layers that each
contain different subtypes of excitatory and inhibitory neurons (Brody, 1955; Jones and
Wise, 1977; Krieg, 1946; Lorente de No, 1938; Wise and Jones, 1977a). The excitatory
cortical populations are often referred to as pyramidal neurons because of the pyramid
shape of their cell bodies (see O'Leary, 1941; Ramón y Cajal, 1911). Each layer of the
cortex contains pyramidal neurons that differ in morphology, size and connectivity
(Figure 1.1). The most superficial layer, Layer 1 (L1), houses the distal dendritic
processes, or “apical tufts”, of deeper layer pyramidal neurons, which receive input from
various modulatory subcortical areas (Lorente de No, 1938; Vaughan and Peters,
1973). Layers 2 and 3, in rodents often combined as a single Layer 2/3 (L2/3), contain
small pyramidal neurons that communicate with other cortical cells in the same cortical
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Figure 1.1: Pyramidal neuron distribution across the layers of the mammalian
cortex. Model of cortical laminar cell types. L2/3 contains small neurons (pink) that
project to deep layer neurons within the cortical column, and in other areas of cortex. L4
receives inputs from sensory regions of the brain. L5a cells (blue) are slightly larger, and
send projections to the striatum and across other regions of cortex, include contralateral
cortex. L5b is a thick layer that contains some of the largest pyramidal neurons in the
cortex (green) that send projections to many different subcortical nuclei, the brainstem,
and the spinal cord. L6a contains small neurons (yellow) that project to the thalamus.
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column, as well as across other cortical regions (Gilbert and Kelly, 1975; Vogt and
Pandya, 1978). Layer 4 (L4), where present, is an important input layer of the cortex,
receiving the axon terminals of many sensory input neurons from other regions of the
brain (Shatz and Stryker, 1978; Woolsey and Van der Loos, 1970). Layer 5 (L5), is
composed of two major subdivisions. Layer 5a (L5a) contains large pyramidal cells that
innervate neurons in the striatum and other regions of the cortex, including the opposite
hemisphere, or “contralateral” cortex (Jones et al., 1975; 1977). Layer 5b (L5b) is an
important effector output layer of the cortex, containing the largest pyramidal neurons
that send their long-range axons to distal targets throughout the subcortical regions of
the brain (Domesick, 1969; Wise and Jones, 1977b; 1977a; Wise et al., 1979). Layer 6
(L6) is primarily represented by layer 6a (L6a), which includes pyramidal neurons that
are important in feedback signaling with the thalamus (Wise and Jones, 1977b).
This laminar architecture is highly conserved across different functional areas of
the cortex, such as visual and auditory regions (Krieg, 1946). However, in the primary
motor cortex (M1) and accessory motor regions such as anterolateral motor cortex
(ALM), there are two notable differences. (1) These areas do not contain a prominent
L4, and (2) they show a broader L5b thickness (Jones and Wise, 1977). Because L5b of
the cortex is a key computational output layer, the greater number of pyramidal neurons
that are accommodated by this widening reflect the importance of motor cortex output
for signaling in motor function. The proper execution of movement requires many stages
of preparatory and executive computation, and the pre-motor and motor cortices of
diverse species are indispensible in this multifaceted processing. These areas help to
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prepare and initiate voluntary movement (Chen et al., 2017; Churchland and Shenoy,
2007; Day et al., 1989; Economo et al., 2018; Evarts, 1968; Inagaki et al., 2018;
Penfield, 1954; Roland et al., 1980; Thach, 1978), participate in the initiation and
execution of dexterous movements (Evarts, 1966; Graziano et al., 2002; Gu et al.,
2017a; Guo et al., 2015; Shibasaki et al., 1993), and are important in the coordination
and refinement of gross movements that takes place during motor learning (Fischer,
1967; Kawai et al., 2015; Lashley, 1942). Accomplishing these varied forms of
processing requires signaling to many areas of the CNS, and therefore many axonal
outputs from these motor areas. And to carry these efferent messages, L5b in these
regions may contain diverse populations of subcortical projection neurons, also known
as corticofugal neurons, that contribute to different aspects of functional output from the
motor cortex (Figure 1.2, see Yu et al., 2008).
Evidence of the heterogeneity of motor cortical neuron populations has been found
in rodents, where different approaches have been employed to determine the neuronal
cell type composition of the different layers. For instance, using electrophysiology, it has
been revealed that in motor areas, the activity of different cells during distinct temporal
and spatial phases of movement is key to the preparation and execution of the
movement (Chen et al., 2017; Economo et al., 2018; Guo et al., 2015; 2014; Harrison et
al., 2012). Importantly, these cells receive electrophysiological input from different
sources depending on their depth in the cortex (Hooks et al., 2013; Mao et al., 2011;
Petreanu et al., 2009; Ueta et al., 2014; Yu et al., 2008). Additionally, their
electrophysiological properties suggest that cells in L5b can show differential degrees of
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Figure 1.2: Cell types of the primary motor cortex layers may be more diverse than
originally thought. The current thinking of motor cortical cytoarchitecture given
published findings and the findings of this study. M1 is agranular and contains no L4. L5b
is thicker in these areas and may contain distinct populations projection neurons. These
cells may send projections to distinct subcortical areas throughout the brain.
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the spike-frequency adaptation necessary for maintaining persistent activity (Hattox and
Nelson, 2007; Oswald et al., 2013; Sheets et al., 2011; Suter et al., 2013; Tantirigama
et al., 2016; 2014). Another approach used to address the heterogeneity of pyramidal
neurons in the motor areas is anatomical tracing, whereby one can label neurons that
project to different areas of the brain by injecting retrograde dyes and reporterexpressing viruses into these target regions. Using these labeling methods, the
projections from L5b of the motor cortex haven been shown to target several different
regions of the subcortex, including the thalamus, the superior colliculus, the pons, the
brainstem, and the spinal cord (Figure 1.3; Arlotta et al., 2005; Economo et al., 2018;
Feng et al., 2000; Gerfen et al., 2016; Oswald et al., 2013) Distinct subpopulations of
L5b neurons appear to have specific combinations of collateral projections rather than
each innervating all of these regions (see Economo et al., 2018). Finally, using highthroughput sequencing methods that assay whole cortical areas, it has been shown that
even within individual sublayers, there may be distinct populations of cells that are
differentiated by their gene expression patterns (Fame et al., 2017; Sugino et al., 2006;
Tasic et al., 2016; 2018). Together these findings have all suggested that the cell typecomposition of the distinct layers of motor cortical areas may be more heterogeneous
than originally suspected. However, it has been difficult to consolidate the findings of
these diverse studies into a comprehensive atlas of L5b cell types and their respective
features. This is due to the fact that, within the same animal, it is challenging to carry
out all of the various physiological, anatomical, and molecular assays used to describe
cell type properties, and therefore impossible to cross-reference a particular feature with
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Figure 1.3: The long-range projections of L5b cells of M1. Sagittal illustration of
projection patterns for the distinct L5b subpopulations of L5b cells, from recent published
studies as well as findings from this study. Together, these populations send long-range
projections to more proximal and distal regions of the subcortex, including the ventral
posteromedial nucleus of the thalamus, the superior colliculus, the pons, and the
brainstem.
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a specific cell in the tissue. Without reproducible anatomical and molecular access to
the individual distinct cell types of L5b, we will not be able to define the unique features
of these neurons across the varied experimental paradigms used to define neuronal
subpopulations.
The ability to visualize specific neuronal populations and profile their specific
patterns of gene expression across experimental assays is the cornerstone of the
Translating Ribosome Affinity Purification (TRAP) technique (Doyle et al., 2008; Heiman
et al., 2008). The ability to introduce transgenes into the mouse genome by using
Bacterial Artificial Chromosomes (BACs) was key to the development of the technique
(Gong et al., 2010; 2003; Shizuya et al., 1992). TRAP relies on the expression of a
subunit of the large ribosomal complex (L10a) fused to a green fluorescent protein
(EGFP; EGFP-L10a). In order to express EGFP-L10a in specific cellular population of
interest, a region of the genome that contains a gene selectively expressed in these
cells is converted into a BAC, where EGFP-L10a is inserted by homologous
recombination downstream of the promoter of the cell type-specific gene. The modified
BAC is then introduced by microinjection into a fertilized mouse zygote, where it
incorporates into the genome by recombination. The cell type-specific gene promoter
then drives transcription of EGFP-L10a in any cells that express that gene. The
fluorescent EGFP allows for the anatomical visualization of this cell type in tissue, and
when isolated by immunoprecipitation (IP), also provides access to the mRNA
molecules that are bound to the ribosomal complex during translation. This technique
has been broadly applied in the study of the molecular underpinnings of cell type-
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specific features across the CNS in both healthy and dysfunctional physiology
(Nakajima et al., 2014; Schmidt et al., 2012; Virk et al., 2016). The TRAP technique is
therefore ideally suited to revealing underlying molecular differences across L5b
pyramidal neuron types that, starting at the level of gene expression, help establish
unique neuronal properties.
While differing patterns of gene expression can impart unique functional properties
and establish anatomical diversity, they can additionally create vulnerabilities to
biological insult. In fact, the selective vulnerability of specific neuron populations is a
hallmark of many neurodegenerative diseases. In these diseases, ubiquitously
expressed mutations cause discrete populations of vulnerable cells to die because the
specific molecular environment found in those cells is not able to mitigate the insult. In
the case of Amyotrophic Lateral Sclerosis (ALS), loss of two different cell types is
observed: upper motor neurons (UMNs) in L5 of the primary motor cortex and lower
motor neurons (LMNs) in the ventral horn of the spinal cord (Charcot and Joffroy, 1869;
Hammer et al., 1979). Progressive loss of these two motor neuron populations is
catastrophic to motor function, and is therefore lethal to the patient. ALS patients
typically become symptomatic at an average age of 55 (als.org and alsa.org), with initial
symptoms often including muscle weakness and tremors. Almost 6000 patients are
newly diagnosed with ALS every year in the US alone, and although disease
progression rates can vary from case to case, patients typically do not survive beyond 5
years post-diagnosis. The vast majority of ALS cases (90%) occur sporadically (sALS)
with no detectable heritable cause (Rowland and Shneider, 2001; Tandan and Bradley,
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1985). For the remaining 10% of cases, heritable mutations to several genes- including
Superoxide dismutase 1 (SOD1), C9orf72, Tar-DNA binding protein (TDP-43), and
Fused in sarcoma (FUS)- account for most familial ALS (fALS) cases (DeJesusHernandez et al., 2011; Kwiatkowski et al., 2009; Renton et al., 2011; Rosen et al.,
1993; Sreedharan et al., 2008; Vance et al., 2009)).
It is not fully understood how mutations in these ubiquitously expressed genes
cause degeneration of UMNs and LMNs specifically, and no effective treatments for
ALS have been developed. Nevertheless, mouse models of ALS that express mutations
in the fALS-associated genes (SOD1, TDP-43, FUS, and C9orf72) have allowed us to
probe disease mechanisms in a controlled context. (Gurney et al., 1994a; Liu et al.,
2016; Verbeeck et al., 2012; Wegorzewska et al., 2009). These models recapitulate
different features of the cellular pathologies often observed in human ALS tissues, such
as cytoplasmic inclusions and cellular atrophy (Bentmann et al., 2013; Jara et al., 2012;
Tsao et al., 2012; Turner and Talbot, 2008). They additionally show some of the motor
deficits that are reminiscent of the symptoms developed by human ALS patients. In
particular, the commonly used SOD1-G93A model (Chiu et al., 1995; Gurney et al.,
1994b) shows the progressive loss of motor function and degeneration of UMNs and
LMNs that is the pathological definition of ALS. As in humans, however, it is not known
how ubiquitously expressed mutant SOD1 in these mice inevitably causes death of
motor neurons. Yet, the field has gleaned many insights into the cellular dysfunctions
that occur in response to mutant SOD1 expression (see Cleveland and Rothstein, 2001;
Turner and Talbot, 2008).
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In healthy cells, SOD1 acts to convert the highly reactive superoxide generated as
part of various cellular functions into less reactive hydrogen peroxide (McCord and
Fridovich, 1969). Mutations to 70 of the 153 SOD1 amino acids have been linked to
fALS and sALS (see Turner and Talbot, 2008). Mouse models that express many of
these human SOD1, including the glycine-to-alanine mutation at the 93rd amino acid
(G93A), have been generated in an effort to study the effects of mutant SOD1 to cellular
function. Across various SOD1 mutants appear to aggregate (Johnston et al., 2000),
mislocalize to mitochondria (Higgins et al., 2002; Jaarsma et al., 2001), lose metal ion
binding ability (Goto et al., 2000; Williamson et al., 2000), and cause downstream
oxidative damage via nitric oxide and hydrogen peroxide substrates (Andrus et al.,
1998; Beal et al., 1997; Bruijn et al., 1997a; Casoni et al., 2005; Estévez et al., 1999;
Ferrante et al., 1997; Singh et al., 1998). Many of these dysfunctions have been
described in studies of the SOD1-G93A model, where one of the cumulative
consequences of these SOD1 phenotypes is the loss of LMNs of the spinal cord (Chiu
et al., 1995; Gurney et al., 1994b).

Characterizing the cellular changes occurring in

LMNs during disease progression has been the primary focus of much ALS research in
the SOD1-G93A mouse. This is primarily due to the fact that LMNs are readily
distinguishable from other spinal cell types by their ventral localization and large size
(Aitken and Bridger, 1961; Light and Metz, 1978), and are therefore relatively easy to
selectively visualize in tissue. From these studies, several of the molecular responses
that take place in these cells during ALS progression have been uncovered, including
oxidative stress (Beal et al., 1997; Bruijn et al., 1997b; Casoni et al., 2005), axon
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transport defects (Warita et al., 1999; Williamson and Cleveland, 1999; Zhang et al.,
1997), dysregulation of glutamate-mediated neurotransmission and excitotoxicity (see
Kuner et al., 2005; Tateno et al., 2004; Trotti et al., 1999), and misfolded protein
aggregation (Bruijn et al., 1997b; Johnston et al., 2000; Watanabe and Nakamura,
2000). While determining these phenotypes is necessary for the future development of
treatments and therapies, it is important to remember that ALS is clinically defined by
the loss of both LMNs of the brainstem and spinal cord, and UMNs of the motor cortex.
Understanding what molecular changes occur in UMNs, in complement with the
responses observed in LMNs, will allow us to more effectively determine what
phenotypes lead to cell type-specific loss in ALS.
Characterizing the molecular changes that occur in UMNs of the motor cortex
during disease has proven challenging. Because the pyramidal neuron types in the
cortex are heterogeneous, even within L5b (Krieg, 1946), visualizing these cells
requires a targeted labeling approach. Using retrograde anatomical tracing methods in
mouse models of ALS, including SOD1-G93A, it has been possible to study the
disease-related changes that take place in corticofugal L5b cells of rodent M1 during
ALS progression (Kim et al., 2017; Ozdinler et al., 2011; Yasvoina et al., 2013; Zang
and Cheema, 2002), also (see Jara et al., 2014). Many of these changes are
reminiscent of phenotypes observed in LMNs, such as hyperexcitability (Fogarty et al.,
2015), atrophy (Ozdinler et al., 2011; Zang and Cheema, 2002), and vacuolization (Jara
et al., 2012). But because the anatomical approaches used in the majority of UMN
studies do not provide the ability to assess molecular cell type heterogeneity, it is still
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not fully understood whether these disease phenotypes represent cell type-specific
changes, or are more indicative of global L5b responses to ALS-causing mutations.
Without a method that allows for reliable visual and molecular access to individual
neuronal subtypes within the potentially heterogeneous population of L5b cells,
including the vulnerable UMN population, we cannot hope to fully advance our
understanding of how mutant SOD1 expression can cause motor neuron-specific loss.
The TRAP technique presents an ideal opportunity to anatomically characterize and
molecularly profile the different L5b populations of the motor cortex in ALS to determine
any subpopulation-selective responses. Additionally, and perhaps more importantly, the
technique would allow us to interrogate how the cell type-specific features of the most
vulnerable population of L5b neurons may be exploited by a ubiquitously expressed
ALS mutation to cause selective degeneration.
In this work, we set out to uncover what unique characteristics define the
vulnerable population of M1 L5b neurons relative to closely related L5b neurons in both
healthy and ALS contexts (Figure 1.4). We first generated transgenic BAC transgenic
mouse lines that expressed EGFP-L10a in L5b cells of M1, via the Colgalt2 and Gprin3
promoters respectively. The EGFP expression in these lines provided us with visual
access to these two L5b populations, which we used to determine the laminar
localization and projection patterns of these cells. We show that Colgalt2 cells are found
in an upper sublayer of L5b (UL5b) and project to the pons and not the spinal cord,
while the Gprin3 population is found in a discrete lower sublayer of L5b (LL5b) and
projects to the pons and the spinal cord. The EGFP-L10a construct also allowed us to
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Figure 1.4: The general findings of this study. A summary of the relevant properties of
L5b cells characterized in this study. Upper L5b (UL5b) Colgalt2 cells (purple) project to
the pons, but not the spinal cord, and are not vulnerable in an ALS mouse model. Lower
L5b (LL5b) Gprin3 cells (green) project to both the pons and spinal cord and are lost in an
ALS mouse model.
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perform Translating Ribosome Affinity Purification (TRAP) to molecularly profile the cells
by their gene expression patterns. We determine that while these cells are very similar,
they show several molecular differences that may have consequences on their neuronal
function. To determine the specific vulnerability of LL5b Gprin3 cells but not UL5b
Colgalt2 in ALS by crossing our lines to the SOD1-G93A ALS mouse model, we then
performed TRAP in these two cell types across healthy and ALS conditions to
understand what cell-type specific responses take place in a vulnerable and resistant
population of neurons during disease progression. We show that these cells diverge in
their molecular responses to SOD1-G93A expression across disease stages, showing a
particularly contrasting response in mitochondrial gene expression modulation. We then
show that these cells show changes in mitochondrial structure during disease that will
need to be explored further in future studies. And lastly, we endeavor to determine
whether LL5b Gprin3 cells are representative of the neurons that are thought to be ALSvulnerable in the human motor cortex, with an eye towards to identifying markers that
effectively visualize potentially disease-relevant populations.
As a whole, this study represents an assessment of the underlying anatomical and
intrinsic molecular differences between M1 L5b cell types, their differential vulnerability
and responses in ALS, and the translatability of their molecular identity to human motor
cortex. The data collected as part of this work should serve to inform future studies of
L5b anatomy and molecular biology across healthy and disease contexts, as well as
across species.
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CHAPTER 2:
Anatomical and molecular characterization of Colgalt2 and Gprin3 bacTRAP cell
populations

The mammalian neocortex is responsible for the processing of associated inputs
from diverse brain regions into relevant functional outputs. But while each cortical region
receives different types of information, i.e. auditory vs. visual, the cortex classically
employs the same laminar organization of neurons to process these diverse inputs.
Each of five anatomically distinct layers (L2/3, L4, L5a, L5b, L6a) contains excitatory
pyramidal neurons that participate in the tiered processing of afferent information (Brody,
1955; Jones and Wise, 1977; Krieg, 1946; Weiler et al., 2008). The output of this
computation is ultimately transmitted out of the cortex by neurons found in its deep
layers, with large L5b pyramidal neurons being important drivers of functional
downstream signaling. The laminar distribution of L5b pyramidal neurons across the
cortex is remarkably uniform in rodents (Krieg, 1946). In mice, it is consistently found at
~50% depth from the pial surface of the cortex, with a thickness of about 150µm
(Franklin and Paxinos, 2008; Lein et al., 2007). In primary motor cortex (M1), the
thickness of L5b doubles, however (Caviness, 1975; Cederquist et al., 2013). Because
the proper functioning of motor cortex in motor learning (Kawai et al., 2015) and
execution (Anderson et al., 2010; Chen et al., 2017; Guo et al., 2015) is highly
dependent on its outputs to other brain regions, it was theorized that this thickening
creates space to accommodate all of the increased number and types of subcortical
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projection neurons required to carry out these motor behaviors (see Yu et al., 2008).
Very recently, using a combination of viral tracing and single cell RNA-Seq, it was
shown that, indeed, L5b of M1 and anterolateral motor (ALM) cortices may contain
diverse pyramidal neuron types, and that together, these cells function in different
stages of preparation and execution of motor output (Economo et al., 2018; Tasic et al.,
2018). These cells also appear to diverge in projection pattern, with some cells showing
collateral projections to proximal regions of the mid- and hindbrain, including the
thalamus, the pons, and the superior colliculus, and others projecting to the superior
colliculus, the pons, and distal brainstem regions (Figure 1.3; Chen et al., 2017;
Economo et al., 2018). Alongside their differences in circuit participation, there is still
very little known about the distinct molecular profiles of the cell types in L5b, and how
their unique differences may contribute to the distinct functional properties observed for
each.
Targeting L5b pyramidal neuron types for further study requires the ability to
reliably visualize the cells separately across experimental paradigms. Previously
generated transgenic mouse lines that target L5b, such as the commonly used Thy1EYFP line (Bareyre et al., 2005; Feng et al., 2000; Yu et al., 2008) and Uchl1-EGFP line
(Yasvoina et al., 2013), show expression of reporters and constructs across all
pyramidal neurons of L5b rather than individual subtypes, and would therefore not be
suitable for studies into the properties that uniquely define each subpopulation. In order
to target these cells for anatomical and molecular characterization, we set out to
generate BAC Transgenic mouse lines (Gong et al., 2010) that express the EGFP-
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tagged ribosomal subunit L10a necessary for performing Translating Ribosome Affiinity
Purification (TRAP; Doyle et al., 2008; Heiman et al., 2008) in specific subsets of L5b
neurons. TRAP is a powerful gene expression profiling technique that allows for the
isolation of actively translated mRNAs from specific cell types in tissues. By
immunoprecipitating EGFP-tagged ribosomes that are expressed in these populations
by cell type-specific promoters, one can interrogate the gene expression patterns of
neuronal populations of interest. Expression of the GFP-tagged subunit in L5b cells
additionally provides reliable and reproducible visualization (across generations and
individuals) of each population, allowing us to carefully characterize the anatomical
properties of these cell types, such as cortical localization and subcortical projection
patterns. We therefore employed L5b TRAP lines to characterize the unique anatomical
and molecular properties of the two subopulations of L5b projection neurons.

2.1 Anatomical distribution of EGFP-labeled cells in the Colgalt2-TRAP DU9
mouse line
In order to gain molecular and anatomical access to L5b pyramidal neurons, we
set out to express the TRAP EGFP-L10a construct in L5b cells in M1 by creating a set
of diverse BAC transgenic animals. The GENSAT project (Gong et al., 2003;
gensat.org) produced many cell-type specific gene expression anatomical maps of the
mouse brain. From these atlases, a number of genes were selected for their specific
laminar expression patterns in L5 of the cortex. BACs were created to express the
EGFP-L10a construct under the control of these cell-type specific gene promoters.
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From the mice that resulted from this BAC transgenic approach (Figure 2.1), two of the
mouse lines generated, Colgalt2-TRAP DU9 and Gprin3-TRAP ES152, showed strong
expression of the TRAP construct across many cells in apparent upper and lower L5b,
with expression driven by the Colgalt2 and Gprin3 BAC promoters, respectively.
Colgalt2-TRAP is expressed almost exclusively in the cortex, with very few cells
observed in subcortical areas (Figure 2.2). Between +2.00-1.50 mm anterior to bregma
(Figure 2.2A), Colgalt2 cells are observed at approximately half the thickness of the
cortex, at a depth visually consistent with L5b across all cortical areas. In prelimbic and
agranular insular cortex, some L6a cells show low levels of expression of the construct.
In the dorsal transition zone, a small cluster of Colgalt2+ cells can also be seen. From
+1.00-0.00 mm anterior to bregma (Figure 2.2B), cells spanned all cortical areas and
appeared to be restricted entirely to L5b, with some cells again detected in L6a of
insular cortex. Near bregma, the distribution of Colgalt2+ cells becomes even more
restricted to L5b, but labeled cells are still observed across the entire extent of cortex.
At -1.00 mm from bregma (Figure 2.2C), L5b expression of Colgalt2 is maintained, but a
small number of cells are additionally observed in the medial CA2 region of
hippocampus and the ventral piriform cortex/cortical-amygdalar transition region.
Between -2.00-3.00 mm from bregma (Figure 2.2D), fewer cells are observed in L5b of
retrosplenial cortex, with L5b in other cortical areas still showing many labeled cells. A
small cluster of labeled cells was also observed in the medial hippocampus, beginning
at the fasciola cinereum and spreading laterally into medial CA1 in more caudal
sections. More caudally in this range, a more superficial population of labeled cells is
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Figure 2.1: Expression of EGFP-L10a in mouse L5b using BAC Transgenics.
Representative brightfield images of GFP immunostaining in mouse lines generated to
express the TRAP EGFP-L10a construct specifically in L5b. Gross laminar distribution
(top row) shows specific expression in L5b of M1, with more detailed distributions shown
below (bottom row). Among the promoters used to drive expression of the TRAP
construct, Colgalt2 and Gprin3 showed expression in the greatest numbers of cells in
L5b, and thus were chosen for further assessment.
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Figure 2.2: Expression of EGFP-L10a in Colgalt2-TRAP DU9 mice is observed in
L5b across the entire cortex. EGFP-L10a expression visualized by GFP
immunostaining and DAB deposition in brightfield-imaged coronal sections of a
Colgalt2-TRAP DU9 mouse. Sections are representative of ranges of anterior-posterior
locations. (A-C) The M1-containing extent of cortex shows labeled Colgalt2 cells across
the whole extent of cortex. Black arrows indicate the boundaries of M1 in the
medial-lateral axis. (D-E) In posterior regions of the brain, Colgalt2 is still observed across
most cortical areas. Section thickness is 40µm. Listed coordinates are approximate to
Paxinos atlas coordinates.
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also visible in perirhinal cortex. At -3.30 mm from bregma (Figure 2.2E), the perirhinal
population of Colgalt2 cells becomes more prominent, while L5b labeling in other
cortical areas is maintained. A very sparse population of labeled cells is observed dorsal
to the substantia nigra reticularis, possibly occupying a ventral area of the
mesensephalic reticular formation. Overall, the Colgalt2-TRAP DU9 line spans L5b of
almost all cortical areas, and would serve as an excellent line for visualizing this output
layer across many different contexts.

2.2 Anatomical distribution of EGFP-labeled cells in the Gprin3-TRAP ES152
mouse line
Broadly, Gprin3-TRAP is expressed in many subcortical regions across the brain,
as well as in L5b of certain anterior regions of the cortex (Figure 2.3). At +2.25 mm from
bregma, Gprin3 cells are only observed in a wide band of pyramidal neurons at a depth
consistent with L5b across secondary and primary motor cortex regions. At +2.00 mm
from bregma (Figure 2.3A), Gprin3 cells in the cortex can be seen in a wide band
beginning medially in secondary motor cortex and extending laterally to insular cortex.
Ventrally, a cluster of cells can be seen in the shell of the nucleus accumbens, as well
as a more ventral structure surrounding the ventral pallidum. At +1.00 mm from bregma,
cortical Gprin3 cells can be seen in L5b, again beginning medially in secondary motor
cortex, and extending laterally through secondary somatosensory cortex. Through M1,
the labeled pyramidal neurons appear to “dip” to a lower sublayer of L5b, however,
suggesting Gprin3 cells may have a LL5b identity in this area. Subcortically, Gprin3+
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Figure 2.3: Expression of EGFP-L10a in Gprin3-TRAP ES152 is localized to anterior
areas of cortex, and found in many subcortical areas of the brain. EGFP-L10a
expression visualized by GFP immunostaining and DAB deposition in brightfield-imaged
coronal sections of a Gprin3-TRAP ES152 mouse. Sections are representative of ranges
of anterior-posterior locations. (A) In an anterior area of cortex, cortical Gprin3 cells are
observed along much of the medial-lateral extent. A small number of cells is observed
subcortically. Black arrows indicate the medial-lateral extent of M1. (B) Closer to Bregma,
in the lateral-to-medial transition between somatosensory cortex and the lateral boundary
of M1, GFP labeled cells appear to dip deeper into the cortex and remain there through
to the medial boundary of M1. GFP+ cells are also seen in the striatum and other
subcortical areas in this range. (C) As M1 begins to disappear in this more posterior area,
GFP+ cells in the cortex become sparser. Subcortical GFP cells are found in many
diverse regions here. (D-E) In posterior regions of the brain, GFP labeling is heavily
concentrated to subcortical areas, and the CA3 region of hippocampus. Section thickness
is 40 µm. Listed coordinates are approximate to Paxinos atlas coordinates.
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cells can be seen in the striatum in a sparsely scattered pattern. Several subpopulations
of labeled cells can be found in the accumbens shell, with a small number also located
in the accumbens core region. A dense population of Gprin3+ cells is visible in a very
ventral area of this brain region, possibly occupying the olfactory tubercle. Cells can
also be seen in the lateral and medial septal nuclei and in what appears to be the island
of Calleja between the accumbens shell and the spetal nuclei. At +0.50 mm from
bregma (Figure 2.3B), the same distribution of labeled L5b neurons is observed in the
cortex between secondary motor and secondary somatosensory cortex, with the “dip” in
primary motor cortex still clearly visible. The sparse but highly expressing striatal
neurons are also observed. The number of cells found in the accumbens shell is greatly
reduced, with a large number of highly-expressing cells visible in the medial septal
nucleus and in various ventral nuclei around the olfactory tubercle. Around bregma, the
distribution of labeled cells in L5b of the cortex becomes much sparser, with fewer cells
generally visible from secondary motor cortex to secondary somatosensory cortex.
Many cells are still observed in the striatum, with a large number of highly-expressing
cells found ventral to the anterior commissure in the various ventral nuclei found in this
region. A small cluster of cells can also be seen in the anteromedial bed nucleus of the
stria terminalis. An additional sparse cluster of neurons can be observed in the
septofimbrial nucleus. At -0.50 mm from bregma, the number of cortical L5b cells has
noticeably decreased, with some cells still remaining in the lateral regions of cortex,
including the insular cortex. Subcortically, a large number of highly-expressing cells can
be found in the globus pallidus and the thin band that comprises the bed nucleus of the
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stria terminalis at the coordinate. A cluster of low-expressing cells can also be seen in
the central medial thalamic nucleus. The ventral regions of the midbrain here, including
the hypothalamus and the anterior amygdalar area, contain many labeled cells showing
varying levels of expression. From -1.00-1.50 mm from bregma (Figure 2.3C), almost all
labeled cortical neurons have disappeared. Gprin3+ cells are primarily localized to
subcortical areas, including the dorsal striatum, the globus pallidus, the lateral
habenula, the central medial, rhomboid, and reuinens nuclei of the thalamus, the zona
incerta, and almost all nuclei of the hypothalamus and the medial forebrain bundle. A
number of labeled cells can also be seen in the CA3 region of the hippocampus. At 2.00 mm from bregma, fewer cells are observed in the ventromedial regions of the
hypothalamus, with some still remaining in the peduncular region of the lateral
hypothalamus. The zona incerta still contains a dense population of labeled cells, as
well as the lateral habenula, the pregeniculate nucleus, and many dorsomedial nuclei of
the thalamus. Gprin3+ neurons can still be seen in the CA3 region of hippocampus, with
an additional cluster of cells observed in the polymorph area of the dentate gyrus. At 2.75 mm from bregma (Figure 2.3D), Gprin3+ cells occupy almost the entire midbrain,
with the exception of a lateral horn of the thalamus composed of the lateral posterior
thalamic nuclei and the dorsolateral geniculate nucleus through to the retroethmoid
nucleus. In the hippocampus, the CA3, polymorph dentate gyrus and the dorsal
subiculum regions also contain labeled cells. The midbrain is densely populated with
labeled cells through to -3.00 mm from bregma (Figure 2.3E), where the only region
containing no Gprin3+ cells is the medial geniculate nucleus. At this coordinate, a
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sparse population of cells in the substantia nigra reticularis and the interpeduncular
nucleus can also be seen. More posterior, the superior colliculus also shows many
labeled cells, along with the periaqueductal gray. The Gprin3-TRAP ES152 line is
therefore useful for the study of L5b cells anterior to bregma, in anterolateral motor
regions, primary motor cortex, and the accessory motor/somatosensory regions. A very
large and diverse population of labeled cells is also found subcortically and in the CA3
region of hippocampus, making the Gprin3 line potentially useful in the molecular and
anatomical characterization of these regions.

2.3 Colgalt2 and Gprin3 neurons represent two distinct populations of layer 5b
pyramidal neurons in primary motor cortex of mouse.
Because both Colgalt2 and Gprin3 cells occupy L5b of M1, we wanted to perform
a closer examination of the precise laminar distribution of the cells. We immunostained
for GFP in Colglat2-TRAP and Gprin3-TRAP mice and imaged the M1 sections by
confocal microscopy (Figure 2.4A-B). We then measured the depth of GFP+ cells using
a custom program that measures the Euclidean distance between the pial surface and
the dorsal surface of white matter. These analyses revealed that in the Colgalt2-TRAP
mouse, GFP+ neurons are found at approximately 50% depth from the pial surface to
the dorsal edge of the white matter of the corpus callosum (CC). This depth is
consistent with a superficial sublayer of L5b (Economo et al., 2018), or upper L5b
(UL5b, Figure 2.4C). The Colgalt2 cells are found between 50-60% depth in other areas
of the cortex as well, suggesting they maintain this identity across all cortical regions. In
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Figure 2.4: Colgalt2 and Gprin3 cells show distinct sublayer distribution within L5b
of M1. (A-B) Representative images of M1 in (A) Colgalt2-TRAP and (B) Gprin3-TRAP
mouse. Immunostaining for GFP (green) shows location of TRAP cells amongst all
NeuN+ neurons of the cortex (red). Colgalt2 cells appear to occupy an upper sublayer of
L5b (UL5b) relative to Gprin3 cells, which instead dip into a lower sublayer of L5b (LL5b)
in this area. Cortical layers were delineated based on approximate depth and size of cell
bodies composing each layer (scale bar = 500 µm). (C) Heatmaps indicating the
frequency at which GFP labeled cells from Colgalt2 and Gprin3 M1 were found at each
depth of the cortex, represented as percent depth from pial surface of the cortex. In M1,
Colgalt2 cells (purple; n = 209) are found more superficially than Gprin3 cells (green; n =
163). In other cortical areas, both cell types are found at the same depth. Frequencies ≥
6 cells are shown in the same shade of color to more readily highlight depths that contain
the most labeled cells.
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M1 of Gprin3 animals, GFP+ neurons were instead observed at a depth of 60-75% from
the pial surface, suggesting they occupy the lower sublayer of L5b (LL5b). In other
cortical areas, Gprin3 cells appeared to reside primarily at 50-60% depth, similar to
Colgalt2 cell depth, suggesting that these two cell types anatomically converge in other
regions of the cortex, and that the sublayer divergence is unique to M1. Together these
data indicate that the Colgalt2 and Gprin3 mice represent the first transgenic lines that
target expression to the two distinct sublayers of M1 L5b, allowing for the consistent and
reliable visualization of these neuron populations without the use of tracers or viruses.

2.4 Colgalt2 and Gprin3 neurons share long-range projection neuron identity, but
project to distinct targets.
Because L5b has been well established as an output layer of the cortex,
containing large pyramidal neurons that display long-range projections targeting
different areas throughout the brain, we wanted to confirm that our Colgalt2 and Gprin3
cells are indeed long-range projection neurons. We first immunostained for Ctip2, a
known marker of subcortical-projection neurons, in our Colgalt2 and Gprin3 brains in
order to assess co-localization with the GFP from our cells (Figure 2.5A). In Colgalt2
brains, 79% of sampled GFP+ cells were Ctip2+, and in Gprin3 mice, 94% of GFP+
cells were Ctip2+ (Figure 2.5B). Colgalt2 and Gprin3 cells additionally showed larger
soma size than other pyramidal neurons in the cortex, with median Colgalt2 soma size
being 233 µm2 and median Gprin3 soma size being 238 µm2, compared to 180 µm2 for
a pooled population of different cortical pyramidal neurons (Figure 2.5C). Together,
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Figure 2.5: Colgalt2 and Gprin3 cells are both positive for Ctip2, a marker for
subcortical projection neurons of the cortex. (A) Representative confocal images of
GFP+ (green) Colgalt2 and Gprin3 cells with staining for the subcortical projection neuron
marker Ctip2 (red, scale bar = 50 µm). (B) Quantification of co-localization of Ctip2 with
Colgalt2 GFP (purple; n = 191 cells) and Gprin3 GFP (green; n = 135 cells) reported as
percent of GFP+ cells that show Ctip2 labeling. Bars show mean±SEM (n.s. = not
significant by two-tailed t-test). (C) Quantification of soma size (µm2) for GFP+ Colgalt2
cells (purple; n = 292 cells), Gprin3 cells (green; n = 285 cells), and other neurons across
layers of cortex (grey; n = 1253 cells). Colgalt2 and Gprin3 cells show larger soma sizes
relative to other neurons in the cortex. Box and whisker plots show median and quartile
boundaries (****p < 0.0001 by one-way ANOVA).
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these data suggest that both UL5b Colgalt2 and LL5b Gprin3 neurons share the longrange projection identity that is classically observed in L5b.
We then set out to identify the targets of the presumptive long-range axonal
projections of Colgalt2 and Gprin3 cells. Across different cortical areas and species, L5b
cells have been shown to project to the thalamus, superior colliculus, pons, brainstem,
and spinal cord (Hattox and Nelson, 2007; Jones et al., 1977; Moya et al., 2014; Oswald
et al., 2013; Wise and Jones, 1977b; Wise et al., 1979). Because UL5b and LL5b cells
were recently shown to share a projection to the pons, but diverge in projections to
more caudal regions (Economo et al., 2018), we chose to first assess whether our
Colgalt2 and Gprin3 cells project to the pons or the cervical spinal cord. We therefore
injected the retrograde tracer cholera toxin beta (CTB) into the pons and C6 cervical
spinal cord (Figure 2.6A-B, left panels) in adult Colgalt2 and Gprin3 mice and visualized
the retrogradely labeled cells in M1 by confocal microscopy following immunostaining
for GFP and CTB (Figure 2.7A-B, left panels). The distribution of pons-CTB+ neurons
varied by injection site, but cells were often observed across L5b of many different
cortical areas. Neurons that were pons-CTB+ were found in both upper and lower L5b
of M1, at similar depths to both Colgalt2 and Gprin3 cells, extending from 45-75% depth
from the pial surface, with bimodal peaks at ~50% and ~70% depth, matching the peak
depths of Colgalt2 and Gprin3 cells respectively (Figure 2.8A). When we quantified colocalization of GFP in CTB+ cells, we found that 38% of pons-CTB+ cells across both
sublayers were positive for Colgalt2. When co-localization is measured only within the
dorsal half of L5b that comprises UL5b, 64% of pons-CTB+ cells were positive for
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Figure 2.6: Retrograde tracing from pons and cervical spinal cord labels L5b
neurons in M1. (A) Schematic representations of CTB (red) injection targets in the pons
and cervical spinal cord with expected corresponding retrograde labeling in the cortex. (B,
top row) Representative confocal images of CTB at the site of injection in pons (left) and
C6 of the cervical spinal cord (right). Cytoarchitecture is shown with NeuN labeling (cyan).
Corresponding retrograde labeling in M1 is shown with CTB staining (red). Pons
injections retrogradely labeled cells across both sublayers of L5b (bottom row, left), while
C6 injections only appeared to label LL5b cells (bottom row, right). Pial surface outlined
with solid white line, target grey matter/white matter boundary outlined with dashed white
line (scale bar = 500 µm).
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Figure 2.7: Retrograde tracing from pons and cervical spinal cord labels Colgalt2
and Gprin3 cells. (A) Schematic representations of CTB (red) injection targets in the
pons and cervical spinal cord with expected corresponding retrograde labeling in the
cortex. (B) Immunostaining for GFP (green) revealed CTB (red) overlap with Colgalt2 (top
row) and Gprin3 (bottom row) cells. Pontine CTB cells appeared to overlap with both
Colgalt2 and Gprin3 cells across both sublayers of L5b. Spinal CTB cells only appear to
spatially overlap with Gprin3 cells in LL5b. Pial surface outlined with solid white line,
corpus callosum outlined with dashed white line (scale bar = 200 µm).
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Figure 2.8 : Colgalt2 cells project to the pons, while Gprin3 cells project to both the
pons and the cervical spinal cord. (A) Heatmaps showing frequency of depth
localization of retrogradely labeled CTB+ cells (red), compared to depths of Colgalt2
(purple; n = 209 cells) and Gprin3 (green; n = 163 cells) cells in M1 following CTB
injections into the pons and C6 of cervical spinal cord. Pontine CTB cells (n = 651 cells)
distributed bimodally across both sublayers of cortex, overlapping in depth with Colgalt2
and Gprin3 cells. Spinal CTB cells (n = 192 cells) were located deeper in M1, overlapping
with the Gprin3 population. Frequencies ≥ 6 cells are shown in the same shade of color
to more readily highlight depths that contain the most labeled cells. (B) Quantification for
co-localization of CTB with GFP from Colgalt2 (purple) and Gprin3 (green) cells following
CTB injection into pons or cervical spinal cord, reported as percent of total CTB+ cell
observed for each injection. 38% of pontine CTB in all of L5b cells co-localize with
Colgalt2 (n = 318 cells), with 48% co-localizing with Gprin3 (n = 613 cells). More
specifically, 64% of pontine CTB in UL5b co-localized with Colgalt2 cells, and 77% of
pontine CTB cells in LL5b co-localized with Gprin3 GFP. Only 9% of spinal CTB
co-localized with Colgalt2 (n = 190 cells), while 82% co-localized with Gprin3 cells (n =
127 cells; bars represent mean ± SEM).
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Colgalt2 GFP (Figure 2.8B). In Gprin3 brains, 48% of pons-CTB+ cells across both
sublayers were Gprin3 GFP positive. When only the ventral half of L5b, or LL5b, is
assessed for co-localization, we found that 77% of pons-CTB+ cells co-localize with
Gprin3 GFP. Additionally, ~20% of pons-CTB+ cells in UL5b co-localize with Gprin3
GFP, due to the small proportion of Gprin3 cells that occupy this sublayer. Together,
these data indicate that Colgalt2 and Gprin3 neurons account for a very large majority
(~85%) of pons-projecting cells of M1 L5b.
To assess spinal cord-projection identity for Colgalt2 and Gprin3 cells, we injected
CTB into cervical spinal cord at the level of C6 (Figure 2.6A-B, right panels) and
visualized retrogradely labeled cells in M1 by confocal microscopy (Figure 2.7A-B, right
panels). C6-CTB+ cell distributions varied by injection site, but were primarily observed
in M1 between 1.00 mm and -0.40 mm from Bregma. C6-CTB+ cells were primarily
located at ~70% depth from pia, in what appeared to be LL5b, and at a similar depth to
Gprin3 (Figure 2.8A). In Gprin3, 82% of C6-CTB+ cells were positive for Gprin3 GFP,
while in Colgalt2 brains, GFP co-localization was only observed for 9% of C6-CTB+
cells (Figure 2.8B). This suggests that in addition to a projection to the pons, the
majority of Gprin3 neurons have a collateral projection to the cervical spinal cord.
Colgalt2 cells, in contrast, project to the pons, but not to the spinal cord. These findings
confirm that UL5b and LL5b cells have divergent collateral projection patterns, and
further establish the Colgalt2 and Gprin3 mouse lines as useful for the reliable
visualization of divergent long-range projection L5b neuron types.
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2.5 Gprin3 cells project to spinal motor neurons through an intermediate
population of neurons in the central spinal cord.
Projections to the spinal cord from the cortex terminate in different functionally
organized regions of the spinal grey matter (see Watson et al., 2008). We therefore
wanted to determine the anatomical localization of axon terminals originating from the
LL5b cells that are represented by our Gprin3 cells. To accomplish this, we injected an
rAAV2 carrying a Cre-dependent EYFP construct into M1 of Gng7-Cre KH67 mice,
which express Cre in all L5b cells of the cortex (Figure 2.9A). We collected the cervical
spinal cord of these mice for sectioning, and visualized the EYFP-labeled terminals of
the L5b cells by immunostaining and confocal microscopy. We observed labeled
terminals in an intermediate region of the spinal grey matter, concentrated in lamina 5,
6, and 7 (Figure 2.9B). Only 1.64% of the ventral horn area occupied by ChAT+ alpha
motor neurons showed EYFP signal (Figure 2.9C-D), suggesting that LL5b cells do not
directly project onto these motor output cells. This intermediate corticospinal projection
pattern that we observe additionally confirms previously reported anatomical results
(Bourane et al., 2015; Hantman and Jessell, 2010; Ueno et al., 2018), where cortical
L5b cells were shown to project to interneuron populations within this central region of
the spinal cord.
The cervical spinal cord contains neurons that function in the control of muscles of
the neck, shoulders, and forelimbs (see Bachmann et al., 2014). But given that the
axons of LL5b cells do not terminate directly on alpha motor neurons, we wanted to
determine whether their projection still participates in spinomuscular circuitry indirectly.
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Figure 2.9: Anterograde labeling of LL5b cells in M1 reveals projections to
intermediate regions of spinal grey matter. (A) Schematic illustration of
Cre-dependent viral construct targeting to cortex in Gng7-Cre animal, with expected
labeling of EYFP-expressing cells and their primary axons. (B) Representative confocal
image of labeling observed in cervical spinal cord following Cre-dependent EYFP
injection into M1. Corresponding map of spinal grey anatomy shown on the right. EYFP
axons (green) show axon terminals of LL5b cells expressing the viral construct at the M1
injection site. ChAT+ cells (red) show the location of spinomuscular alpha motor neurons
in the ventral horn. EYFP+ terminals are primarily apparent in the intermediate lamina 5,
6, and 7, and are not visible in the ventral horn (scale bar = 300 µm). (C) Representation
of strategy for measuring density of labeled terminals in different anatomical areas of the
spinal grey matter. White outlines show examples of region-of-interest boundaries used
for measurement. Location of ChAT signal (red) was used to determine boundaries of
ventral horn areas, while intermediate laminar areas were selected at random from
regions showing EYFP signal (green; scale bar = 250 µm). (D) Quantification of percent
of region-of-interest areas that showed EYFP terminal labeling after thresholding EYFP
signal channel. 25% of intermediate laminar areas were occupied by EYFP+ terminals.
2% of ventral horn areas were occupied by EYFP+ terminals (****p < 0.0001 by two-tailed
t-test; bars represent mean ± SEM).
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We employed a trans-synaptic retrograde pseudorabies (PRV) viral tracing strategy to
accomplish this. When injected into a target site, PRV enters the cell at the pre-synaptic
terminal, and is retrogradely transported to the cell body of this primary neuron. The
virus is then passed upstream across dendritic synapses, labeling any cells that project
to the primary cell. This trans-synaptic transfer continues until the animal is sacrificed,
labeling any cells that eventually innervate the primary neuron through indirect
projections. We injected PRV293.mCherry into the upper forelimb muscles (bicep,
tricep, trapezius, deltoid) of Colgalt2 and Gprin3 mice to determine if these cells
indirectly participate in spinomuscular circuitry (Figure 2.10A). We then visualized
mCherry reporter expression in cells after 5 days (Figure 2.10B). Consistent with our
retrograde CTB injections, Colgalt2 GFP was found in 19% of forelimb-mCherry+ cells,
suggesting they do not significantly contribute to forelimb spinomuscular output (Figure
2.10C). Surprisingly, while we observed many forelimb-mCherry+ cells adjacent to our
Gprin3 neurons, only 30% of forelimb-mCherry+ cells co-localized with Gprin3, whereas
CTB injections into C6 of the spinal cord showed an 80% overlap with Gprin3 cells.
Together, these data indicate that while Gprin3 cells project to the spinal cord, they do
not appear to substantially participate in forelimb control circuitry. In addition to forelimb
alpha motor neuron pools, however, the cervical spinal cord contains motor neurons
that control dorsomedial shoulder and neck muscles. It is therefore possible that the
Gprin3 cell projections to cervical spinal cord instead participate in the control of these
more anteromedial muscle groups, although more tracing experiments must be carried
out to address this question.
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Figure 2.10: PRV tracing reveals that neither Colgalt2 nor Gprin3 cells participate
in proximal forelimb muscle control circuitry. (A) Schematic illustration showing PRV
expression and labeling paradigm with expected mCherry (red) expression pattern. After
injection into forelimb muscles, PRV is retrogradely transported to cell bodies of
innervating alpha motor neurons in the ventral horn. The virus is trans-synaptically
passed retrogradely until it reaches cortical L5b cells that terminate in the spinal grey
matter. (B) Representative confocal images following immunostaining for Colgalt2 (top)
and Gprin3 (bottom) GFP (green), and mCherry expressed by PRV (red). mCherry+ cells
appear below UL5b Colgalt2 cells and amongst LL5b Gprin3 cells. (C) Quantification for
co-localization of mCherry with Colgalt2 GFP (purple) and Gprin3 GFP (green), reported
as a percentage of all mCherry+ cells observed. 19% of mCherry+ cells co-localized with
Colgalt2 GFP (n = 124 cells). 30% of mCherry+ cells co-localized with Gprin3 GFP (n =
206 cells). This suggests that neither cell type greatly participates in forelimb muscle
control circuitry (n.s. = not significant by two-tailed t-test; bars show mean ± SEM).
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2.6 Colgalt2 and Gprin3 neurons represent two molecularly related, but
nevertheless distinct, populations of L5b pyramidal neurons.
Because Colgalt2 and Gprin3 cells have historically been very difficult to
distinguish from each other anatomically as well as molecularly, we wanted to
determine if their similarity is reflected at the level of mRNA by comparing the gene
expression profiles of Colgalt2 and Gprin3 cells to other cell types in the cortex. For this,
we took advantage of the controlled expression of the EGFP-L10a ribosomal subunit in
our two mouse lines to perform TRAP, a technique that provides access to cell typespecific mRNAs via immunoprecipitation (IP) of the tagged ribosomal subunit (Doyle et
al., 2008; Heiman et al., 2008). Ribosome bound mRNA molecules from Colgalt2 and
Gprin3 cells were IP’ed from whole cortex homogenates and polysome-bound mRNAs
were analyzed by high throughput RNA sequencing. We determined the success of the
isolation by confirming that known pyramidal neuron marker genes were enriched and
glial genes were depleted in each dataset. We then set out to determine how similar
Colgalt2 and Gprin3 mRNA expression patterns are relative to other cell types in the
brain. By PCA, these cells cluster closely together, along with L6a cells (Figure 2.11A).
In contrast, Colgalt2 and Gprin3 cells cluster away from striatal neurons, L4 neurons in
the cortex, and samples from the S100a10 mouse line that expresses in L5a neurons
and endothelial cells. Next, we assessed Euclidean distance between these cell types
by measuring the distances between samples in the whole transcriptome-dimensional
normalized counts space. Hierarchical clustering of these distances revealed that
Colgalt2 and Gprin3 cells, as well as deep L6a neurons, exist closer together in this
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Figure 2.11: Colgalt2 and Gprin3 cells have gene expression profiles that suggest
that, among other neuronal populations, they are closely related. (A) Principal
component analysis (PCA) showing relative positioning of different TRAP sample
replicates along the first two principal components. (B) Heatmap showing hierarchically
clustered Euclidean distances between TRAP replicate samples for different cell types.
Each row/column represents one replicate sample. Bold black box shows deep layer
cortical cells, including UL5b Colgalt2 cells and LL5b Gprin3 cells, which cluster together
and show relatively short distances between each other, suggesting they are more
related to each other than to other neuronal cell types (C) Heatmap of Pearson correlation
values between TRAP replicate samples for different cell types. Each row/column
represents one replicate sample. Bold black box highlights the deep layer populations of
UL5b Colgalt2 cells, LL5b Gprin3 cells, and L6a Ntsr1 cells, which all correlate highly,
suggesting that they show similar patterns of gene expression (magenta = S100a10 L5a
IP samples, purple = Colgalt2 UL5b IP samples, orange = Ntsr1 L6a IP samples, green =
Gprin3 LL5b IP samples, grey = whole cortex input samples, yellow = Cdh6 L4 IP
samples, cyan = Drd1 striatal IP samples, blue = Drd2 striatal IP samples).
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space than they do to other cell types (Figure 2.11B). Pearson correlation of normalized
gene expression counts similarly showed that deep layer neurons are highly correlated
with each other (Figure 2.11C). Together, these results confirm that in the context of the
whole transcriptome, UL5b Colgalt2 and LL5b Gprin3 cells are more similar to each
other than to other cell types in the cortex and subcortex.
Next, we performed differential expression (DE) analysis between Colgalt2 and
whole cortex input, and between Gprin3 and cortex input to determine whether known
L5b marker genes are enriched in these cells relative to whole cortex (Figure 2.12A-B).
We generated a list of marker genes for glutamatergic L5b neurons using the DE tool
available for cortical single cell RNA-Seq data available through the Allen Brain Atlas
(http://celltypes.brain-map.org/rnaseq/mouse).

Both

Colglat2

and

Gprin3

cells

expressed marker genes for L5b pyramidal tract neurons at high levels relative to whole
cortical input samples (Figure 2.12C). Together, these data confirm that our Colgalt2
and Gprin3 datasets reveal a potentially fundamental molecular identity for these cells,
namely that of L5b pyramidal neurons. To determine what genes instead define the
molecular differences between Colgalt2 and Gprin3 cells, we performed DE analysis
directly between Colgalt2 and Gprin3 cells (Figure 2.13A). Genes that showed
significant (adjusted p-value < 0.05) enrichment in either cell type and with a mean
Log10 counts per million (CPM) expression value greater than 3 across Colgalt2 and
Gprin3 were run through gene ontology (GO) analysis to determine what pathways,
classes, or groups of genes were enriched between the two cell types. GO categories
returned from these analyses revealed that several genes enriched in Colgalt2 cells are
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Figure 2.12: Colgalt2 and Gprin3 cells are related in part by their expression of
known L5b genes. (A-B) MA Plot showing average Log10 counts per million (cpm) value
and Log2 fold enrichment in IP over cortical input from differential expression (DE)
analysis. Genes that showed significant enrichment (adjusted p < 0.05 and Log2 fold
enrichment < -1 or > 1) in either IP or cortex are shown in pink. All other genes shown in
grey. Genes that were highly expressed (Log10 cpm > 3) and significantly enriched in IP
samples are shown in purple for Colgalt2 cells (A) and green for Gprin3 cells (B). These
genes were considered to be highly expressed in their respective cell type. (C) Heatmap
showing Log2 fold enrichment over cortical input for Allen Brain Atlas L5b marker genes
in Colgalt2 and Gprin3 cells. Glial gene enrichment shown as a control. Sidebars show
whether the gene represented in that row was significantly enriched (pink) or not
significantly different (grey; n.s. = not significant). Both Colgalt2 and Gprin3 cells appear
to highly express many of the known L5b marker genes, further confirming their laminar
identity through their gene expression profile.
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Figure 2.13: Differential expression between Colgalt2 and Gprin3 cells reveals
molecular differences between UL5b and LL5b cell types. (A) MA Plot showing
average Log10 counts per million (cpm) value and Log2 fold enrichment in IP over cortical
input from differential expression (DE) analysis. Genes that showed significant
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are shown in pink. All other genes shown in grey. Genes that were highly expressed
(Log10 cpm > 3) and significantly enriched in IP samples are shown in purple for Colgalt2
cells and green for Gprin3 cells. (B) Genes highlighted as highly enriched in Colgalt2 or
Gprin3 cells were assayed for gene ontology (GO) enrichment. Classes of genes that
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Classes of genes enriched in Gprin3 cells (green bars) contain mitochondrial pathways
(bars represent Log10 p-values for enrichment of each cateogory).
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involved in maintaining neuronal structure and function (Figure 2.13B, left panel). In
Gprin3 cells, many mitochondrial genes, particularly Oxphos-associated genes, showed
enrichment over Colgalt2 (Figure 2.13B, right panel). While all of these data together
confirm that UL5b Colgalt2 and LL5b Gprin3 cells share a basic molecular L5b identity,
further highlighting the utility of transgenic lines that can distinguish between these cell
types, our sequencing data also provide us with the ability to identify potentially
important functional differences between the two cell types.

2.7 Discussion
Here, we present two transgenic lines that target expression of the EGFP-L10a
TRAP construct to distinct populations of L5b cells in M1. We found that Colgalt2-TRAP
DU9 cells are found all across the cortex, and are restricted to an upper sublayer, UL5b
(Figure 2.14, left panel). Gprin3-TRAP ES152 cells are instead found primarily in rostral
areas of the cortex, mostly restricted to LL5b of ALM and M1. While in M1, the
distribution of Colgalt2 and Gprin3 cells is clearly divided into UL5b and LL5b, while in
other areas of cortex, Colgalt2 and Gprin3 cells converge in the same layer. While the
thickness of each of the 6 cortical layers often varies across the different functional
regions of cortex, this subdivision of L5b appears to be unique to the motor region of
cortex. The laminar distribution of L5b is likely programmed during cortical patterning in
late pre-natal development. Because deep layers of the cortex are established first
during cortical neuron migration in laminar development (Rakic, 1974), the differential
intersections of expression gradients for cortical patterning factors such as Fgf8
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Figure 2.14: Summary of UL5b and LL5b anatomical divergence. We show that L5b
in mouse M1 is subdivded into two discrete sublayers, upper L5b (UL5b) and lower L5b
(LL5b) containing molecularly distinct populations of cells (left panel). We additionally
show that cells found in UL5b (purple) only project to the pons, while LL5b cells (green)
project to both the pons and the intermediate regions of the cervical spinal cord (right
panel).
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(Fukuchi-Shimogori and Grove, 2001; Garel et al., 2003) and Emx2 (Bishop et al., 2002;
Hamasaki et al., 2004) may influence the timing and duration of L5b cell migration and
differentiation. These timing differences could establish different thicknesses of L5b
throughout the cortex, with more anteromedial regions such as M1 and ALM developing
a thicker L5b than other cortical areas. Additionally, these gradients may help determine
the medial-lateral and anterior-posterior extents of Colgalt2 and Gprin3 cell identity.
Once positioned in the cortex, L5b pyramidal neurons begin to send projections to
various long-range target regions. Here we show that UL5b Colgalt2 cells and LL5b
Gprin3 cells diverge in long-range projection patterns. While Colgalt2 cells have
pyramidal tract (PT) collaterals that terminate in the pons but not the spinal cord, Gprin3
cells send PT axon collaterals to both the pons and spinal cord (Figure 2.14, right
panel). For L5b cells, subcortical vs. intratelencephalic (IT, or cortico-cortical) projection
is the first hierarchy of projection identity that must be determined. Expression of Fezf2
and Ctip2 (Chen et al., 2008), and absence of Satb2 (Alcamo et al., 2008) are
necessary and sufficient to specify that a L5b axon should be directed subcortically.
Once out of the cortex, the unique sets of transcription factors found in each cell type
influence the expression of axon guidance receptors that specifically respond to
attractive and repulsive cues, establishing correct collateral targeting for each neuron
class (for review, see Lodato et al., 2015). The distinct subcortical projection pattern that
we observe for M1 L5b cells suggests that Colgalt2 and Gprin3 cells express different
genes during axon guidance that are responsible for differentiating their projection to the
spinal cord and other areas. In fact, developmental evidence suggests that both UL5b
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and LL5b cells develop a collateral to the spinal cord during post-natal axon outgrowth,
but the collateral axon is lost for UL5b cells (Wang et al., 2017). When Lmo4 is
conditionally knocked out from Emx1+ neurons during development, M1 L5b sublayer
lamination is correctly established, but UL5b cells instead maintain the collateral to the
spinal cord into adulthood (Cederquist et al., 2013). It would therefore be interesting to
determine if in an Lmo4 conditional knock-out mouse, Colgalt2 cells would show a
spinal collateral in adulthood, allowing us to probe the molecular origin of PT neuron
projection divergence. Additionally, expression of the TRAP construct in this context
may help to uncover the downstream receptors responsible for generating such precise
axonal targeting during L5b projection patterning.
Establishing appropriate connectivity during development is critical to the proper
functioning of many cortical circuits. For L5b cells, the targeting of neuronal signaling to
precise areas over long distances is even more important, as they represent an
important output layer of the cortex. L5b cells of M1 participate in motor planning,
learning, and execution via these projections (Gu et al., 2017b; Guo et al., 2015; Kawai
et al., 2015; Lashley, 1942; Suter et al., 2013). In the latter case, projections to the
spinal cord communicate the information necessary for alpha motor neurons to direct
the contraction of appropriate muscle groups. Our data reveal, however, that Gprin3
axons do not project directly onto alpha motor neurons of the cervical spinal cord, but
instead terminate in an intermediate spinal grey area around lamina 5, 6, and 7.
Together with the results from our trans-synaptic retrograde PRV tracing from forelimb
muscles, these data additionally reveal that Gprin3 cells do not heavily participate in the
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control of forelimb muscles through this projection. Motor neurons that control other
more anterior muscle groups in the body are also found in the cervical spinal cord, and
using more trans-synaptic tracing targeted to these areas, we will be able to address
whether Gprin3 cells instead participate in the control of these muscle groups.
In primates, the motor cortex is important for the execution of voluntary
movement (Evarts, 1968; Lee and Tatton, 1975; Thach, 1978), and the sophisticated
repertoire of dexterous movements that are displayed by non-human primates, apes,
and humans benefit from the direct projection of a subpopulation of L5b cells, namely
corticomotoneurons, onto alpha motor neurons in the spinal cord (Iwatsubo et al.,
1990). Conversely, the relative simplicity of movement patterns seen in lower mammals
likely explains the lack of direct projections from M1 LL5b cells onto spinal motor
neurons, although this is not fully understood (see Gu et al., 2017b). To address the
functional contribution of LL5b Gprin3 cells to motor output in the mouse, we must first
carefully delineate the muscle groups that receive indirect input from these cells.
Additionally, specifically ablating Gprin3 cells, using either virally-delivered toxins or
optogenetic silencing, can allow us to observe the behavioral consequence to these
muscle groups during motor output, and begin to uncover a potential functional
relationship between corticospinal neurons in the mouse and the ones found in
primates.
The functional properties of distinct neuron types are influenced by the
differential expression of channels, receptors, and other signaling components, both
during development and in adulthood. The molecular diversity of L5b cells was recently
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shown to be greater than originally known (Economo et al., 2018; Tasic et al., 2018).
Here, we show that Colgalt2 and Gprin3 cell gene expression patterns suggest they are
closely related, and that genes associated with establishing/maintaining L5b excitatory
pyramidal neuron identity likely drive this similarity. However, Colgalt2 and Gprin3 cells
show differences in gene expression that may contribute to differences in function. For
instance, mitochondrial genes appear to be enriched in our Gprin3 population, perhaps
because of the extra lengths of dendrites and axon that have to be energetically
maintained in these cells. It would be interesting to see how the Lmo4 cKO that causes
UL5b cells to develop an axonal projection to the spinal cord affects the expression
level of these genes, and to determine what physiological differences in ATP-synthesis
already exist between Colgalt2 and Gprin3 cells.
Overall, we show that Colgalt2 and Gprin3 cells diverge in both laminar
distribution and projection identity, with both cell types displaying different distributions
across whole cortex. We confirm that UL5b Colgalt2 cells in M1 project to the pons, and
that M1 LL5b Gprin3 cells innervate both the pons and the spinal cord. The spinal
collaterals displayed by these anterior Gprin3 cells terminate on an intermediate
population of neurons rather than on alpha motor neurons directly, and these terminals
do not appear to participate in upper forelimb muscle control circuits, instead potentially
influencing the control of anteromedial muscles, such as neck and shoulder, indirectly.
Finally, Colgalt2 and Gprin3 cells show gene expression patterns that suggest that while
these cells are very similar to each other, they show key differences that may
corroborate their anatomical and functional uniqueness.
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CHAPTER 3:
Generating tractable models for studying cell-type vulnerability and resistance in
the primary motor cortex of SOD1-G93A mice.

Amyotrophic Lateral Sclerosis (ALS) is a fatal motor neuron disease that is
clinically and pathologically defined by the loss of lower motor neurons (LMNs) of the
spinal cord and upper motor neurons (UMNs) of the cortex (Tandan and Bradley, 1985).
The cellular features that make these populations the most vulnerable to ALS-causing
mutations are not known, and the pathways that ultimately lead to death of these two
populations are likewise not entirely understood. To begin to uncover these
mechanisms, LMNs have been primarily targeted, as they are readily identifiable among
the diverse cell types of the spinal cord by their large size, unique morphology, and
ventral localization (Aitken and Bridger, 1961; Light and Metz, 1978). In fact, many of
the insights into disease pathology, mechanisms, and progression have thus far
originated from studies of LMNs for this reason (see Turner and Talbot, 2008). UMNs of
the primary motor cortex, by virtue of being localized among cells that are
morphologically very similar and share many of the same markers, have proven more
difficult to study with such rigor in the disease. To understand the full spectrum of cell
type-specific pathology, and if effective therapies are ever to be developed, It is
essential that the molecular responses of UMNs in disease be characterized in a
targeted manner.
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In mouse models of ALS that express human disease mutations in TDP-43
(Wegorzewska et al., 2009), FUS (Verbeeck et al., 2012), and SOD1 (Gurney et al.,
1994a), have begun to provide insights into cortical pathologies in ALS (Huang et al.,
2011; Jara et al., 2015; Ozdinler et al., 2011; Tsai et al., 2010). Some of the most
commonly used models leverage human mutants of Cu/Zn superoxide dismutase 1
(SOD1) to recapitulate the disease in mice (Turner and Talbot, 2008). SOD1 is an key
antioxidant enzyme that converts highly reactive superoxide, generated during
biological processes such as electron transport in oxidative phosphorylation (Oxphos)
and in the ER (Chance et al., 1979), into less reactive hydrogen peroxide (McCord and
Fridovich, 1969). The most studied mutation to SOD1 is a glycine-to-alanine missense
mutation at the 93rd amino acid position, G93A. It is unclear how the SOD1-G93A
mutation causes disease. At the structural level, the G93A mutation causes the Cu/Zn
binding regions of the protein appear to be more disordered, potentially encouraging
aggregation of the protein (Galaleldeen et al., 2009). At the enzymatic level, the activity
level of human SOD1-G93A appears to increase when expressed in mice (Gurney et al.,
1994a), but it is unclear whether this is true in patients with SOD1 mutations
(Robberecht

et

al.,

1994).

The

SOD1-G93A

transgenic

mouse

line,

Tg(SOD1*G93A)1Gur, that expresses ~25 copies of human mutant SOD1-G93A on
chromosome 12 and shows disease progression and progressive motor deficits that are
characteristic of human ALS (Chiu et al., 1995). More importantly, it has been shown
that in addition to spinal motor neurons, neurons in L5b of M1 appear to degenerate in
this model, with the spinal-projecting subpopulation of these cells appearing to be the
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most vulnerable (Kassa et al., 2009; Ozdinler et al., 2011; Spalloni et al., 2011; Zang
and Cheema, 2002). These cells additionally show early signs of disease in the form of
ER stress, dendritic atrophy, and changes in excitability (Fogarty et al., 2015; Jara et al.,
2015; 2012; Kim et al., 2017; Spalloni et al., 2011). But how mutant SOD1 disrupts
cellular function and leads to death of these neurons is largely not known. Likewise, it is
not understood how, even with ubiquitous expression of mutant SOD1, death is specific
to motor neurons. For this reason, having molecular access to the specifically
vulnerable population of UMNs would allow us to probe the causal changes that lead to
downstream pathophysiology, as well as the underlying properties that may be exploited
by the mutation to cause cell-type specific death.
The vulnerable population of cortical neurons has been shown to reside in L5b of
M1 across species (Eisen et al., 1992; Kassa et al., 2009; Mochizuki et al., 2011;
Ozdinler et al., 2011; Spalloni et al., 2011; Tandan and Bradley, 1985; Zang and
Cheema, 2002), but it has not been determined whether there is a sublayer specificity to
this vulnerability, i.e. whether the degenerating cells reside in UL5b, LL5b, or across all
of L5b. Our Colgalt2 and Gprin3-TRAP lines are therefore ideally suited to first
determine the sublayer specificity of ALS UMN vulnerability, and then to molecularly
profile the vulnerable cells during disease progression. We therefore set out to generate
mice that express our L5b-specific TRAP constructs in the SOD1-G93A mouse. By
visualizing Colgalt2 and Gprin3 cells during disease progression, we determined
whether they degenerate in this ALS model, laying the foundation for carrying out
assessments of cell type-specific gene expression changes in disease.
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3.1 Breeding SOD1-G93A mice to Colgalt2 and Gprin3-TRAP mice does not
disrupt disease progression.
In order to generate an ALS model that would provide us with molecular access to
L5b cells, we crossed the SOD1-G93A mouse to our Colgalt2-TRAP DU9 and Gprin3TRAP ES152 mice. To confirm that crossing these mice to SOD1-G93A does not impair
or alter disease progression, we evaluated the general behavior and symptom
development of SOD1-G93A mice expressing either Colgalt2-TRAP or Gprin3-TRAP.
Both Colgalt2 and Gprin3 mice crossed to SOD1-G93A showed no differences in
survival compared to uncrossed SOD1-G93A mice (Figure 3.1A). Median survival age
was approximately 160 days for all mice, consistent with published survival times for the
SOD1-G93A model (Gurney et al., 1994a). Classically, the SOD1-G93A mouse begins
showing signs of disease around post-natal day 60 (P60). Hindlimb tremors and rigidity
appear first, followed by hindlimb weakness that progresses rostrally toward the
forelimbs. These gross symptoms were observed at similar ages in our SOD1-G93A
mice crossed to our TRAP lines, suggesting that disease progression in our transgenic
mice was not affected. For a more quantitative assessment of disease progression, we
tested the performance of our crossed mice on an accelerating rotating rod (rotarod
test). Both Colgalt2 and Gprin3 mice crossed to SOD1-G93A showed progressively
shorter latencies to fall off the rotarod, with disease mice falling after ~100 seconds
(Figure 3.1B-C). These deficits are consistent with the disease progression observed in
the SOD1-G93A model that is not crossed to TRAP lines, with rotarod performance
deficits appearing around P90 (Oliván et al., 2015). Taken together, these data show
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Figure 3.1: Expression of EGFP-L10a in Colgalt2 and Gprin3 mice does not alter the
progression of disease in a SOD1-G93A context. (A) Survival curves showing the
lifespan of SOD1-G93A mice, both uncrossed, and when crossed to either
Colgalt2-TRAP DU9 or Gprin3-TRAP ES152 mice. Expression of the TRAP construct in
either Colgalt2 or Gprin3 mice has no effect on survival. SOD1-G93A median survival =
163 (n = 8), Colgalt2-TRAP::SOD1-G93A median survival = 158 (n = 7)
Gprin3-TRAP::SOD1-G93A median survival = 164 (n = 5). (B) Rotarod performance of
Colgalt2-TRAP mice, WT vs. SOD-crossed, measured as latency to fall in seconds.
Colgalt2 mice that express SOD1-G93A show a shorter latency to fall in later weeks
relative to WT littermates, suggesting they develop a motor deficit over disease
progression. Data presented as mean±SEM (WT group n = 4, SOD group n = 3). (C)
Rotarod performance of Gprin3-TRAP mice, WT vs. SOD-crossed, measured as latency
to fall in seconds. Gprin3 mice expressing SOD1-G93A also show a shorter latency to fall
in later weeks when compared to WT littermates, highlighting a progressive motor deficit
during disease. Data represented as mean±SEM (*p < 0.05, WT group n = 9, SOD group
n = 12).
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that the expression of the TRAP construct in the SOD1-G93A model, either under the
control of the Colgalt2 or the Gprin3 promoter, does not affect disease progression,
establishing these two lines as potentially useful for the characterization of cell type
vulnerability and molecular responses of L5b cells when SOD1-G93A is expressed.

3.2 Both Colgalt2 and Gprin3 mice show activated glial invasion when SOD1G93A is expressed.
In order to confirm that our TRAP-crossed SOD1-G93A mice show hallmark signs
of neurodegeneration in tissue, we first looked for signs of neuro-inflammation by
staining for the activated astrocyte marker GFAP. Invasion of activated glia has been
observed in ALS tissues, across spinal cord and cortex (Bruijn et al., 1997b; Jaarsma et
al., 2000; Kassa et al., 2009; Ozdinler et al., 2011). We therefore cervical spinal cord at
a symptomatic stage of disease (> P100) to confirm broad mutant SOD1-mediated
inflammation, and cortical tissue to visualize possible neuroinflammation around
Colgalt2 and Gprin3 cells. Coronal sections of cervical spinal cord and cortex were
made and immunostained for GFAP, as well as markers for cell types of interest: either
alpha motor neuron ChAT (spinal cord) or Colgalt2/Gprin3 GFP (cortex). Images of
immunostaining were collected by confocal microscopy. In the spinal cord sections at
this symptomatic stage, invasion of GFAP+ activated astrocytes can be readily seen
around ChAT+ alpha motor neurons of the ventral horn when SOD1-G93A is expressed
(Figure 3.2A). Staining for astrocytosis in the cortex revealed the presence of activated
astrocytes in M1 of both Colgalt2 and Gprin3 mice when SOD1-G93A was expressed
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Figure 3.2: GFAP-positive astrocytes invade L5b in Colgalt2 and Gprin3 mice that
express SOD1-G93A. (A) Confocal images of WT and SOD1-G93A ventral horn of
cervical spinal cord at the level of C6 at symptomatic age, stained for ChAT (green) to
label alpha motor neurons and GFAP (red) to visualize activated astrocytes. In
SOD1-G93A, GFAP signal is observed in this area, but ChAT+ neurons disappear as they
degenerate (scale bar = 100µm). (B) Representative confocal images of Colgalt2 and
Gprin3 cortex, WT vs. SOD1-G93A symptomatic age, cropped to highlight depth of
labeled cell populations. Colgalt2 and Gprin3 cells labeled with GFP (green), and
activated astrocytes labeled with GFAP (red). Activated astrocytes can be seen in L5
around GFP+ cells in SOD1-G93A (scale bar = 100 µm). (C) Quantification of
activated-astrocyte depth in WT and SOD TRAP cortex represented as a frequency
distribution for percent depth from the pial surface. In SOD cortex, the presence of
activated astrocytes in L5 appears to increase dramatically (WT group n = 3 animals, 86
cells. SOD group n = 3 animals, 130 cells).
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(Figure 3.2B). The GFAP+ signal varied in depth, but was largely observed in L5,
around the GFP+ TRAP cells (mean depth of GFAP+ cells at 54% from pia, Figure
3.2C). These data confirm that our Colgalt2 and Gprin3 transgenic mice develop one
classic sign of neurodegeneration around our cells of interest, further establishing M1 as
an important region to anatomically and molecularly characterize during disease
progression.

3.3 Gprin3 cells are vulnerable to degeneration in SOD1-G93A, while Colgalt2
neurons are resistant.
Since L5b cells of M1 with long-range subcortical projections appear to be the
most vulnerable in SOD1-G93A mice (Ozdinler et al., 2011; Zang and Cheema, 2002),
and because UL5b Colgalt2 and LL5b Gprin3 cells both have long-range projections to
the pons and, in the case of Gprin3 neurons, to the spinal cord, we set out to determine
if either or both Colgalt2 and Gprin3 cells show vulnerability when SOD1-G93A is
expressed. In order to determine direct vulnerability of Colgalt2 and Gprin3 cells to
SOD1-G93A, we collected coronal brain sections from pre-symptom onset (Pre, ~P70)
stage and post-symptom onset/symptomatic (Post, ~P110) stage of disease, and
counted the number of GFP+ cells in 20X fields of view (FOVs, Figure 3.3). Notably,
Colgalt2 cells along the extent of M1 did not show a difference in number in mice
expressing SOD1-G93A (Figure 3.4A). Gprin3 neurons, in contrast, showed a
significant decrease in number of around 23% at symptomatic stage (Post) across all of
M1. When cell counts were instead assessed for individual anatomical positions along
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Figure 3.3: GFP staining reveals loss of Gprin3 cells in SOD1-G93A mice, but no
loss of Colgalt2 cells. Representative confocal images from Colgalt2 and Gprin3 M1, in
WT and SOD1-G93A showing 20X field-of-view that was used to assess density of GFP+
cells. Colgalt2 and Gprin3 cells were visualized by GFP staining (green). Images are
shown for pre-symptomatic age (“Pre”) WT, Pre SOD1, and post-symptom onset age
(“Post”) SOD1. A decreased density of GFP+ cells can be seen in symptomatic age
Gprin3 M1 when SOD1-G93A is expressed (scale bars = 100 µm).
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Figure 3.4: Gprin3 cells are lost in SOD1-G93A mice, but Colgalt2 cells remain. (A)
GFP+ cells per 20X field in Pre and Post age Colgalt2 M1 (upper panel) and Gprin3 M1
(lower panel) between WT and SOD1-G93A, averaged across full AP extent of M1, and
reported as percent of corresponding WT mean. No change in Colgalt2 cell number is
observed at any stage of disease, whereas Gprin3 cells show a 23% decrease at
symptomatic stage (*p < 0.05; bars show mean±SEM, Colgalt2 WT Pre n = 6, SOD Pre n
= 7; Colgalt2 WT Post n = 4, SOD Post n = 5; Gprin3 WT Pre n = 8, SOD Pre n = 4; Gprin3
WT Post n = 7, SOD Post n = 5). (B) GFP+ cells per 20X field in Pre and Post age
Colglat2 M1 (upper plots) and Gprin3 M1 (lower plots), averaged per anatomical position
along the AP axis of M1, and reported as percent of corresponding WT mean. Again,
Colgalt2 cells show no change in number during disease progression, but Gprin3 cells
show a decrease in posterior areas of M1 of ~55% (bars show mean±SEM, Colgalt2 WT
Pre n = 5, SOD Pre n = 8; Colgalt2 WT Post n = 7, SOD Post n = 5; Gprin3 WT Pre n =
8, SOD Pre n = 5; Gprin3 WT Post n = 7, SOD Post n = 5).
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the anterior-posterior axis of M1, we observed a greater, although non-significant, loss
of Gprin3 cells (up to 55% decrease) at more posterior M1 coordinates, revealing a
potential posterior-to-anterior axis for progressive loss of cells (Figure 3.4B). We did not
observe a loss of Colgalt2 cells at any coordinate along this AP extent. This loss of
Gprin3 neurons but not Colgalt2 neurons in the presence of SOD1-G93A confirms that
spinal-projecting neurons of M1 L5b are the most vulnerable cortical population in this
model. The greatest loss of Gprin3 cells was observed in more posterior regions of M1,
suggesting that even within this cell type, there may be differential vulnerability to
SOD1-G93A. The data also broadly implicate an intrinsic molecular difference between
Colgalt2 and Gprin3 cells as potentially underlying the distinct sensitivity to mutant
SOD1 observed between the two cell types.

3.4 Discussion
Cells of L5b in rodent M1 have been shown to be vulnerable in the SOD1-G93A
mouse model (Ozdinler et al., 2011; Thomsen et al., 2014; Zang and Cheema, 2002).
Using molecular marker staining and retrograde tracing from subcortical regions, a
temporally progressive loss of L5b neurons is observed throughout disease. Here, we
show that the vulnerability of neurons observed for L5b is specific to LL5b where Gprin3
cells are found, with UL5b Colgalt2 neurons showing resistance to degeneration in
SOD1-G93A mice (Figure 3.5). These findings confirm that corticospinal neurons of
LL5b are likely the most vulnerable to SOD1-G93A insult. And by contrast, cells that
have long-range projections to more proximal regions, such as the thalamus and pons,
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Figure 3.5: Summary of cell type-specific loss observed in L5b in SOD1-G93A mice.
The We show that in SOD1-G93A mice, UL5b Colgalt2 cells (purple) do not degenerate,
while LL5b Gprin3 cells (green) decrease in number. Invasion of activated astrocytes is
also observed in L5b of these mice (red).
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show no obvious vulnerability to degeneration. The relationship between projection
identity and disease vulnerability is still a very open question, however. And given the
differences in motor circuit participation for UL5b and LL5b cells, it is not understood
how loss of LL5b neurons in the ALS models affects the function of motor circuitry in
these animals. ALS-associated motor dysfunction in the SOD1-G93A model begins in
hindlimb regions and progresses in a posterior-to-anterior manner as the animal ages,
eventually affecting forelimb, shoulder and neck muscle groups (Gurney et al., 1994a).
Because Gprin3 cells are found in areas that functionally map to control of anterior
muscle groups (see Chapter 2), it is possible that these cells are the last to be affected
during disease progression. This could explain why we observe a posterior-to-anterior
gradient of Gprin3 cell loss, as cells that map to more posterior muscle groups would be
lost first. In this scenario, however, it would be unlikely that loss of Gprin3 has any
obvious outward consequence to gross motor output. Instead, it is possible that loss of
Gprin3 cells affects the more subtle aspects of motor control, namely preparation,
learning, and execution of dexterous movement (Chen et al., 2017; Guo et al., 2015;
Kawai et al., 2015; Ueno et al., 2018). Unfortunately, none of the behavioral tests that
we carried out in this study fully parse the cortical contribution to motor control from the
spinal contribution, and therefore do not address these possibilities. It would be
interesting to determine whether there is a progressive change in the ability of the mice
to carry out tasks that are specifically shown to depend on M1 input. It would
additionally be interesting to specifically drive loss of cortical motor neurons via toxin or
Cre-dependent ablation, to more carefully assay what effect, if any, loss of the cortical
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component of the motor circuit, particularly for anterior muscle groups, has on functional
motor output.
It is not understood what mechanisms cause the loss of motor neurons in the
spinal cord and cortex: two cell types that are distinct in regional localization,
morphology, and molecular identity, but that nevertheless share a functional connection.
Theories about a prion-like spread of disease between these two cell types have left
many open questions (see Braak et al., 2013a; Münch et al., 2011; Polymenidou and
Cleveland, 2011). Some experiments have been done to address a “dying-forward”
hypothesis, where corticospinal neuron dysfunction promotes disease in the
downstream alpha motor neurons of the spinal cord (Eisen et al., 1992). For instance,
when mutant SOD1-G93A is knocked down in the cortex of ALS model rats, the
degeneration of both upper and lower motor neurons is slowed (Thomsen et al., 2014).
This suggests that the degeneration of lower motor neurons is at least tied to, and at
most caused by, the degeneration of the upper motor neurons. In rodents, the
innervation of UMNs onto LMNs is, as discussed previously, not direct and has an
intermediate interneuron populations in between (Bourane et al., 2015; Hantman and
Jessell, 2010; Ueno et al., 2018). How this interneuron population responds to disease
in the context of dying-forward from the cortex is not known, but is key to understanding
the mechanism by which disease is “transmitted” downstream. In humans, a direct
projection between a subset of corticospinal neurons and alpha motor neurons spinal
cord provides a better foundation for a direct propagation of disease between upper and
lower motor neurons. For instance, hyperexcitability observed in motor cortex could
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drive stress in alpha motor neurons, which may promote death of the cells (Menon et al.,
2015; Vucic and Kiernan, 2006; Vucic et al., 2008). For these reasons, carefully
assessing the point of origin of disease using cell-type specific ablations or more
targeted expression of SOD1-G93A becomes important for understanding how this
disease is able to affect two distinct cell types. Additionally, mechanisms of disease
propagation would make very good targets for therapeutic intervention for halting or
slowing of progression, as long as these molecular mechanisms can be said to reflect
human disease pathology.
For any study that attempts to uncover innate biological properties of neurons using
transgenic mouse lines, it is important to discuss the limitations in interpreting the
findings. As a model for ALS, the SOD1-G93A mouse shows the loss of upper and
lower motor neurons (UMNs and LMNs) that exemplifies the human disease. However
there are some who question the representative capacity of the SOD1-G93A mouse for
human ALS (Turner et al., 2013). This primarily derives from an inability to translate
treatments that successfully slow disease progression in the mouse model into human
patients (Benatar, 2007). Additionally, SOD1 models do not recapitulate all cellular
pathologies observed in human patients, such as TDP-43 inclusions (Robertson et al.,
2007). And while this may be explained in part by the fact that the model overexpresses
mutant SOD1 at extremely high levels, it is possible that any changes that we observe
in our SOD1-G93A experiments are not representative of changes that occur in human
UMNs in ALS. This uncertainty cannot be resolved until a validation of mechanisms
observed in this mouse model is undertaken in human tissues in the future. However, it
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is important to remember, that while the pathological mechanisms that lead to cell death
may not be similar in ALS across species, the selective vulnerability of motor neurons is
still observed in the SOD1-G93A mouse. The model therefore still provides an important
and useful platform for studying motor neuron-specific vulnerability to certain genetic
perturbations, and its associated molecular changes across cell types.
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CHAPTER 4:
Molecular responses to SOD1-G93A observed by TRAP in Colgalt2 and Gprin3
neurons.

Studies into molecular mechanisms of neurodegeneration focus primarily on
understanding what pathways lead to cell-specific dysfunction and death. In particular,
the goal is to understand how ubiquitously expressed mutations leverage unique cell
type features during disease progression. In ALS, it is not known how expression of
mutant SOD1 in the whole CNS causes specific death of UMNs in the cortex and LMNs
in the spinal cord. A first step in understanding this phenomenon is characterizing the
molecular changes that occur in these cells during disease. Neuronal dysfunction
phenotypes, such as hyperexcitability and dendritic atrophy in UMNs, are now being
uncovered in models of ALS (Fogarty et al., 2015; Genç et al., 2017; Jara et al., 2015;
Kim et al., 2017; Ozdinler et al., 2011; Saba et al., 2015; Wegorzewska et al., 2009).
Using a variety of sequencing approaches, the field has also begun to understand how
gene expression changes that occur during disease progression may contribute to the
phenotypes that precede cell death in the mutant SOD1 context (Bandyopadhyay et al.,
2013; de Oliveira et al., 2013; 2014; Malaspina et al., 2001; Saxena et al., 2009; Sun et
al., 2015). These studies have shown that underlying the gross neuronal changes are
early signs of ER stress, unfolded protein response, and mitochondrial dysfunction. But
because it is not trivial to isolate specific neuron populations from each other in this
model (although see Saxena et al., 2009), it has been difficult to determine whether
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these changes occur specifically in the vulnerable population or in the assayed tissues
as a whole. Developing successful treatments or therapies for ALS will require us to
determine the disease phenotypes that are specific to motor neurons over other cell
types, and by contrast, the molecular coping mechanisms of cell types that are resistant
to degeneration.
Despite being molecularly similar to disease-vulnerable LL5b Gprin3 (Chapter 2),
our UL5b Colgalt2 cells did not appear to degenerate in the SOD1-G93A model
(Chapter 3). From a disease mechanism standpoint, this presents a unique opportunity
to study what specific disease-triggered gene expression changes in Gprin3 cells may
lead to their selective degeneration. And more importantly, having molecular access to
Colgalt2 gene expression allows us to interrogate potential coping strategies for
surviving mutant SOD1 expression. Understanding these changes could then lead us to
probe how the underlying intrinsic differences between these two cell types may
contribute to their respective molecular responses, and inevitably cause specific
vulnerability of one population over the other.
We therefore set out to determine what gene expression changes occur in
Colgalt2 and Gprin3 during disease progression by performing TRAP at two different
time points in SOD1-G93A animals. An early pre-symptomatic time point was assayed
in order to reveal potential early regulatory mechanisms of later stage dysfunction. A
symptomatic time point was collected to determine how late disease mechanisms may
lead to death of LL5b Gprin3 cells, and survival of UL5b Colgalt2 cells. We then
attempted to compare the findings from these disease datasets to results from our
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original comparison of intrisinic cell type differences in an effort to understand how the
disease-sensitive mechanisms differ between the two cell types to begin with.

4.1 Isolating mRNA from Colgalt2 and Gprin3 cells expressing SOD1-G93A.
When Colgalt2 and Gprin3 mice are crossed to SOD1-G93A, only a loss of LL5b
Gprin3 neurons is observed. In order to understand what cell-type specific gene
expression changes occur in these two distinct cell types in SOD1-G93A mice, we
performed TRAP in our crossed mice. We isolated mRNAs from both healthy and
diseased Colgalt2 and Gprin3 cells at two time points: pre-symptom onset (“Pre”, ~P70),
and

post-symptom

onset

(“Post”,

~P110;

Figure

4.1).

After

sequencing

immunoprecipitated (IP’ed) mRNAs, we first wanted to confirm that samples in these
cohorts were enriched for genes that we knew from previous Colgalt2 and Gprin3 TRAP
samples to be cell-type specific. We broadly assessed expression of these cell-type
genes using aligned reads visualized in IGV viewer. Colgalt2 disease cohort samples
shared expression profiles with benchmark Colgalt2 sample across cell type-specific
genes such as Ctip2, Fezf2, Colgalt2, Tmem200a, Fam84b, and Kcng1 (Figure 4.2A).
They additionally showed lower levels of expression for astrocyte genes highly
expressed in the Aldh1l1 TRAP line. Gprin3 disease cohort samples in turn shared
expression profiles for Gprin3 marker such as, Crabp1, Klhl1, Rasgrp2, and Ctip2, and
were also depleted for astrocyte markers (Figure 4.2B). Additionally, replicate samples
for each cell type were highly correlated with each other in whole genome expression
profiles by Pearson correlation (Figure 4.2C). Together, these gene expression patterns
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Figure 4.1: Summary of all TRAP IP samples from Colgalt2 and Gprin3 ALS cohorts.
(A-B) Schematic illustrations showing approximate M1 location of cell types interest for
RNA-Seq in the SOD1-G93A model. Accompanying tables indicate what samples were
collected and named for each timepoint of healthy (control, WT) and disease (SOD)
conditions. (A) The pre-symptomatic “Pre” timepoint (~P70) samples for Colgalt2 cells
were named for “Colgalt2 WT Pre” (light grey) and “Colgalt2 SOD Pre” (light blue) for
healthy and disease conditions respectively. Symptomatic “Post” timepoint (~P110)
samples for Colgalt2 cells were called “Colgalt2 WT Post” (dark grey) and “Colgalt2 SOD
Post” (blue) for control and disease conditions respectively. (B) The pre-symptomatic
“Pre” timepoint (~P70) samples for Gprin3 cells were called for “Gprin3 WT Pre” (light
grey) and “Gprin3 SOD Pre” (light blue) for healthy and disease conditions respectively.
Symptomatic “Post” timepoint (~P110) samples for Gprin3 cells were named “Gprin3 WT
Post” (dark grey) and “Gprin3 SOD Post” (blue) for control and disease conditions
respectively.
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Figure 4.2: Colgalt2 and Gprin3 TRAP IP samples from ALS cohorts show
expression of benchmark cell type-specific genes. (A-B) IGV Tracks showing aligned
reads from RNA-Seq samples. (A) Colgalt2 WT Pre (light grey), SOD Pre (light blue), WT
Post (dark grey), and SOD Post (blue) samples appear to match expression patterns for
the selected genes (black box) that are enriched in the benchmark Colgalt2 replicates
(purple). Additionally, the cells appear to be depleted for Aldh1l1 astrocyte marker genes
relative to the astrocyte cell type (red). Gprin3 benchmark samples (green) and whole
cortex input samples (black) are also shown. (B) Gprin3 WT Pre (light grey), SOD Pre
(light blue), WT Post (dark grey), and SOD Post (blue) samples appear to match
expression patterns for the selected genes (black box) that are enriched in the
benchmark Gprin3 samples (green). Additionally, the cells appear to be depleted for
astrocyte marker genes relative to the Aldh1l1 astrocyte samples (red). Colgalt2
benchmark samples (purple) and whole cortex input samples (black) are also shown.
Biological replicate tracks are overlaid to better show where reads aligned most
consistently across replicate samples. (C) Heatmap of Pearson correlation values for
different ALS cohort samples, compared to benchmark Colgalt2 and Gprin3 samples
(bottom left corner). Replicate samples and samples within cell types appear highly
correlated.
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indicate that RNA isolations from our populations of interest were successful and could
be used for assessment of gene expression changes in disease.

4.2 Pre-symptomatic changes in gene expression in Colgalt2 and Gprin3 cells.
Changes in gene expression that precede cell loss can provide some insight into
the mechanisms that lead to the initiation of cell death mechanisms. For this reason, we
wanted to determine what changes occur in the degeneration-resistant Colgalt2 and
vulnerable Gprin3 populations at the “Pre” disease stage in the SOD1-G93A context.
We performed differential expression (DE) analysis between healthy and SOD1-G93A
TRAP samples using DESeq2 with default parameters. We found that no gene foldchanges met statistical significance when the Benjamini-Hochberg-adjusted p-values
were used to disprove the null hypothesis. For this reason, we opted to use the unadjusted p-values (determined by Wald test in DESeq2; Love et al., 2014) as a more
subjective measure of potential biological significance. This provided us with more
genes to interrogate in later analyses and experiments, at the expense of potentially
increased Type I, or false positive, error. We generated lists of genes that were up- or
down-regulated in SOD1-G93A animals relative to healthy animals at this presymptomatic time point (by un-adjusted p < 0.05). In Colgalt2 cells, we observed 219
genes that were differentially expressed in SOD1-G93A. 128 genes were up-regulated,
with 91 down-regulated (Figure 4.3A). Gene ontology (GO) enrichment analysis was
performed using Metascape (Zhou et al., 2019) on these changed genes to determine
groups and classes of genes that may be regulated in response to SOD1-G93A
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Figure 4.3: Pre-symptomatic Colgalt2 samples reveal early changes in gene
expression in UL5b cells in response to SOD1-G93A. (A) MA scatter plot showing all
genes plotted by average Log10 counts per million (CPM; x-axis), and Log2 fold change
(FC; y-axis) in SOD (n = 2 replicates) relative to WT (n = 3 replicates) by differential
expression (DE) analysis. Grey dots represent individual genes, with genes that were
significantly (unadjusted p-value < 0.05) up-regulated in SOD colored light orange, and
down-regulated colored in light blue. (B) Bar plots show gene ontology (GO) categories
of genes that were significantly enriched among the genes that showed significant up- or
down- regulation by DE analysis. Categories found in up-regualted genes (left, light
orange) were primarily ribosomal. Down-regulated genes (right, light blue) included
nucleotide binding genes. Bars represent Log10 p-values from GO enrichment analysis.
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expression (Figure 4.3B). P-values for enriched GO categories were calculated by
Metascape using the hypergeometric test and Bejamini-Hochberg correction. Ribosomal
categories were enriched among up-regulated genes, suggesting that there may be
increased translation in Colgalt2 cells during early stages of disease. GO categories
enriched among down-regulated genes included cytoskeletal genes, implicating
potential early morphological rearrangement in UL5b cells.
At this pre-symptomatic stage, Gprin3 cells showed differential regulation of 140
genes: 61 were up-regulated and 79 were down-regulated with SOD1-G93A expression
(Figure 4.4A). GO analysis revealed that categories associated with ion transport were
significantly enriched among the genes up-regulated in Gprin3 cells expressing SOD1G93A (Figure 4.4B). This could indicate early changes in excitability in these cells. To
further implicate this mechanism, the ion transport category was also enriched among
down-regulated Gprin3 genes at this early time point. Early changes in gene expression
could underlie later stage disease mechanisms, but how the changes that we observe
here affect disease progression is something that needs to be further investigated.

4.3 Symptomatic changes in gene expression in Colgalt2 and Gprin3 cells reveal
opposing molecular responses to SOD1-G93A expression.
To elucidate mechanisms that are differentially regulated during symptomatic
stages of disease, we performed differential gene expression analysis between WT and
SOD1-G93A at “Post” stage, for both Colgalt2 and Gprin3. Because Colgalt2 cells are
resistant to degeneration, changes in gene expression in these cells may reveal
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Figure 4.4: Pre-symptomatic Gprin3 samples reveal early changes in gene
expression in LL5b cells in response to SOD1-G93A. (A) MA scatter plot showing all
genes plotted by average Log10 counts per million (CPM; x-axis), and Log2 fold change
(FC; y-axis) in SOD (n = 3 replicates) relative to WT (n = 2 replicates) by differential
expression (DE) analysis. Grey dots represent individual genes, with genes that were
significantly (unadjusted p-value < 0.05) up-regulated in SOD colored light orange, and
down-regulated colored in light blue. (B) Bar plots show gene ontology (GO) categories
of genes that were significantly enriched among the genes that showed significant up- or
down- regulation by DE analysis. Categories found in up-regualted genes (left, light
orange) included transcription-associated genes. Down-regulated genes (right, light blue)
included zinc-finger transcription factors. Bars represent Log10 p-values from GO
enrichment analysis.
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molecular strategies for successfully coping with mutant SOD1 expression. In Colgalt2
cells, many more genes were significantly regulated (un-adjusted p < 0.05) between WT
and SOD1-G93A at this stage compared to the “Pre” stage. 1076 showed significant
changes in gene expression in SOD: 628 showing an up-regulation and 448 showing a
down-regulation. For GO analysis, we selected genes that had a mean Log10 CPM
expression value ≥ 2.5 to limit analysis to highly expressed genes whose modulation
may have more functional consequence to the cells (Figure 4.5A). GO categories that
were enriched in up-regulated genes were associated with oxidative phosphorylation
(Oxphos) and translation (Figure 4.5B). The Oxphos gene category included Atp5l,
Ndufa4, and Cox6b1, from separate components of the electron transport chain (ETC).
Categories that were enriched among down-regulated genes in Colgalt2 cells at “Post”
stage appeared to primarily be associated with maintaining DNA integrity. Together,
these patterns suggest that Colgalt2 cells may be increasing their levels of respiration
while dampening a response to DNA damage and transcription. To understand whether
these changes were specific to resistant Colgalt2 cells, we assessed whether the genes
that showed significant up- or down-regulation in Colgalt2 cells were similarly changed
in Gprin3. We compared the directionality of WT vs. SOD LogFCs for these genes
between the two cell types (Figure 4.5C). Very few of the genes that were significantly
changed in Colgalt2 cells were similarly modulated in Gprin3 cells, with many genes
even showing an opposing change in these cells. This finding suggests that the gene
expression changes occurring in Colgalt2 cells at the symptomatic stage are specific to
this resistant UL5b population.
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Figure 4.5: Symptomatic Colgalt2 samples reveal late changes in gene expression
in resistant UL5b cells in response to SOD1-G93A. (A) MA scatter plot showing all
genes plotted by average Log10 counts per million (CPM; x-axis), and Log2 fold change
(FC; y-axis) in SOD (n = 3 replicates) relative to WT (n = 2 replicates) by differential
expression (DE) analysis. Grey dots represent individual genes, with genes that were
highly expressed (CPM > 2.5) and significantly (unadjusted p-value < 0.05) up-regulated
in SOD colored dark orange, and down-regulated colored in blue. (B) Bar plots show
gene ontology (GO) categories of genes that were significantly enriched among the
genes that showed significant up- or down- regulation by DE analysis. Categories found
in up-regualted genes (left, dark orange) included ribosomal and mitochondrial genes.
Down-regulated genes (right, blue) included DNA-associated genes. Bars represent
Log10 p-values from GO enrichment analysis. (C) Heatmap shows the fold-change
values of genes that showed significant change in disease in Colgalt2 cells, juxtaposed
with the fold-change values for the same genes from DE analysis in Gprin3 cells. Genes
changed in disease in Colgalt2 cells did not generally show the same directionality or
magnitude of change in Gprin3 cells in SOD, suggesting contrasting changes in response
to SOD1-G93A between Colgalt2 and Gprin3 cells.
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Gprin3 cells showed 620 significantly (un-adjusted p < 0.05) regulated genes in
disease: 381 up-regulated and 239 down-regulated genes. For performing GO analysis,
we once again selected genes that showed base mean Log10 CPM of ≥ 2.5, to enrich
for highly expressed genes (Figure 4.6A). GO categories enriched for up-regulated
genes in Gprin3 cells were primarily centered around neuronal functions and behavior
(Figure 4.6B). Surprisingly, and in contrast to Colgalt2 cells, one of the categories that
appeared enriched among down-regulated genes in Gprin3 cells was the Oxphos
category, which included Cox5b, Ndufc1, and Atp5e. Again, to determine the cell-type
specificity of these changes, we compared the LogFC directionality of significantly
changed genes from Gprin3 cells to LogFCs from “Post” DE in Colgalt2 cells. We found
that genes changed in “Post” Gprin3 cells rarely showed the same directionality of
change in Colgalt2 cells in disease (Figure 4.6C), suggesting that the changes observed
in Gprin3 cells are specific to this vulnerable LL5b cell type. A down-regulation of
Oxphos genes in Gprin3 cells at this disease time point, contrasting the up-regulation of
the same class of genes in Colgalt2, additionally suggests that depending on the
directionality, modulating respiration during disease may have different consequences
to cell survival.

4.4 Oxidative phosphorylation genes are differentially regulated in SOD1-G93A
between Colgalt2 and Gprin3 cells.
Oxphos genes appeared to be up-regulated in Colgalt2 cells and down-regulated
genes in Gprin3 cells by TRAP at a symptomatic time point, so we wanted to determine
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Figure 4.6: Symptomatic Gprin3 samples reveal late changes in gene expression in
vulnerable LL5b cells in response to SOD1-G93A. (A) MA scatter plot showing all
genes plotted by average Log10 counts per million (CPM; x-axis), and Log2 fold change
(FC; y-axis) in SOD (n = 3 replicates) relative to WT (n = 3 replicates) by differential
expression (DE) analysis. Grey dots represent individual genes, with genes that were
highly expressed (CPM > 2.5) and significantly (unadjusted p-value < 0.05) up-regulated
in SOD colored dark orange, and down-regulated colored in blue. (B) Bar plots show
gene ontology (GO) categories of genes that were significantly enriched among the
genes that showed significant up- or down- regulation by DE analysis. Categories found
in up-regualted genes (left, dark orange) were of varying subcellular association.
Down-regulated genes (right, blue) notably included mitochondrial genes. Bars represent
Log10 p-values from GO enrichment analysis. (C) Heatmap shows the fold-change
values of genes that showed significant change in disease in Gprin3 cells, juxtaposed
with the fold-change values for the same genes from DE analysis in Colgalt2 cells. Genes
changed in disease in Gprin3 cells did not generally show the same directionality or
magnitude of change in Colgalt2 cells in SOD, once again suggesting contrasting
changes in response to SOD1-G93A between the two cell types.
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if these changes reflected a broader change in whole mitochondrial gene expression.
We plotted individual LogFCs from “Pre” and “Post” disease DE in Colgalt2 and Gprin3
cells for different functional classes of mitochondrial genes, such as citric acid cycle
(TCA) genes and antioxidant genes (Figure 4.7A). In Colgalt2 cells, Oxphos genes
showed a particularly high proportion of significantly changed genes for “Post” stage
DE, though most functional groups of mitochondrial genes appeared to skew towards
up-regulated. And while fewer genes were significantly changed in Gprin3 cells at the
“Post” time point, there were several significantly changed genes in the Oxphos
category, with the median LogFC (black bar) for Oxphos genes indicating a general
down-regulation of this category (Figure 4.7B).
We next validated these TRAP findings by performing qPCR on a subset of
representative mitochondrial genes from Colgalt2 and Gprin3 ALS cohort cDNA
libraries. Assayed genes were chosen from differentially expressed genes from either
Colgalt2 or Gprin3 disease DE to represent either a subunit of the ETC, or a particular
functional pathway. We quantified differences in the expression of these genes between
conditions using the comparative cycle time (CT) method (ddCT) normalizing to Actb
and Gapdh expression in each condition. P-values were calculated by two-tailed t-test
on dCT replicate values between WT and SOD conditions. Colgalt2 cells showed an
increased level of mitochondrial transcripts in disease relative to WT across many of the
mitochondrial genes tested, especially at the “Post” disease time point (Figure 4.8A),
although most of these differences were not significant. Gprin3 cells showed a slightly
decreased level of Oxphos gene transcripts at “Post” between disease and WT (Figure
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Figure 4.7: Between Colgalt2 and Gprin3 cells, mitochondrial genes show
contrasting changes in gene expression in response to SOD1-G93A. (A-B)
Scatterplots showing the Log2 fold-change in SOD relative to WT by RNA-Seq DE
analysis for different functional categories of mitochondrial genes. Plots are shown for
“Pre” DE fold-changes (light blue, upper panel) and “Post” DE fold-changes (blue, lower
panel). Genes that showed a significant change (unadjusted p-value < 0.05) are colored
in red. (A) Log2 fold-change scatterplots show that Oxphos genes are up-regulated in
Colgalt2 cells during disease progression, along with mitochondrial genes from other
functional groups. (B) Log2 fold-change scatterplots reveal that, in contrast to Colgalt2
cells, several Oxphos genes are down-regulated in symptomatic Gprin3 cells. A small
subset of other mitochondrial genes also show down-regulation at this disease stage.
Black bars indicate median values for each category.
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Figure 4.8: qPCR for mitochondrial genes confirm contrasting changes in gene
expression for disease Colgalt2 and Gprin3 cells. (A-B) Colgalt2 and Gprin3 qPCR
Log2 fold-change data for different mitochondrial genes at “Pre” (light blue bars) and
“Post” (blue) stages. Values were calculated by ddCT between SOD and WT. Actb and
Gapdh were used as housekeeping gene controls (bars show mean ± SEM). (A) In
Colgalt2 cells, genes associated with Oxphos (left) and appear to be increased in
expression in SOD relative to WT. Other mitochondrial genes (right) also appear to be
up-regulated in SOD. (B) In Gprin3 cells, Oxphos genes appear to be down-regulated in
SOD samples at the “Post” disease stage, while other mitochondrial genes don’t appear
to change (* p < 0.05 by two-tailed t-test of dCT values).
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4.8B), but did not show similar decreases for other non-Oxphos mitochondrial genes.
Again, the majority of these differences were not statistically significant. These data
partly confirm the changes in Oxphos gene expression that we observed by TRAP, and
indicate that among all functional groups of mitochondrial genes, Oxphos genes appear
to be the most strongly targeted for gene expression modulation, particularly in the
vulnerable LL5b population.

4.5 Oxphos genes that show expression changes in SOD1-G93A are differentially
expressed between healthy Colgalt2 and Gprin3 cells.
Because we observed contrasting regulation of Oxphos genes in Colgalt2 and
Gprin3 cells during disease, we wanted to understand how the baseline expression
levels of these genes in healthy Colgalt2 and Gprin3 cells may contribute or predispose
to the changes we observe during disease. We first plotted the Log2 fold-enrichment
from Gprin3 vs. Colgalt2 TRAP DE for the different functional groups of mitochondrial
genes (Figure 4.9A). Consistent with the GO analysis discussed previously (Chapter 2),
many of the functional categories of mitochondrial genes, including Oxphos, showed
genes that were enriched in Gprin3 cells. To confirm these TRAP results, we performed
qPCR on Colgalt2 and Gprin3 cDNA libraries, for a representative subset of
mitochondrial genes (Figure 4.9B). P-values were calculated from dCT values using
two-tailed t-test. Oxphos genes appeared to be enriched in Gprin3 cells over Colgalt2
cells, anywhere between 1-fold and 3-fold (log2), although only Atp5g3 and Sod1
showed statistical significance. Other mitochondrial genes did not show similar levels of
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Figure 4.9: Mitochondrial genes, including Oxphos genes, are enriched in Gprin3
cells relative to Colgalt2 cells. (A) Scatterplots showing Log2 fold-enrichment from
Gprin3 vs. Colgalt2 DE for different functional groups of mitochondrial genes. Individual
green dots represent single genes. Red dots indicate genes that were significantly
enriched. (B) Bar graph shows the Log2 fold-enrichment of different mitochondrial genes
in Gprin3 cells relative to Colgalt2 cells by qPCR. Enrichment was calculated by ddCT,
using Actb and Gapdh as housekeeping gene controls. Genes associated with Oxphos
(shown on the left) appear to be enriched in Gprin3 cells (green bars). Other
mitochondrial genes do not consistently show the same level of enrichment in Gprin3
cells, however. Purple bar shows where genes were enriched in Colgalt2 cells (bars show
mean ± SEM; * p < 0.05 by two-tailed t-test of dCT values).
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enrichment between the two cell types. These findings leave open the question of how
underlying differences in mitochondrial gene expression may contribute to selective
vulnerability to mutant SOD1, an enzyme closely tied to mitochondrial function.
Experiments to address the functional connection between levels of mitochondrial gene
expression and mitochondrial biology in these neurons, particularly in the context of
SOD1-G93A, should be carried out to answer this question.

4.6 A respiratory transcription factor is differentially expressed between Colgalt2
and Gprin3 neurons.
We next wanted understand how the genes that are up- or down-regulated in
disease may be modulated by upstream transcriptional regulation mechanisms. We
performed HOMER TF Motif analysis, which searches the sequences found upstream of
a set of genes of interest to determine if they share any TF binding motifs, and by
extension, regulatory TFs. We performed this analysis on the cohort of genes that were
significantly changed in “Post” disease in our two cell types. These analyses revealed
several canonical TF binding motifs for these genes (Figure 4.10A). To understand how
these TFs may contribute to the cell-type specific disease changes that we observe, we
then set out to determine whether the TFs associated with these motifs showed
differential expression between healthy Colgalt2 and Gprin3 cells. TFs for further
analysis were selected if their associated motif was enriched in a statistically significant
way (p < 0.05) in motif analysis above. We assessed relative expression values (zscores) for these TFs between healthy Colgalt2 and Gprin3 cells, and observed that
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Figure 4.10: Transcription factor motif analysis reveals motifs and factors
associated with genes that change in disease. (A) Examples of HOMER transcription
factor (TF) motifs that were enriched among the genes that were up- (bottom row) or
down-regulated (top row) during “Post” disease stage in Colgalt2 cells (left column) and
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Pre relative gene expression values of TFs that were enriched by HOMER TF motif
enrichment analysis. Several TFs appear to be differentially expressed between Colgalt2
and Gprin3 cells at this age. Of note, Nrf1, a TF that is key to mitochondrial biogenesis
appears to be expressed more highly in Gprin3 cells. Annotation above the heatmap
indicates whether the TF motif came from Colgalt2 disease genes (purple), Gprin3
disease genes (green), or was seen in both (yellow).
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many of these TFs show differential levels of expression between these two cell types
(Figure 4.10B). Notably, Nuclear Respiration Factor 1 (Nrf1), a TF important in the
regulation of expression of genes associated with ETC and Oxphos, showed higher
levels of expression in Gprin3 cells relative to Colgalt2 cells. These TF motif analyses
suggest that distinct changes in gene expression may be influenced by differential
expression of upstream factors across these two cell types, but more data are needed
to understand whether there is a causal link between these two findings.

4.7 Discussion
The mutations that cause neurodegenerative disease are often found on genes
that are ubiquitously expressed, but death is typically only observed for specific cell
types. For many neurodegenerative diseases, it is not known how these mutations
trigger the cell-type specific molecular responses that inevitably lead to death. Our
Colgalt2 and Gprin3 lines present us with a unique opportunity to understand how the
SOD1-G93A mutation molecularly affects two related but distinct L5b cell types, where
one shows vulnerability and the other resistance to degeneration in this model. Through
TRAP and RNA-Seq, we show that two distinct populations of L5b cells regulate the
expression of different classes of genes in the SOD1-G93A ALS model. In particular, it
appears that these two cell types differentially regulate Oxphos gene expression (Figure
4.11). The resistant UL5b Colgalt2 population shows an up-regulation of Oxphos genes,
while the vulnerable LL5b Gprin3 population shows a down-regulation of these genes.
Our analyses additionally reveal that in a WT condition, the vulnerable LL5b neurons
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Figure 4.11: Summary of TRAP and RNA-Seq findings from SOD1-G93A
Colgalt2-TRAP and Gprin3-TRAP animals. Colgalt2 cells (purple) up-regulate Oxphos
gene expression at a symptomatic stage of disease (left panel), while Gprin3 cells (green)
appear to instead down-regulate Oxphos genes at this stage. In healthy brains, Gprin3
cells show ~2.8x higher levels of Oxphos gene expression than Colgalt2 cells
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express Oxphos genes at higher levels than the closely-related resistant UL5b cell type,
suggesting that there may be underlying differences in the levels of energetic demand
of these cells, and that perhaps these differences contribute to differential sensitivity to
SOD1-G93A overexpression.
Mitochondrial dysfunction has been observed for many neurodegenerative
diseases and their models (see Lin and Beal, 2006). In fact, changes in mitochondrial
fission and fusion, as well as mitophagy are hallmarks of many neurodegenerative
diseases (Bossy-Wetzel et al., 2003; Burté et al., 2015; Chen and Chan, 2009; Itoh et
al., 2013; Knott et al., 2008). In models of ALS, many phenotypes associated with
mitochondrial structure or function have been reported (Lopez-Gonzalez et al., 2016; Lu
et al., 2012; Mattiazzi et al., 2002; Menzies et al., 2002; Vehviläinen et al., 2014). By
gene expression analysis, changes in Oxphos gene expression can also be observed in
disease (Bandyopadhyay et al., 2013; Olsen et al., 2002), which may manifest as
changes in the protein composition of mitochondria in cells (Li et al., 2010). Additionally,
a decrease in ETC enzyme activity can be observed in the spinal cord of human ALS
patients (Borthwick et al., 1999; Wiedemann et al., 2002). However, many ETC and
Oxphos genes are expressed throughout the body, leaving open the question of how a
ubiquitously expressed disease mutation can cause cell type-specific mitochondrial
dysfunction, and how cell-type specific features may affect the levels of gene
expression for key cell biological pathways.
Regulation of mitochondrial gene expression is influenced by many different
functional signaling pathways in the cell. A principal effector of these signals is Pgc1a,
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and the nuclear respiratory factors Nrf1 and Nrf2, which directly bind the promoters of
metabolic genes to increase their expression (Scarpulla, 2011; Virbasius et al., 1993a;
1993b; Wu et al., 1999). Homeostatic sensing mechanisms regulate the activation of
these factors in an effort to maintain the levels of ATP production necessary for proper
cellular functions. For neurons, this energetic tuning, as well as mitochondrial Ca2+
buffering, is essential for carrying out neuronal functions such as pre- and post-synaptic
signaling, axon transport, and action potential propagation (Kann and Kovács, 2007;
Zenisek and Matthews, 2000). SOD1-G93A overexpression is thought to cause many
disruptions in neuronal function (see Geevasinga et al., 2016; Ilieva et al., 2009), but it
is not known whether mitochondrial dysfunction is a direct result of mutant insult or
indirectly caused by other disease pathologies. It is similarly not understood how the
changes in mitochondrial gene expression commonly observed in neurodegenerative
diseases lead to death or survival of cells. In our case, the resistant Colglat2 cells
showed a striking up-regulation of Oxphos genes in disease. It is not clear whether this
change represents a successful coping strategy for SOD1-G93A overexpression, or if it
reflects a response to other cellular dysfunctions not measured here. It is likewise not
clear whether a down-regulation of Oxphos genes in vulnerable Gprin3 cells is causal to
death or merely a hallmark of general dysfunction caused by SOD1-G93A. Testing the
causal relationship between mitochondrial gene expression changes and cellular
pathologies would not be trivial, as regulating the abundance, localization, or function of
an entire organelle requires very careful control over the many cellular mechanisms and
factors, such as Pgc1a and Nrf1, that modulate its features. It is nevertheless essential
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that this relationship be studied carefully to understand what role mitochondria play in
cell-type specific vulnerability in disease.
Our data additionally reveal that in the healthy brain, there appear to be underlying
differences in mitochondrial gene expression between L5b cells. It is not known how
different cellular properties and features influence the relative levels of mitochondrial
gene expression that may differ from neuron type to neuron type. More specifically, why
does a LL5b neuron express Oxphos genes at higher levels than an UL5b neuron? One
possible explanation for this takes into consideration a difference in cell size due to
differing lengths of axonal projections. Additional collaterals to long-range targets, such
as the spinal cord, could require more ATP for active transport across their lengths.
Another possible explanation considers that different neuron types within a region of
cortex display different levels and patterns of activity as they process afferent input. This
is dependent on the amount and type of signals they receive, as well the levels of
downstream activity- ie. action potentials- they have to produce. In order to maintain
active signaling in the neuron, levels of ATP and Ca2+ must be tightly regulated, in part
by mitochondria (Kann and Kovács, 2007). But in order to understand the causal link
between cellular function and dysfunction in the cell and changes in mitochondrial gene
expression, the general neuronal properties listed above would need to be perturbed in
a tightly regulated manner. For instance, if levels of Oxphos gene expression could be
up- or down-regulated in our two cell types, we could begin to understand the effects of
changes in mitochondrial gene expression on the regulation of cellular energetics.
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One caveat to note from the TRAP findings of this study is that while we do
observe many changes in gene expression due expression of mutant SOD1, we were
surprised to find no changes in previously reported ER stress, unfolded protein
response, or cell death gene expression in our datasets, across any time point we
assayed. It is possible that these cellular mechanisms are activated in an extremely
transient manner, and would require us to perform RNA-Seq with greater temporal
resolution during disease progression. For the Gprin3 population, however, we
additionally observe fewer changes in gene expression between SOD1 and WT overall.
This may also be in part due to the heterogeneous timing of disease progression that
we observe anatomically, where more posterior Gprin3 cells appear to be lost first in the
disease. In a scenario where posterior Gprin3 cells are mixed with anterior Gprin3 cells
when isolating RNA, the more advanced disease mechanisms would be diluted by the
earlier responses, minimizing the appearance of both in the dataset. These molecular
experiments should perhaps be repeated with a more careful anterior-posterior
anatomical dissection for cellular isolation to assay the distinct “stages” of disease that
may be occurring across the global Gprin3 population. Nevertheless, the Oxphos gene
expression changes that we observe in the global populations of Colgalt2 and Gprin3
cells are robust, and present an avenue for further biological assessment in ALS.
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CHAPTER 5:
Visualizing and modulating mitochondrial structure and function in the context of
SOD1-G93A

Mitochondrial structure and function are regulated by many different cellular
mechanisms (Boldogh and Pon, 2006; Jeyaraju et al., 2009; Scarpulla, 2011; Vander
Heiden et al., 1997). Mitochondrial fission, fusion (Cagalinec et al., 2013), trafficking
(Mironov, 2006), and energetic homeostasis (Kann and Kovács, 2007) are additionally
influenced by many of the properties and functions of a neuron. Processes such as
synaptic signaling, axon potential propagation, and membrane potential maintenance
(Attwell and Laughlin, 2001; MacAskill and Kittler, 2010; Miller and Sheetz, 2004;
Mironov, 2009) require a substantial amount of energy to carry out. Mitochondrial
dysfunctions can in turn be found downstream of many cellular pathologies (Budd and
Nicholls, 1996; Rainbolt et al., 2014), and in fact are often observed in
neurodegenerative diseases (see Bossy-Wetzel et al., 2003; Chen and Chan, 2009;
Cozzolino et al., 2013; Knott et al., 2008; Lin and Beal, 2006; Moreira et al., 2010). In
ALS and its models, changes decreases in ETC complex activity (Borthwick et al., 1999;
Wiedemann et al., 2002), mitochondrial vacuolization (Dal Canto and Gurney, 1995;
Kong and Xu, 1998; Wong et al., 1995), and dysregulated structural dynamics (Magrané
et al., 2009; Song et al., 2013) are often observed (see also Lopez-Gonzalez et al.,
2016; Lu et al., 2012; Mattiazzi et al., 2002; Menzies et al., 2002; Vehviläinen et al.,
2014). But the cell-type specificity of dysfunctional regulation of mitochondrial structure
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and function in this disease has not been thoroughly assessed. For the SOD1-G93A
ALS model, elucidating cell-type specific changes to mitochondria is of particular
interest because of SOD1’s antioxidant role in clearing reactive oxygen species
generated during ETC (McCord and Fridovich, 1969; Okado-Matsumoto and Fridovich,
2001), and because many of the dysfunctions observed for mutant SOD1, such as
oxidative stress (Beal et al., 1997; Casoni et al., 2005; Estévez et al., 1999) and protein
aggregation (Bruijn et al., 1997b; 1998; Watanabe et al., 2001) can have consequences
to mitochondrial function (Cole et al., 2010; Salehi et al., 2015). In our studies, despite
SOD1 ubiquitous expression, we observed contrasting changes in mitochondrial gene
expression across disease-vulnerable LL5b Gprin3 and disease-resistant UL5b Colgalt2
cells when SOD1-G93A is expressed in the animal (Chapter 4). In Colgalt2 cells, at a
symptomatic stage of disease, Oxphos gene expression increased relative to a healthy
age-matched control. In vulnerable Gprin3 cells, we detected a decrease in the level of
Oxphos gene expression that contrasted the change in Colgalt2 cells. When we
assessed the levels of mitochondrial gene expression between Colgalt2 and Gprin3
cells in healthy animals, we determined that Gprin3 cells are enriched for Oxphos genes
relative to Colgalt2 cells, indicating that these cell types enter into a disease context
with differing levels of expression of respiration genes to begin with.
In order to more precisely understand how levels of mitochondrial gene expression
and expression of SOD1-G93A affect the structure and function of mitochondria, we set
out to characterize mitochondrial morphology in a cell-type specific manner in L5b cells
across both healthy and ALS animals. Additionally, we attempted to modulate levels of
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Oxphos to determine the causal relationship between levels of Oxphos gene expression
and disease progression in our cell types.

5.1 Mitochondria of upper and lower L5b cells occupy similar volumes in the
soma.
In order to understand how UL5b and LL5b cell types differ in their mitochondrial
composition, we set out to visualize the mitochondria in these cells in a cell-type specific
manner. We chose to virally target expression of a mitochondrial reporter to L5b cells
that express Cre-recombinase in the Gng7-Cre KH67 mouse line. To accomplish this,
we cloned the coding region for an EGFP construct with an N-terminal mitochondrial
localization signal (MitoGFP, Addgene plasmid #50057; Sancak et al., 2013) into a
pAAV plasmid that contained DIO Lox sites (Figure 5.1B). We packaged the construct
into rAAV2/9 for neuronal transduction. When the virus is injected into the pons of
Gng7-Cre mouse, which expresses Cre in L5b cells across the cortex (Figure 5.1B),
expression of MitoGFP can be observed in L5b cells across the entire cortex (Figure
5.1C). Because expression is observed in both the upper and lower sublayers of M1,
the cells can be specifically classified as UL5b or LL5b cells depending on their visual
depth in L5b, thereby giving us visual access to mitochondria within both L5b cell types
in an internally controlled system.
Given that Gprin3 cells show a higher level of expression of Oxphos genes when
compared to Colgalt2 cells (see Chapter 2 and 4), we wanted to determine if this had
any overt effect on gross mitochondrial morphology in these neurons. We injected the
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Figure 5.1: Generating a construct for expressing a mitochondrially localized GFP
reporter in a cell type-specific manner. (A) Schematic illustration of the mitoGFP

expression construct cloned into a viral expression plasmid and packaged into
an AAV capsid. The EGFP coding sequence with an N-terminal mitochondrial
localization signal (MLS) was DIO floxed for Cre-dependent constitutive
expression by an eF1a promoter. (B) Schematic illustration of the experimental
design showing the pontine viral injection paradigm and expected expression
patterns in M1 of the Gng7-Cre mice. MitoGFP will be expressed in
Cre-expressing L5b cells by transduction of the virus because of their projections
to the pons. (C) Representative confocal image of mitoGFP expression (green)
in M1 of a Gng7-Cre mouse following an injection of AAV.DIO.mitoGFP into the
pons. Dashed line delineates the estimated boundary between UL5b and LL5b
used to classify the cells during subsequent analysis. Both sublayers of L5b
show expression of mitoGFP due to their shared projection to the pons (scale bar
= 250 µm).
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Cre-dependent mitoGFP virus into the pons of Gng7-Cre mice. In this way, we were
able to label the mitochondria of UL5b and LL5b cells with mitoGFP that could be
visualized by confocal microscopy (Figure 5.2A). Additionally, to visualize Oxphos
machinery in our cells, we performed immunostaining for Cox6c, a component of
complex IV of the ETC, in these tissues. UL5b and LL5b cells were sampled from
laminar subdivisions that were visually established at low magnification, and highmagnification (63X) confocal images of individual labeled cells were collected. To
account for differences in levels of expression of the reporter and in antibody detection
caused by differential depth within the section, each image was thresholded such that
the same percentages of total pixels were included above the threshold limit across all
images. We first assessed what percentage of the cytoplasm was occupied by
MitoGFP+ mitochondria in L5b cells by calculating the area of GFP signal relative to the
total area of cytoplasm (Figure 5.2A outlines). Mitochondria appear to occupy
approximately 24% of the cytoplasmic space in both UL5b and LL5b cells (Figure 5.2B).
The total number of Cox6c + puncta, in these cells also appeared to be the same
(Figure 5.2C). We next determined the size of the Cox6c particles in UL5b and LL5b
cells, and found that LL5b cells showed slightly larger Cox6c+ particles than UL5b cells
(difference of 0.0196 µm2), although this difference was not statistically significant.
When we normalized the Cox6c+ area to the MitoGFP+ area, we also found that LL5b
cells show a slightly greater level of Cox6c signal per area of MitoGFP+ mitochondria
(difference of 0.1333), although again, this difference was not significant. Together
these data suggest that while total mitochondrial volume may not be different between
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Figure 5.2: UL5b and LL5b cells show similar mitochondrial volume. (A)
Representative 100X confocal images of UL5b (left) and LL5b (right) cells expressing
mitoGFP (green). Dashed white lines outline the areas of cytoplasmic space in the cells
that were delineated for analyses of mitochondrial size, number, etc. (scale bar = 10 µm).
(B) Distributions of cytoplasmic area occupied by mitoGFP signal shown as box and
whisker to highlight median and quartile boundaries and expressed as percent of total
cytoplasmic area. UL5b (purple; n = 13 cells) and LL5b (green; n = 14 cells) cells do not
appear to differ in mitochondrial density. (C) Number of Cox6c immunostaining “particles”
after thresholding. There was no difference in the number of Cox6c “particles” found
between UL5b (n = 14 cells) and LL5b (n = 14 cells) cells. (D) Box and whisker plots
showing the quantification of the size of Cox6c immunostaining “particles”. There
appeared to be no difference between UL5b and LL5b Cox6c particle size. (E) Cox6c
density per mitochondrial area, expressed as a ratio of Cox6c immunostaining area to
mitoGFP area. LL5b cells show a slightly greater density of Cox6c staining per
mitochondrial area, although this difference was not statistically significant (p = 0.1071;
n.s. = not significant by two-tailed t-test).
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UL5b and LL5b cells, the number of ETC components per mitochondrion may be subtly
different, with LL5b cells showing a slightly greater density of Cox6c signal than UL5b
cells.

5.2 Gprin3 cells display wider cristae than Colgalt2 cells.
Inner mitochondrial membrane complexity, or cristae morphology, is often used as
a proxy for levels of ETC machinery in mitochondria, as structural determinants, such as
Opa1, interact with some components of the ETC to physically produce the bend in the
inner mitochondrial membrane that creates cristae structure (Lee and Yoon, 2018;
Quintana-Cabrera et al., 2018). In order to determine how different levels of Oxphos
gene expression observed between healthy Colgalt2 and Gprin3 cells affect
mitochondrial morphology in these cells with greater detail, we visualized mitochondria
by EM in healthy Colgalt2 and Gprin3 TRAP animals. To identify our cell types of
interest under the microscope, we immunostained for GFP using a standard
immunogold amplification protocol for EM imaging. In images of Colgalt2 and Gprin3
soma, we measured the widths of individual cristae when they could be visualized
readily (Figure 5.3A). These analyses revealed that Colgalt2 cells had significantly
narrower cristae than Gprin3 cells, with average cristae appearing 59% as wide (21.58
nm Colgalt2, 36.31 nm Gprin3) as Gprin3 cristae (Figure 5.3B). This suggests that
Colgalt2 cells have more complex inner mitochondrial membrane structure that may
contain greater levels of ETC machinery. These findings are inconsistent with the
difference in the level of Oxphos gene expression we observed by TRAP, where we
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Figure 5.3: Gprin3 cells show larger mitochondrial cristae widths than Colgalt2
cells. (A) Representative electron micrographs of Colgalt2 and Gprin3 cytoplasm
containing mitochondria, outlined in purple for Colgalt2 and green for Gprin3.
Immunogold particles in the image indicate the presence of EGFP-L10a used to
determine cell type identity (scale bar = 500 nm). (B) Quantification of cristae widths (in
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101 cristae), with Gprin3 cells (green) showing a larger mean cristae width of 36 nm (n =
103 cristae; **** p < 0.0001 by two-tailed t-test).
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observe that Gprin3 cells express Oxphos genes at a higher level than Colgalt2 cells.
These findings are preliminary, and should therefore be repeated to confirm the
difference observed. Additionally, further investigation into Oxphos output in Colgalt2
and Gprin3 cells is required in order to understand how Oxphos gene expression leads
to differences in the energetic biology of these cells.

5.3 LL5b cells but not UL5b cells show greater size and decreased number of
mitochondria when SOD1-G93A is expressed.
It is often difficult to maintain Cre transgenic expression when studying the effects
of an additional disease transgene, such as SOD1-G93A, on organismal biology. For
this reason, we sought to develop a viral expression system that would allow for cell
type-specific visualization of mitochondria without the expression of Cre. For this, we
chose to employ a new retrograde AAV variant, rAAV2-retro (Tervo et al., 2016), here
referred to as “SL1”. Because different cell types often show distinct projection patterns
to various regions of the brain, targeting injections of this Cre-independent retrograde
expression vector to the unique projections of these cells can label them in a typespecific manner. We cloned a C-terminal mCherry-tagged human TOMM20, an outer
mitochondrial membrane transporter, into a Cre-independent pAAV plasmid (Addgene
plasmid # 55146, Michael Davidson, Figure 5.4A). In collaboration with the Janelia Farm
Virus Core, the vector was packaged into the SL1 virus, which enters neurons at the
pre-synaptic terminal and is transported retrogradely to the nucleus where it can be
expressed. When this virus is injected into the pons of the mouse (Figure 5.4B),
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Figure 5.4: Generating a Cre-independent construct for expression of
TOM20-mCherry mitochondrial reporter in a cell type-specific manner across
healthy and disease L5b. (A) Schematic diagram of construct for eF1a-driven
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Representative confocal image of TOM20-mCherry expression in M1 of a WT mouse.
Dashed line indicates the approximate boundary between UL5b and LL5b that was used
to classify the cell types for analysis. Both sublayers show expression of the construct
following injection into the pons due to their shared projection to this region (scale bar =
250 µm).
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expression of the TOM20-mCherry construct is observed across L5b the cortex(Figure
5.4C), allowing for visualization of UL5b and LL5b mitochondria in a once again
internally controlled system.
Because we observed contrasting changes in Oxphos gene expression between
Colgalt2 and Gprin3 mice during disease, we wanted to assess gross morphological
differences between WT and SOD1-G93A mitochondria in UL5b and LL5b cells at a
symptomatic stage. Because we already required the SOD1-G93A transgenic mouse
line for these experiments, to avoid introducing a second transgenic Cre mouse, we
used the Cre-independent SL1.TOM20-mCherry retrograde viral system to visualize
L5b mitochondria in disease. By injecting this virus into the pons, we were able to label
both UL5b and LL5b cells in M1 of WT and SOD1-G93A mice (Figure 5.4C). After
visually assessing upper or lower L5b identity at low magnification, we acquired highmagnification (100X) images of individual cells containing mCherry+ mitochondria
(Figure 5.5A) in order to quantify gross morphological features. Once again, images
were thresholded so that the upper 25% of all pixels in the pixel value distribution were
included above the threshold limit. In UL5b cells, the size of mCherry+ particles was the
same between WT and SOD. Similarly, there was no difference in the total area of the
cytoplasm occupied by mCherry+ mitochondria or in the number of mitochondrial
particles per cell (Figure 5.5B). This suggests that while Colgalt2 cells up-regulate levels
of Oxphos gene expression in disease, there may not be an overt change in
mitochondrial size or shape to reflect this change. We next analyzed morphology of
LL5b cell mitochondria. In SOD, LL5b cells show slightly larger mCherry+ particle sizes
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Figure 5.5: LL5b cells show changes in TOM20-mCherry distributions that are not
observed in UL5b cells. (A) Representative confocal images of TOM20-mCherry
labeling (red) in UL5b (left) and LL5b (right) cells. Dashed lines indicate the boundaries of
cytoplasmic space that were analyzed for various properties of TOM20-mCherry labeling,
such as size, area, etc. (scale bar = 10 µm). (B) Distributions of quantified properties of
thresholded TOM20-mCherry labeling “particles” in UL5b cells across WT (black) and
SOD1-G93A (SOD; blue). No significant difference was observed between WT (n = 11
cells) and SOD (n = 9 cells) for particle size (µm2; left), total labeled area (µm2; middle),
or total number (right; n.s. = not significant by two-tailed t-test). (C) Distributions of
quantified properties of thresholded TOM20-mCherry labeling “particles” in LL5b cells
across WT and SOD. No significant difference was observed between WT (n = 15 cells)
and SOD (n = 21 cells) for total area of TOM20-mCherry labeling (µm2; middle). However,
a significant difference was noted for TOM20-mCherry particle size and total number,
showing an increase and a decrease in SOD, respectively (*p < 0.05, n.s. = not significant
by two-tailed t-test).
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relative to WT cells (Figure 5.5C). There was no difference in the total area occupied by
these particles in the cytoplasm, however. This necessitated that the number of
mitochondria be lower in SOD, which is indeed what was observed. These data indicate
that LL5b cells may decrease the number of discrete mitochondria in response to
SOD1-G93A, while maintaining total mitochondrial volume. It is difficult to reconcile
these findings with the Oxphos gene expression decrease that we observe by TRAP, as
it does not address morphology due to Oxphos changes, but rather broad morphological
rearrangements of mitochondria. But, together, these data highlight that UL5b and LL5b
cells may show contrasting mitochondrial changes at the level of gross morphology and
distribution in SOD1-G93A, where LL5b cells show a decrease in the number of
mitochondria that is not observed in UL5b cells.

5.4 Gprin3 and surrounding cells expressing SOD1-G93A show changes in cristae
morphology by EM.
To better visualize mitochondrial ultrastructure and its changes in LL5b Gprin3
cells, we visualized WT and SOD1-G93A Gprin3 cells by EM. We immunostained for
GFP with immunogold amplification in order to easily identify our cells of interest under
the microscope. In images of Gprin3 soma (Figure 5.6A), we measured individual
cristae widths in the mitochondria of Gprin3 cells, as well as in cells that were
immediately adjacent to the GFP+ Gprin3 cells. The widths of cristae in both Gprin3 and
neighboring cells appeared to increase in SOD1-G93A (Figure 5.6B), suggesting that
these cells may be decreasing levels of ETC components in the inner mitochondrial
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Figure 5.6: Cells in LL5b of M1 show increased cristae width in SOD1-G93A. (A)
Representative electron micrographs of WT (left) and SOD1-G93A (SOD; right) LL5b,
containing GFP+ Gprin3 cells (outlined in green) and adjacent GFP- cells of
indeterminate identity (outlined in yellow; scale bar = 1 µm). (B) Quantification of cristae
widths (nm) between WT (black) and SOD (blue) for GFP+ Gprin3 cells (WT n = 316,
SOD n = 302 cristae) and adjacent GFP- cells (WT n = 76, SOD n = 72 cristae). Both cell
types show an increase in cristae width in SOD (****p < 0.0001 by two-tailed t-test). (C)
Quantification of density of matter within each mitochondrion, reported as the mean pixel
value measured within each mitochondrion normalized to the mean pixel value of “empty”
cytoplasm, and represented as a frequency distribution of normalized pixel values. In
both GFP- and GFP+ cells, SOD mitochondria (blue distribution) showed a decrease in
normalized pixel value relative to WT mitochondria (black line), suggesting that the mean
pixel value in SOD mitochondria became darker. This in turn suggests that more
“material” is found inside each mitochondrion in disease. Yellow and green bars highlight
the distance between the WT and SOD distribution means for GFP- (WT n = 80, SOD n
= 166 mitochondria) and GFP+ (WT n = 240, SOD n = 166 mitochondria) cells
respectively.

105

membrane in disease. These results require a more exhaustive study of cell-type
specific mitochondrial changes in SOD1-G93A to understand, including staining for
components of the Oxphos pathway, and functional analyses of mitochondrial function
across different cell types in disease.

5.5 Strategies for modulating levels of respiration and ETC activity in UL5b and
LL5b cells.
Our characterization of mitochondrial morphology, alongside our TRAP gene
expression findings, suggests that there are some changes in structural mitochondrial,
and possibly respiration, during disease progression. In order to determine how these
changes may affect the survival or vulnerability of L5b cells to SOD1-G93A, particularly
because we observed an increase in Oxphos gene expression in ALS-resistant UL5b
cells, we attempted to increase the levels of respiration in these cells. We first opted to
leverage an endogenous signaling mechanism to increase the levels of Oxphos in the
mouse by injecting mice with all-trans retinoic acid (RA). RA treatment in cell culture has
been shown to increase the levels of respiration in cells (Tourniaire et al., 2015), and
retinoid signaling additionally appears to be disrupted in ALS (Kolarcik and Bowser,
2012; Malaspina et al., 2001). We wanted to determine if increased Oxphos by RA
signaling would change the survival time or disease progression of SOD1-G93A mice.
We performed intraperitoneal (IP) injections of RA (1 mg/kg animal weight) or corn oil
vehicle (4 ul/g animal weight) every two days into SOD1-G93A mice beginning at a
symptomatic stage to determine if increased RA levels would have any effect on
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disease survival time or progression. Survival time did not appear to be affected in RAinjected animals (Figure 5.7A). To determine any changes to symptom onset or
progression, we also subjectively assessed symptom severity during treatment by
noting the presence of tremors, limb weakness, limb dragging, and overall mobility
impairment. However, we found no significant difference in symptom progression
between RA- and vehicle-injected animals (Figure 5.7B).
The lack of cell-type specificity in this RA strategy set us to next attempt a more
targeted modulation of Oxphos gene expression using a cell-type specific approach.
Pgc1a has been shown to induce mitochondrial biogenesis and respiration through
increased expression and activation of nuclear respiratory factors (NRFs; Uldry et al.,
2006; Wu et al., 1999). Additionally, exogenous expression of Pgc1a in cultured SOD1G93A cells was shown to normalize mitochondrial structural changes and prevent cell
death (Song et al., 2013). We therefore packaged a pAAV plasmid containing a human
copy of the Pgc1a coding sequence under the control of a constitutive CMV promoter
(Figure 5.8A, Xiong et al., 2015) into the retrograde SL1 virus for overexpression. By
injecting this virus into the left pons of pre-symptomatic Gprin3 animals, we could
retrogradely target the GFP+ LL5b cells and in the ipsilateral left hemisphere of M1 for
Pgc1a overexpression, while leaving the contralateral right hemisphere unaffected as
an internal control (Figure 5.8B). Tissues were collected when mice reached end stage
of disease and required euthanasia. We immunostained for GFP and counted the
number of GFP+ Gprin3 cells in the left and right hemispheres in both WT and SOD1G93A to determine if increased Oxphos by Pgc1a overexpression had any effect on cell
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Figure 5.7: Modulating levels of Oxphos by retinoic acid injections does not alter
disease progression. (A) Survival curves showing survival of SOD1-G93A mice that
received IP injections of either oil vehicle (yellow curve; median survival = 150 days; n =
3 mice) or retinoic acid (RA; magenta curve; median survival = 177 days; n = 3 mice). (B)
Subjective symptom severity score plotted as a function of time for SOD1-G93A mice that
received IP injections of either oil vehicle (yellow curve; n = 3 mice) or RA (magenta
curve; n = 3 mice). Increased symptom severity score indicates increased overt symptom
severity in the animal (lines show mean values for each time point, with shading indicating
SEM).
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Figure 5.8: Modulating levels of Oxphos in L5b cells by Pgc1a overexpression does
not alter disease progression. (A) Schematic of viral construct for constitutive
CMV-driven overexpression of exogenous Pgc1a. (B) Schematic illustration of the
experimental design showing the pontine viral injection paradigm and expected ipislateral
(cyan) expression patterns relative to contralateral cortex (purple) in M1 of WT or
SOD1-G93A mice. (C) Cell counts along the AP extent of M1 for M1 ipsilateral to the
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purple). No significant difference in cell number was noted between Ipsi M1 (n = 6
animals) and Contra M1 (n = 6 animals). Values are reported as a percent of the
Pgc1a-injected WT mean at the matching anatomical coordinate (points indicate mean
values for each coordinate, with bars showing SEM).
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survival. We found no significant difference between the number of Gprin3 cells across
the ipsilateral left and contralateral right hemispheres (Figure 5.8C), suggesting that
Pgc1a overexpression in these cells may does not affect cell survival. One notable
caveat to this experimental design was that we relied on the HA and His tags to
visualize exogenous Pgc1a overexpression. Immunodetection of these tags proved
difficult in our tissues, so we were not able to determine to what extent Pgc1a
overexpression overlapped with our Gprin3 population. This confound could be
corrected if the experiment were repeated with a Pgc1a construct that additionally
expresses a reporter that can be easily visualized in tissue. Additionally, Pgc1a
activation is post-translationally regulated by many upstream molecular signaling
pathways (see Austin and St-Pierre, 2012), potentially limiting an overexpression
strategy. Overall, our two Oxphos modulation strategies were technically limited in
various ways, making it difficult to interpret the results from each experiment in the
biological context of mutant SOD1. However, they serve to highlight the need for careful
targeting and assessment of gene expression modulation when studying neuronal ATPsynthesis, and reveal how even heavy-handed approaches to modulate levels of
Oxphos may not always present the most effective strategies for studying the effect of
changes in respiration on cellular biology.

5.6 Discussion
Mitochondrial morphology can reflect many functional and dysfunctional states of a
cell. In particular, many neurodegenerative diseases display changes in mitochondrial
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structure and function (Bossy-Wetzel et al., 2003; Burté et al., 2015; Chen and Chan,
2009; Itoh et al., 2013; Knott et al., 2008). In the ALS SOD1-G93A model, we observed
contrasting changes in Oxphos gene expression between degeneration-vulnerable
Gprin3 and resistant Colgalt2, as well as baseline differential enrichment of these genes
in healthy Gprin3 cells over Colgalt2 cells (Chapter 4). We therefore set out to
determine if changes in gene expression reflect alterations in mitochondrial structure
that could be visualized at the subcellular level. We observed that in healthy Colgalt2
and Gprin3 cells, there is a slightly greater amount of Cox6c signal per mitochondrial
area in Gprin3 cells, but Colgalt2 cells show narrower cristae by EM (Figure 5.9). These
findings lie in opposition to each other, indicating that Gprin3 neurons display greater
levels of the Oxphos component Cox6c, but wider cristae that are associated with lower
levels of ATP synthesis. Because cristae width can be regulated at the level of energetic
demand based on activity patterns (Cserép et al., 2018), one possible explanation for
this finding is Colgalt2 neurons are more active than Gprin3 cells, and permitochondrion levels of Oxphos proteins that are higher than in Gprin3 neurons. It is
also possible that cristae width does not provide the best proxy for overall levels of ETC
proteins in these cells, or that the Oxphos enrichment that we observe in Gprin3 gene
expression reflects a cell-type specific assembly of ETC components. Indeed, it has
been shown that for Complex IV (COX) in particular, there are tissue-specific isoforms
that differ across cell types (Hüttemann et al., 2001; Stiburek et al., 2005). It is therefore
possible that different expression levels of Cox6c and other subunits observed between
Colgalt2 and Gprin3 cells do not reflect different levels of Oxphos, but rather cell-type
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Figure 5.9: Summary of mitochondrial morphology analysis in Colgalt2 and Gprin3
cells. Mitochondria of Colgalt2 cells (purple) appear to have narrower cristae by EM, but
fewer Cox6c puncta (red) per mitochondrial area than Gprin3 mitchondria (green). Gprin3
mitochondria appear to have wider cristae (left panel). In SOD1-G93A mitochondria
(blue), cristae of L5 cells appear to increase in size relative to healthy L5 mitochondria
(black; right panel)
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specific differences in complex make-up. These differences would still present a very
interesting avenue for the establishment of potential cell-type specific differences in how
ATP is synthesized, even if rates of synthesis are not affected by different subunit
composition of the ETC complexes.
Because metabolism appears to be affected with mutant SOD1 expression (Allen
et al., 2014), and because we observed contrasting changes in Oxphos gene
expression changes between resistant Colgalt2 and vulnerable Gprin3 cells (Chapter 4),
we next determined how these changes manifest themselves in mitochondrial structure
during disease. We found no significant changes in overt mitochondrial morphology in
Colgalt2 cells when SOD1-G93A was expressed, but observed that Gprin3 neurons
show a decrease in mitochondrial number coupled with an increase in individual
mitochondrion size. By EM, cristae widths appeared to increase in SOD1-G93A in both
Gprin3 mitochondria and GFP- neighboring mitochondria. These data indicate that in
Gprin3 cells, the overt size and number of mitochondria are regulated simultaneously
with inner mitochondrial membrane structure. In mutant SOD1 animals, dilated cristae
and overt vacuolization of mitochondria have been reported during disease progression
(Dal Canto and Gurney, 1995; Kong and Xu, 1998; Wong et al., 1995). The increased
width of Gprin3 cell cristae is consistent with these findings, and suggests that these
cells produce less ATP in the disease state. It is not clear to what extent this is causal to
cell death, however, as these changes appear to precede apoptosis in LMNs (Bendotti
et al., 2001). Additionally, the cristae widening we observed does not appear to be cell
type specific, as neighboring cells show a similar phenotype, suggesting it may be a
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generic response to SOD1-G93A expression. While we were not able to identify the
types of cells that composed these neighboring populations, whether glial or neuronal, it
is possible that dysfunction in these surrounding cells influences Gprin3 cells in a
likewise adverse way (Tripathi et al., 2017; Vargas et al., 2005). In order to understand
this further, we must perform the same assessment of mitochondrial structure in
Colgalt2 cells during disease, and compare the changes to changes in neighboring
cells. It will also be important to identify the cell types that represent these neighboring
populations, particularly because neighboring astrocytes may be experiencing
mitochondrial dysfunction as well (Cassina et al., 2008).
We next wanted to understand how modulation of Oxphos gene expression may
affect disease progression by employing both global and cell-type specific inducers of
respiration and Oxphos gene expression. Neither strategy provided conclusive results
with regards to disease progression or survival, as there were various technical
limitations with each strategy. This does not except dysfunction of mitochondria from
affecting

disease

progression,

however,

because

our

sequencing

data

and

morphological analyses suggest that there may be disease-related changes in
mitochondrial function in L5b cells. Given the link between mitochondrial dysfunction
and neurodegenerative diseases, including ALS (Chen and Chan, 2009; Cozzolino et al.,
2013; Lin and Beal, 2006; Moreira et al., 2010), it is very much worth exploring how cell
type-specific changes in mitochondrial structure and function affect the health of the
vulnerable LL5b cells in ALS, particularly in the context of underlying cell-specific
differences in respiration in the healthy brain.
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CHAPTER 6:
Finding markers for L5 cell types in human motor cortex

The diversity of L5b projection neuron types in the motor cortex of rodents is only
now being elucidated. Using BAC transgenic animals expressing TRAP, we have shown
that in mice, M1 L5b contains two distinct populations of corticofugal neurons that each
occupies its own discrete sublayer. Colgalt2 cells of the upper L5b sublayer (UL5b)
project to the pons but not spinal cord, while Gprin3 neurons found in the lower sublayer
(LL5b) project to both the pons and the spinal cord (see Chapter 2). This newly
described heterogeneity in L5b cell type identity in mouse M1 now raises the question of
whether a similar diversity exists across L5 of the motor cortex in other species. This is
particularly important to understand in the context of ALS, where we show that
corticospinal LL5b Gprin3 cells are vulnerable to degeneration. Because corticospinal
neurons of the human primary motor cortex are thought to be the most vulnerable
cortical population in ALS (Eisen and Weber, 2001; Eisen et al., 1992; Tandan and
Bradley, 1985), it is important to understand whether our mouse findings represent a
cell type-specific vulnerability that recapitulates the human condition. Uncovering the
cell-type specificity of L5 neuron degeneration in human ALS would ultimately allow us
to explore the translatability of our findings in ALS mouse models to relevance in human
disease.
The cell type diversity of human cortex has been challenging to define. While
many

have

shown

the

laminar

distributions
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of

single

markers

through

immunohistochemical staining (see Jacobs et al., 2018), they have rarely been able to
determine the cell type-specificity of these markers across neurons in the same layer.
This is primarily due to the technical limitations present in performing combinatorial
immunofluorescence staining in tissues that, through the various stages of post-mortem
handling, develop high levels of auto-fluorescence. However, combinatorial marker
staining through multi-channel immunofluorescence is required to understand the
molecular overlap of different cortical populations in the absence of anatomical tracing
and transgenic reporters. For this reason, we set out to first establish a reliable
immunofluorescence protocol for human neuronal staining and visualization in the
primary motor cortex. Using the molecular profiles for the distinct mouse L5b cell types
available through our Gprin3 TRAP profiling, we also sought out a combination of
markers that can allow us to distinguish populations of L5 cells across mouse and
human motor cortex. With the EGFP expressed in these TRAP cells, we are additionally
able validate the specificity of candidate markers to L5b cells. With these markers, we
aim to not only characterize the heterogeneity of L5 pyramidal neuron types in this
region of cortex, but also to provide a system for reliably visualizing the populations of
cells that are relevant to cortical degeneration in ALS.

6.1 Narrowing down candidate markers for L5b cells across species.
In order to identify combinations of markers that are able to distinguish L5b
subpopulations in mouse and human tissue, we first generated a list of possible
candidate genes thought to be specifically expressed in L5 cells. Using a combination of
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TRAP data, available ISH data from the Allen Brain Atlas, as well as previously reported
markers for L5b cells, a set of candidate genes was generated (Table 6.1). We tested
antibodies against these markers, or in situ hybridization (ISH) probes when efficacious
antibodies could not be obtained, and assessed the specific localization of staining
within L5b of mouse M1. Results from this screen are summarized in Table 6.1. We
found that in some cases, markers were distributed across more layers than just L5b in
mouse (labeled “~Yes” in Table 6.1), but were still included for human L5 marker
screening as long as strong staining in mouse L5b cells was evident. Many of the
markers that showed L5b staining in mouse did not work in human primary motor cortex
staining (labeled “No” in Table 6.1), however we did see L5 staining for three of the
markers that we tested across mouse and human tissue: Pcp4, SMI-32 (a nonphosphorylated variant of Nefh) and Crym (Figure 6.1). Pcp4 was more broadly
distributed across all cells in the deep layers of mouse M1 from L5a to L6a (Figure 6.1A,
top panel). Crym was visible in what appeared to be LL5b cells, but was also observed
in some L6a cells (Figure 6.1A, middle panel). SMI-32 appeared to more selectively
label neurons across upper and lower L5b, with very few cells observed in other layers
(Figure 6.1A, bottom panels). In human motor cortex, Pcp4 staining appeared to be
principally localized to a visually estimated L5, with a small subset of cells visible in L3
(Figure 6.1B, top panel). Crym staining appeared to label L5 cells exclusively (Figure
6.1B, middle panel), while SMI-32 appeared to label a diverse set of neurons across L5
and L3 (Figure 6.1B, lower panel). Because they appeared to more selectively label
specific subpopulations of L5b cells in the mouse, we selected Crym and Nefh/SMI-32
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Table 6.1: Candidate markers for L5b cells across species. If marker appeared to
specifically stain L5b in M1 of either mouse or human, it appears labeled as “Yes”. If a
marker stained L5b cells as well as other cells in the cortex, it is labeled as “~Yes”. If a
marker failed to stain L5b cells, it appears labeled as “No”. Markers were selected based
on apparent specificity in published studies, Allen Brain Atlas data, and RNA-Seq data
from motor cortex.

Markers for L5b cells across species
Marker

Stains L5b in Mouse

Stains L5b in Human

Bcat1

Yes

No

Crim1

No

No

Crym

~Yes

Yes

Cygb

No

No

Gng7

Yes

No

Lypd1

~Yes

No

Nefh, aka SMI-32

Yes

~Yes

Nurr1

No

No

Pcp4

~Yes

Yes

Penk

No

No

Scn4b

Yes

No

Sh3bgrl2

No

No
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Figure 6.1 Staining for Pcp4, Crym, and SMI-32 in mouse and human tissue allows
for visualization of deep layer neurons in the motor cortex. (A) Representative
confocal images of Pcp4 and SMI-32 immunofluorescence, and Crym FISH, showing the
laminar distribution of signal across mouse motor cortex. Solid white lines indicate the
visually estimated dorsal and ventral boundaries of L5b, with the dashed line showing the
approximate location of the subdivision between UL5b and LL5b (scale bar = 300 µm).
(B) Representative confocal images of Pcp4, Crym, and SMI-32 immunostaining in
human motor cortex. Solid white lines indicate visually estimated dorsal and ventral
boundaries of L5 in each section (scale bar = 500 µm).
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as our markers of interest for determining subpopulation distributions across L5 in
mouse and human primary motor cortex. Additionally, Crym and SMI-32 have been
individually used to label L5 neurons across species in other studies, with SMI-32 the
most commonly used to visualize large neurons in the motor cortex of many animals
(Arlotta et al., 2005; Campbell and Morrison, 1989; Fink et al., 2015; Molnár and
Cheung, 2006; Rouaux and Arlotta, 2013). We therefore additionally took this as an
opportunity to clarify the subpopulation specificity of these markers within L5 of mouse
and human.

6.2 Crym and Nefh ISH label populations of neurons in L5b of mouse primary
motor cortex.
Crym and SMI-32 have previously been used as markers for L5b cells (Arlotta et
al., 2005; Campbell and Morrison, 1989; Fink et al., 2015; Molnár and Cheung, 2006;
Rouaux and Arlotta, 2013). However, until recently, the heterogeneity of cell types in
L5b was poorly understood, so it was not clear what subpopulations may be targeted in
staining

for

these

markers.

Unfortunately,

we

were

not

able

to

visualize

immunofluorescence staining for Crym tissue sections, so we opted to instead perform
fluorescence in situ hybridization (FISH) on sections from Gprin3-TRAP brains using
probes against Crym and Nefh to determine marker co-localization with our LL5b cell
types. Immunofluorescence staining for GFP was performed following ISH for these
markers, and the sections were imaged by confocal microscopy (Figure 6.2A). Crym+
cells were distributed across the deepest layers of the cortex, including L5a and L6a
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Figure 6.2: FISH against Crym and Nefh labels populations of L5b cells in M1 of
mouse. (A) Representative confocal images of Gprin3 M1 showing GFP immunostaining
(green; top row), Crym ISH (red; middle row), and Nefh ISH (magenta; bottom row). In
L5b, Crym is primarily observed in LL5b, while Nefh signal appears to span both UL5b
and LL5b. Solid white lines delineate the estimated upper and lower boundaries of L5b,
and dashed white line indicates the approximate division between UL5b and LL5b (scale
bar = 300 µm). (B) Heatmaps indicating the depths of L5b marker+ cells within L5b,
shown as percent of depth from the pial surface and represented as frequency of
appearance at that depth. Gprin3 cells (green; n = 62 cells) were found deep in the cortex
at ~75% depth, and represent a LL5b population. Crym+ cells (red; n = 106 cells) were
also seen at this depth, suggesting they also label LL5b cells. Nefh+ cells (magenta; n =
183 cells) were found in this LL5b region as well as superficially, in what is likely UL5b.
Frequencies ≥ 6 are shown in the same shade to more readily highlight the depths at
which cells were the most concentrated. (C) Quantification for co-localization of Gprin3
GFP (n = 73 cells) with Crym and Nefh ISH labeling. 92% of GFP+ cells were Crym+ (red
outline) and 89% of GFP+ cells were Nefh+ (magenta outline; bars show mean ± SEM).
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(Figure 6.2A, middle panel), but within L5b, were only observed in the lower sublayer
(Figure 6.2B). Nefh+ cells in L5b were instead distributed across both sublayers of M1
L5b (Figure 6.2A, bottom panel), although their distribution appeared to be slightly more
concentrated to LL5b (Figure 6.2B). Crym co-localized with 92% of Gprin3 cells, and
Nefh co-localized with 89% of Gprin3 cells (Figure 6.2C). These data suggest that while
Nefh may label cells across both sublayers of L5b based on its broader distribution
across this layer, Crym appears to more exclusively label the corticospinal Gprin3
population over other L5b cells. We will need to carry out the same marker staining
approach in Colgalt2 tissues to determine the specificity of these markers in UL5b, but
with these results, we have established a combinatorial set of markers that may allow
for the visualization of this LL5b population in non-transgenic animals.

6.3 Crym and SMI-32 staining allows for visualization of L5 cells in human primary
motor cortex.
To determine if Crym and Nefh additionally allow for visualization of L5 cell types
in human motor cortex, we performed dual staining for Crym and SMI-32 (the nonphosphorylated variant of Nefh), in human primary motor cortex sections (Figure 6.3).
Paraffin-embedded blocks of different regions of motor cortex were sectioned to
between 10 and 14 µm (depending on brain bank source). Slides with mounted sections
were deparaffinized before performing acid and heat-based antigen retrieval and
immunofluorescence staining. Images of Crym and SMI-32 immunostained sections
were then collected by confocal microscopy. Boundaries of cortical lamination were
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estimated visually based on neuron size and approximate depth, and with the help of
published data on cortical lamination in primates. In a lateral area of motor cortex
associated with the control of facial and neck muscles (Figure 6.3A, see Penfield and
Boldrey, 1937), the distribution of SMI-32+ cells appeared broad. Large SMI-32+ cells
were observed in deep L3, with a subset of SMI-32+ cells in L5 showing lower levels of
signal (Figure 6.3B, right panel). The distribution of SMI-32 staining that we observed
here is consistent with previously reported localization of SMI-32+ cells across different
areas of primate cortex (Campbell and Morrison, 1989). Additionally, this distribution is
distinct from what we observed for Nefh staining in mouse, where Nefh+ cells were
found almost entirely in L5b. Crym+ cells in the lateral region of human motor cortex
were observed in deeper L5, with a small subset of cells positive for both Crym and
SMI-32 found at this depth. In a medial area of motor cortex that maps to limb control
(Figure 6.3A), a subset of SMI-32+ cells was also observed in deep L3, with the majority
of SMI-32+ cells localizing to L5 (Figure 6.3B, right panel). Many of the SMI-32+ cells in
L5 appeared to also be positive for Crym in this medial region, with the exception of the
occasional very large pyramidal neuron that appeared to be selectively positive for SMI32 (white arrow in Figure 6.3B, right panel). These anatomical data suggest that, even
across different subregions of human motor cortex, the laminar distribution of Crym and
SMI-32+ cells can vary, and that this may represent a diversity of L5 cell types in these
areas.
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Figure 6.3: Crym and SMI-32 staining reveals distinct laminar populations of cells
across human primary motor cortex. (A) Schematic representation of the regions of
primary motor cortex that were targeted for staining. The medial region of motor cortex
functionally maps to limb regions, and is thought to be the primary area containing Betz
cells. The lateral area maps to facial regions and is thought to not contain many
corticomotoneurons. Axial legend is shown in the bottom right (D = dorsal, V = ventral, M
= medial, L = lateral). (B) Representative confocal images showing the laminar
distribution of Crym and SMI-32 marker immunostaining in lateral motor cortex (left) and
medial motor cortex (right). In lateral motor cortex, Crym (red) appeared to specifically
label a population of L5 cells. SMI-32 (green) strongly labeled a population of large L3
cells and weakly labeled a subset of L5 cells. In medial motor cortex, Crym again
appeared to specifically label a population of L5 cells. SMI-32 in this medial region also
strongly labeled the same subset of L5 cells, and weakly labeled a small subset of L3
cells. Occasionally, a very large SMI-32+ cell that was negative for Crym was also seen
in L5 of this medial region (white arrow). Approximate layer boundaries according to cell
sizes and published marker distributions.
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6.4 Basic distinguishing features of marker-positive cells in medial human motor
cortex and mouse M1.
In order to determine if human and mouse L5 share similar Crym and SMI-32 cell
type composition and features, we broadly assessed the population make-up of the
marker stained cells, as well the relative size for each type across species. In LL5b of
mouse M1, 64% of labeled cells were positive for both Crym and Nefh ISH, 31% were
positive for Nefh only, and 5% were positive for Crym only (Figure 6.4C). Using Gprin3
GFP as a marker for corticospinal identity, we then assessed the population make-up of
corticospinal LL5b cells (Figure 6.4A). 90% of Gprin3 cells were positive for both Crym
and Nefh, 7% were positive for Nefh only, and 3% were positive for Crym only (Figure
6.4C). The Gprin3 population that was positive for only Nefh did not show any difference
in soma size to Gprin3 cells that were positive for both Crym and Nefh (Figure 6.4D).
Together, these data suggest that, while marker stained cells do not differ in size, even
within LL5b, there may be further subpopulations of neurons that have yet to be defined.
In human medial motor cortex, Crym and SMI-32 double positive cells made up
96% of labeled cells in L5 (Figure 6.4B-C). Additionally, we observed a very small
proportion of L5 cells (3%) that showed strong SMI-32 signal, but weakly stained or did
not stain for Crym. These SMI-32-positive/Crym-negative cells display significantly
larger soma than the rest of the Crym+ population of L5 cells (Figure 6.4E), and were
primarily found in deep L5. The very large neurons that reside in the medial regions of
motor cortex in L5 of human motor cortex are thought to represent the
corticomotoneuron Betz cell population important for dexterous movement of proximal
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Figure 6.4: Crym and SMI-32 staining can anatomically dissociate putative Betz
cells from other neurons in L5 of human motor cortex. (A) Representative images of
LL5b Gprin3 cells in mouse M1, stained for GFP (green), Crym ISH (blue), and Nefh ISH
(red). Most GFP+ cells stain positive for both Crym and Nefh ISH (left), with a small
subset only staining positive for Nefh ISH (right; scale bar = 25 µm). (B) Representative
images of human L5 cells that were double-positive for Crym (red) and SMI-32 (green;
left), and a putative Betz cell that was only positive for SMI-32 (scale bar = 50 µm). (C)
Stacked bar graphs show composition of marker+ cells for all cells in LL5b, Gprin3 GFP+
cells in LL5b, and human L5. Across all of mouse LL5b (including GFP+ and GFP- cells),
64% of cells are double positive for Crym and Nefh ISH (blue bar), 31% were positive for
only Nefh ISH (magenta bar), and 5% were positive for Crym ISH (red bar; n = 229 cells).
90% of LL5b Gprin3 cells are positive for both Crym and Nefh ISH, 7% were only Nefh
ISH+, and 3% were only Crym ISH+ (n = 60 cells). In human, 96% of L5 cells are positive
for both Crym and SMI-32, with remaining 4% showing only SMI-32 labeling (n = 158
cells). (D-E) Quantifications of soma size for different marker+ cell types in mouse LL5b
and human L5. In mouse (D), all cell types appeared to be of similar size (Both n = 19
cells; Nefh only n = 24 cells; n.s. = not significant by two-tailed t-test).In human (E), cells
that were positive for only SMI-32 tended to be larger than cells that were double-positive
for Crym and SMI-32 (Both n = 54 cells; SMI-32 only n = 11; ****p < 0.0001 in two-tailed
t-test).
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and distal limbs (Kaiserman-Abramof and Peters, 1972; Rivara et al., 2003; Walshe,
1942). Our marker staining suggests that the very large L5 cells that we observed as
being SMI-32-positive and Crym-negative in medial motor cortex may also represent
this Betz cell population. If so, these results present the first combinatorial molecular
marker staining that has dissociated Betz cells from the broader L5 population of human
primary motor cortex.
Together, these anatomical data suggest that using Crym and SMI-32 marker
staining in tandem can reveal diverse populations of L5 cell types across both mouse
and human motor cortex, and that even within the mouse corticospinal population
(represented by Gprin3), there may be more cell type heterogeneity than originally
thought. More experiments must be carried out to understand the anatomical and
molecular relationship between these L5 cells across species, particularly if the Gprin3
cells are to be treated as representative of ALS-vulnerable populations in humans.

6.5 Discussion
Parsing the cell types that compose the human cortex has proven very difficult.
Without the ability to perform anatomical tracing, differentiating the cell types by
projection pattern in tissue has not been possible. Cell types in the motor cortex have
until now primarily been classified by their electrophysiological responses during
functional motor tasks in vivo (Phillips, 1956), and by their relative cell body sizes in
tissue sections (Kaiserman-Abramof and Peters, 1972; Rivara et al., 2003). Discovering
markers that allow us to visually distinguish motor cortical cell types from each other
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would greatly advance our ability to anatomically characterize subpopulations of L5 cells
in both healthy and disease tissues.
In rodents, it is possible to easily screen markers for specific neuronal
subpopulations alongside anatomical tracing or transgenic cell type reporters. However,
the extent to which these populations represent human neuron types is a subject of
much controversy, particularly in the motor cortex, where the divergence in axonal
projection anatomy and functional contributions of this area to movement across
species are readily evident (see Lemon and Griffiths, 2005; Yoshida and Isa, 2018). But
in order to begin establishing cell type relationships across L5 of rodents and primates,
we must first determine the cellular make-up of the population important for motor
cortex output.
We set out to screen various putative L5 markers and their antibodies for the
ability to stain specific subpopulation of L5b cell types in mouse and human motor
cortex. We show that staining for Crym and SMI-32 (a variant of Nefh), markers
previously used separately to visualize populations of L5b cells across species, can
successfully be carried out in tandem in post-mortem, fixed human cortex sections. In
combination, these markers reveal distinct subpopulations of L5 cells in human: a
Crym+/SMI-32+ population that appears to account for the vast majority of L5 cells in
the medial motor region and likely includes corticospinal neurons, and a subset that is
only positive for SMI-32 (Figure 6.5). This cells of the latter population are not only
larger than their Crym+ counterparts, but it is only found in medial and not lateral
regions of the motor cortex of the human. These characteristics suggest that these
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Figure 6.5: Summary of Crym and SMI-32 L5 cell type distribution across mouse
and human motor cortex. Within L5b of the mouse, Crym staining (red) appears to be
primarily restricted to LL5b, where cells are primarily double positive for Crym and SMI-32
(yellow). Rare subsets of LL5b cells only stain positive for either SMI-32 (green) or Crym.
In human medial motor cortex, L5 shows a majority of pyramidal neurons that are positive
for both Crym and SMI-32. Rarely, a very large SMI-32+ neuron is seen among these
cells. These may be Betz cells
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neurons may be Betz cells, which are thought to be corticomotoneurons that synapse
directly onto alpha motor neurons of the spinal cord (Kaiserman-Abramof and Peters,
1972; Walshe, 1942). It is thought that these neurons participate in the control of
proximal and distal limb movements and produce dexterous movement by so doing
(Heffner and Masterton, 1983; Yoshida and Isa, 2018). Until now, Betz cells have been
typically identified solely by their large size relative to other L5 cells (Braak et al., 2017;
Genç et al., 2017; Hammer et al., 1979). However, in conditions where Betz cells
atrophy and therefore change in size (Genç et al., 2017), this strategy would not allow
for the identification of Betz cells that fall below a size threshold due to pathological
changes. For this reason, having markers that can be used to visualize these cells
reliably is key for further study of changes in Betz cell morphology and number in
diseases such as ALS.
Even with marker staining, we cannot know whether the Crym+/SMI-32+ human
L5 cells that we observe share the same anatomical identity as Gprin3 cells by
projection pattern. In other words, if a subset of Crym-/Nefh+ Gprin3 cells molecularly
represents a Betz-like population that projects directly onto alpha motor neurons, why
does this Gprin3 subpopulation not directly innervate spinal motor neurons in the
mouse? Interestingly, during post-natal rodent development, a subset of corticospinal
projection cells extend a collateral axon into the ventral horn that is then retracted (Gu
et al., 2017b; Kuang and Kalil, 1994; Maeda et al., 2016). If these collaterals are instead
allowed to endure by conditionally knocking-out PlexA1, a semaphorin receptor that is
important in axon guidance and pruning (Bagri et al., 2003; Winberg et al., 1998), these
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animals outperform WT mice in dexterous movement tasks (Gu et al., 2017a). This
suggests that while LL5b cells of M1 may not directly innervate alpha motor neurons in
mice, they may have the capacity to do so. Does this mean that the molecular identity of
the corticospinal population is similar to Betz cells even transiently? This may be
reflected in their molecular identity, so it would be very interesting to determine to what
extent a corticomotoneuron Gprin3 population in PlexA1 cKO mice overlaps with
corticospinal and cortiomotorneuron populations in human motor cortex.
While it is currently not feasible to confirm the corticospinal identity of our marker+
cells in human tissue, however, it may be possible to do so in non-human primates,
which also contain Betz cells in primary motor cortex (Jacobs et al., 2018). Staining for
Crym and Nefh in non-human primate non-human primate (NHP) motor cortex, coupled
with retrograde tracing from the spinal cord, could give us a better understanding of how
translatable this marker identity for corticospinal neurons is across rodents and
primates. Extrapolating the projection patterns and marker staining of NHP Betz cells to
human Betz cells is likely the only way to know how well our combinatorial marker
staining distinguishes cells based on projection identity. Corroborating marker staining
with NHP anatomical tracing would also allow us to determine with greater certainty,
what neuron types in human L5 are likely the most vulnerable in ALS, and to
understand to what extent projection identity contributes to this vulnerability. Using our
markers, we should therefore attempt to determine whether Crym+ and Nefh+ cell types
show greater vulnerability in disease, and whether loss of these cells reflects
corticospinal neuron vulnerability in ALS.
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CHAPTER 7:
Study Conclusions

This study represents an endeavor to determine how cortical L5b neurons of
primary motor cortex are uniquely defined in both healthy and disease contexts. Using a
combination of anatomical, molecular, and sequencing techniques, we have begun to
outline the features that distinguish these cells, and how these features may be relevant
in the study of cell type-specific vulnerability in ALS.
We show that L5b is laminarly composed of two distinct sublayers: upper L5b
(UL5b) and lower L5b (LL5b; Chapter 2, Figure 2.14). UL5b contains cells that project to
the pons but not the spinal cord (Figure 1.4). LL5b instead contains neurons that send
axon collaterals to both the pons and cervical spinal cord. Using BAC transgenic
animals, we show that two cell types that occupy these sublayers, Colgalt2 cells of
UL5b and Gprin3 cells of LL5b, appear to be molecularly similar by TRAP RNA-Seq
relative to other cell types in the cortex, but are nevertheless distinct in ways that may
be functionally important. In an animal model of ALS carrying the SOD1-G93A mutation,
the Colgalt2 population does not degenerate, while the Gprin3 population is lost as the
disease progresses (Chapter 3, Figure 3.5). Colgalt2 cells appear to increase their
levels of Oxphos gene expression during disease, while Gpri3 cells decrease it (Chapter
4, Figure 4.11), potentially revealing a coping strategy in the case of Colgalt2 cells, and
a dysfunctional mechanism in the case of Gprin3 cells. Underlying these diseaserelated changes are intrinsic differences in mitochondria between the two cell types that
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may predispose the cells to differentially respond to mutant SOD1 expression. Finally,
we show that gene expression profiles of these L5b cells in mouse primary motor cortex
can be used to screen for markers of L5 cells in human primary motor cortex (Chapter
6, Figure 6.5), and that these markers allow for distinguishing a putative ALS-vulnerable
Betz cell population from other pyramidal neurons in L5.
The projection patterns of L5 of the cortex have been broadly characterized
(Arlotta et al., 2005; Economo et al., 2018; Feng et al., 2000; Gerfen et al., 2016;
Oswald et al., 2013). While it was known that deep layer 5b cortiospinal neurons in the
motor cortex have collateral projections to the pons in rodents (Heffner et al., 1990;
Ugolini and Kuypers, 1986), we and others are providing novel evidence that reveals
that within M1 L5b, there exists an upper sublayer just above the corticospinal L5b cells
that contains a second corticofugal population that projects no further than the pons
(Chapter 2; Economo et al., 2018). Independently, the corticopontine population has
been described for many regions of the cortex across many species (Leergaard and
Lakke, 1995; Moya et al., 2014; Wiesendanger and Wiesendanger, 1979; 1982). During
early post-natal development in the visual cortex, these corticopontine are initially
corticospinal and have a collateral to the pons. By ~P10, the spinal collateral is retracted
(Stanfield and O'Leary, 1985). A similar pattern of development was incidentally
described for corticopontine cells of the primary motor cortex (Wang et al., 2017).
Indeed it appears that the field has been circling around the discovery of two distinct
corticofugal populations in M1 L5b for a long time but, due to limitations in the ability to
simultaneously visualize multiple cell types, has not managed to distinguish them from
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each other. The ability to independently visualize the two populations studied here using
BAC transgenics, with the help of retrograde labeling, was invaluable in being able to
distinguish these populations.
Layer 5b pyramidal neurons in primary motor cortex of rodents were already
known to be vulnerable in human ALS and its models (Hammer et al., 1979; Ozdinler et
al., 2011; Tandan and Bradley, 1985; Zang and Cheema, 2002). Because the
heterogeneity of L5b corticofugal populations in M1 L5b had not yet been established,
the cellular specificity of this loss has not been addressed. Our corticopontine Colgalt2
and corticospinal Gprin3 TRAP lines allowed us to confirm that neuronal loss appears to
be specific to corticospinal L5b neurons in M1, rather than affecting all L5b projection
neurons. Additionally, the expression of the TRAP construct in these cells presented us
with the opportunity to molecularly profile a vulnerable and a closely related, but
resistant, population for innately distinct features, as well as unique responses to
expression of mutant SOD1. These experiments revealed that UL5b cells respond by
up-regulating Oxphos gene expression, while LL5b cells down-regulate the expression
of these metabolic genes (Chapter 4, Figure 4.11). We also observe that the baseline
levels of Oxphos gene expression between these two cell types are different, with LL5b
Gprin3 cells displaying 2.8x greater levels of expression than Colgalt2 cells.
Very few studies in ALS have attempted to determine the cell type-specificity of
molecular changes in disease. This is of course extremely valuable, as slowing disease
progression is valuable in the management of ALS in humans. However, from a basic
research standpoint, the truly fundamental question in ALS remains: Why do
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corticospinal motor neurons and spinal motor neurons selectively degenerate in this
disease? And how is it that many different mutations can lead to the specific
degeneration of these populations? Because ALS is not a monogenic disease, we must
consider how the cells may instead be broadly incapable of coping with the stress of
different types of mutant insult. And so the discussion of cell type specific vulnerability
leads us think about how the unique features of these cells may be exploited by all of
the mutations associated with ALS.
We have two examples of cell-type specific degeneration in discrete CNS
structures that allow us to explore possible theories: corticospinal neuron loss in L5b of
the motor cortex, and alpha motor neuron loss in the ventral horn of the spinal cord. The
intrinsic features uniquely shared by these two neurons may help us understand what
establishes them as the most vulnerable in the disease. For instance, within their
respective regions, these cells are among the largest, as they have very large soma
relative to other cell types in the same structure. They also have the longest axons in
the CNS, with terminals extending to very distal regions. These two structural features
likely require a great deal of energy to maintain, and in fact, our data suggest that
corticospinal LL5b cells express Oxphos genes at higher levels than their more
proximally-projecting UL5b counterparts (Chapters 2, Figure 2.14 and 4, Figure 4.11). If
one additionally considers that motor neurons display high levels of electrophysiological
activation during motor behaviors (Burke et al., 1973; Evarts, 1966; 1968; Thach, 1978)
that also demand a great deal of energy to produce, we begin to paint a picture of two
cell types that must tightly control energetic homeostasis to maintain proper functioning.

135

Disruptions to this metabolic balance via dysfunction of antioxidant mechanisms in the
case of mutant SOD1, or by introducing additional sources of energetic demand in the
form of irreversible stress granule formation in the case of mutant TDP-43, FUS, and
C9orf72 (Mori et al., 2013; Tan et al., 2007; Vance et al., 2009), could have catastrophic
effects in these neurons. Diverting metabolic resources to coping with these
dysfunctions could eventually lead the cells to degenerate. In support of this idea, we
observe an increase in Oxphos gene expression during disease in UL5b Colgalt2 cells
that are resistant to degeneration in the SOD1-G93A model (Chapter 4, Figure 4.11).
Perhaps coping with mutant SOD1 expression requires that respiration be increased to
provide sufficient energy to fuel mechanisms that mitigate mutant SOD1 damage. In the
case of LL5b Gprin3 cells that do degenerate, they may not be able to sufficiently
increase Oxphos gene expression because they already express these genes at such
high levels in their baseline state. Thus the inability to energetically cope with cellular
dysfunction may be what ultimately leads to their loss. But these theories require us to
more carefully understand the causal link between respiration and cell death in the
context of ALS mutations, and to carefully confirm the changes in mitochondrial ATPsynthesis occurring in cells during disease progression.
Another important consideration in the cell type-specificity of vulnerability that we
observe is the contribution of the anatomical projection itself. The fact that
corticomotoneurons in the human motor cortex directly innervate LMNs (KaisermanAbramof and Peters, 1972; Walshe, 1942) has led many in the field to consider that the
disease and its associated dysfunctions may be propagated from one cell type to
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another via some mechanism of transfer. The “dying-forward” hypothesis for disease
spread, in particular, has a basis in many studies of dysfunction and symptom origin
during pathology. For instance, it has been shown that UMNs develop a
hyperexcitability phenotype pre-symptomatically in disease (Eisen et al., 1993; Mills,
2003; Mills and Nithi, 1997). It is thought that this increased activity drives the
downstream LMNs to stress in forcing an electrophysiological response. The “dyingback” hypothesis also has some basis in ALS symptomology, where some patients
display the muscle weakness and fatigability associated with LMN loss before showing
signs of tremor and fasiculation that are more associated with UMN loss (Ravits et al.,
2007). In this scenario, antidromic stimulation initiated at the UMN-LMN synapse could
propagate a hyperexcitability phenotype originating in LMNs. For both “dying-back” and
“dying-forward”, the transfer of misfolded and aggregated protein from one motor
neuron to another via a prion-like mechanism has also been posited as a possible
mechanism of disease propagation along this circuit (see Braak et al., 2013b; Münch et
al., 2011; Polymenidou and Cleveland, 2011). But while the direct projection of human
corticomotoneurons onto LMNs allows us to consider the possibility of direct transfer of
disease between these cells, it is important to remember that in mice, there is no direct
projection between vulnerable corticospinal neurons and alpha motor neurons (see
Chapter 2, Figure 2.14), and yet degeneration of these cells is still observed. The
intermediate spinal neuron population that exists to disynaptically transmit information
from the cortex to the spinomuscular system has not been thoroughly characterized.
Markers for these cells are now being established (Ueno et al., 2018), which will be
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important tools in the study of potential disease propagation across spinal synapses in
the ALS mouse. Until we can understand how all the cells of this corticospinomuscular
circuit are affected during disease progression, we will not be able to determine how the
corticospinal projection of LL5b cells contributes to establishing their vulnerability in this
disease.
The divergence in corticospinal projection anatomy between rodents and primates
has been a subject of much evolutionary debate. Functionally, corticospinal neuron
populations across rodents and primates function in the control of voluntary movement
and in motor learning (Deecke et al., 1969; Evarts, 1966; 1968; Fischer, 1967; Guo et
al., 2015; Kawai et al., 2015; Lashley, 1924; Thach, 1978; Wang et al., 2017). The direct
projections observed for primate corticomotoneurons are thought to additionally be
important for the execution of more dexterous movements by prehensile appendages in
primate species (Heffner and Masterton, 1983; Yoshida and Isa, 2018). Rodents display
a relatively simple repertoire of movements, even for trained dexterous behaviors (Guo
et al., 2015; Wang et al., 2017), all of which can be carried out without a direct
projection onto spinal motor neurons. The innate species divergence in corticospinal
projection anatomy between dexterous and non-dexterous mammals therefore leaves
open the question of whether L5b cell types across these species are molecularly
related.
We show here that corticospinal LL5b Gprin3 cells, despite not having a direct
projection onto alpha motor neurons, show the vulnerability in ALS that has been shown
for corticomotoneurons of the human motor cortex (see Chapter 3, Figure 3.5; Braak et
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al., 2017; Genç et al., 2017; Hammer et al., 1979; Tandan and Bradley, 1985). We
therefore ask how L5 cell types may be related to each other across these species.
Understanding whether molecularly defined L5 cell types of human motor cortex exist in
mouse motor cortex may allow us to translate the molecular findings from studies of
disease rodent models to relevance in human ALS. In this work, we show that markers
identified from molecular and anatomical studies of LL5b Gprin3 cells can be used to
visualize populations of L5 cells in the human motor cortex (Chapter 6, Figure 6.5).
Additionally, we were able to use a combinatorial staining approach for Crym and SMI32 to distinguish a potential Betz corticomotoneuronal cell type from the broader
population of L5 cells. These markers will be useful in further understanding the
relationship between corticospinal and corticomotoneuronal populations across species,
and will allow for the characterization of cell type specificity of L5 neuronal loss in
human ALS.
Together, the findings of this study carry forward our understanding of cell typespecific features that define L5b corticofugal cell types in health and disease. We hope
that these findings help to inform studies of motor cortical anatomy across species and
ALS disease mechanisms in the motor cortex.
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MATERIALS AND METHODS
Animals
All animal procedures and experiments were done with approval from The Rockefeller
University Institutional Animal Care and Use Committee (IACUC) and in accordance
with National Institutes of Health (NIH) policies and guidelines.
Colgalt2-TRAP DU9 and Gprin3-TRAP ES152 mice, as well as TRAP lines for other
cortical cell types, were generated using BAC methods and transgenics (Gong et al.,
2010; 2002) at The Rockefeller University. Sequence homology to the region upstream
of the ATG start codon of the Colgalt2 and Gprin3 genes was cloned into the pS296
targeting vector (Heiman et al., 2008) containing EGFP-L10a. Recombination was
performed in competent DH10β bacteria containing a pSV1.RecA plasmid by
electroporating the BAC into the cells. The modified BAC was isolated and
microinjected into the pronuclei of fertilized FVB/N mouse oocytes at 0.5 ng/μl.
Transgenic founder mice were generated and crossed to C57BL/6J mice. F1 progeny
were

screened

for

proper

transgene

expression

by

EGFP

genotyping

and

immunohistochemistry. Expression in L5b was used a benchmark for transgenic line
expansion. C57Bl/6J (Jackson Laboratory, #000664) were used for breeding in this
study. The Tg(SOD1*G93A)1Gur mice (Jackson Laboratory, #002726) were used for
ALS work.
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Plasmids and vectors
The pAAV-CMV-Flag-PGC1a-6His was a gift from Connie Cepko (Addgene plasmid
#67637; http://n2t.net/addgene:67637; RRID:Addgene_67637). The plasmid was
unedited before packaging into the retroAAV2 (or “SL1; Tervo et al., 2016) virus in
collaboration with the Janelia Farm Viral core. The MitoGFP construct was acquired
from the pLYS1-FLAG-MitoGFP-HA plasmid, as a gift from Vamsi Mootha (Addgene
plasmid #50057; http://n2t.net/addgene:50057; RRID:Addgene_50057). The coding
region was cloned into a Cre-dependent DIO pAAV plasmid (Nectow et al., 2017) by
adding plasmid sequence homology to the MitoGFP insert at its 5’ and 3’ ends. The
virus was then packaged into AAV2/9 by UPenn Viral Vector core. The TOMM20mCherry construct was also acquired from the mCherry-TOMM20-N-10 plasmid, as a
gift from Michael Davidson (Addgene plasmid #55146; http://n2t.net/addgene:55146;
RRID:Addgene_55146), and was cloned by homologous recombination into a non-Credependent version of the above pAAV plasmid for constitutive expression. The
construct was packaged into the “SL1” virus in collaboration with the Janelia Farm Viral
core. PCR to add sequence homology was performed using CloneAmp HIFI PCR
reagents (Takara). All cloning reactions were carried out using the In-Fusion HD cloning
system (Takara) for homologous recombination insertion.
The following primer sequences were used to add sequence homology for homologous
recombination cloning reactions:
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Cloning reaction

FWD/REV

Sequence (5’ to 3’)

MitoGFP into DIO pAAV

FWD

TCGTGAGGTACCGGATCCATGGCGGCCG

REV

GCTTGATATCGAATTCTTATGCGTAGTCAGGC

FWD

TGAGGTACCGGATCCATGGTGGGTCGGAAC

REV

CTTGATATCGAATTCTTACTTGTACAGCTCGTCCATGCC

TOMM20-mCherry into
pAAV

qPCR:
Reactions for qPCR were carried out using LightCycler 480 SYBR Green I Master
(Roche). All samples were run in triplicate. A LightCycler 480 (Roche) was used to carry
out reactions with default SYBR Green I protocol. Primers were targeted to 3’ ends of
spliced transcript sequences. The maximum second derivative of each amplification
curve was taken as the cycle time (CT) value for analysis. CT values that were > ±1 CT
from the rest of the replicate samples were excluded from analysis as long as 2
replicates still remained. The average of the Actb and Gapdh CTs were used for
housekeeping gene controls. ddCT calculations for mitochondrial gene qPCR in disease
cohorts were carried out on average replicate CT values as follows:
−"CT%&'( *+,+ − CT-(./+0++1&,* 2

345

− "CT%&'( *+,+ − CT-(./+0++1&,* 2

67

ddCT calculations for mitochondrial gene qPCR in healthy cell type samples were
carried out on averaged replicate CT values as follows:
−"CT%&'( *+,+ − CT-(./+0++1&,* 2

819&,:

− "CT%&'( *+,+ − CT-(./+0++1&,* 2

;(<*=<'>

The following primer sequences were used for mitochondrial qPCR reactions:
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Gene name

FWD/REV

Sequence (5’ to 3’)

Aco2

FWD

CCCCTCCGACTATAACAAGATTC

REV

TCTCGTTGAAGGTGTGGTTC

FWD

GGCTGAGGACTTTGTACATT

REV

GGACTTCCTGTAACCACTTATT

FWD

GATCTTGTTTGCCATGTAACAG

REV

GGAGTCACAGCAAGATACAC

FWD

GATGACTGAGTACCTGAACCG

REV

CAGAGACAGCCAGGAGAAATC

FWD

CCTTGGGTGTTCGGTATTT

REV

ACTCAGTCTCCCTTCACTT

FWD

GACCCTTACTCTGTGTGGA

REV

AGCAGAAGGGATGGAAGA

FWD

GAGCATCTCCCTCACAATTT

REV

GGGTGCAGCGAACTTTAT

FWD

TCTGAGAGACCTAGGAGTAAAC

REV

GCTTTGCTTCACTCTTGTATTC

FWD

GTTTCCCGTGCAATCAGTTC

REV

AGCCTTCTCACCATTCACTTC

FWD

TCGATTATGGAAAGCTGGGC

REV

TTGTGTAGTTCCCATTCTGACC

FWD

GACTCAGACCAGCTCCTTTAC

REV

ACACCATGCAAGTACAGAGC

FWD

CGAAGCAGTACCCTTACAATAA

REV

CCATCAAGCCTCCTCAGATA

FWD

GGGCAAAGGTGGAAATGA

REV

ACCACACAGGGAATGTTTAC

FWD

TGCTCTAATCAGGACCCATTG

REV

CATTCTCCCAGTTGATTACATTCC

Actb

Atp5g3

Bcl2

Colgalt2

Cox6a1

Gapdh

Gprin3

Gpx1

Mrpl17

Mrpl37

Ndufb8

Sod1

Sod2
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Timm13

Timm44

Tomm20

Tomm40

Tomm70a

Uqcrh

FWD

TGAGGGTGGGTTAAGTGT

REV

GCTCCTTTGGTGCTTATGT

FWD

TCAAGAACTCCAAAGGCGAG

REV

GAGGCTGAGATGTCCAGAAG

FWD

TGACAAATGCCATTGCTGTG

REV

ATCTTCAGCCAAGCTCTGAG

FWD

GTGGGTGTGGAGTTTGAGG

REV

CCCACGATCCAGTTACTGTTC

FWD

CTGAAGCCAGGACATACTTG

REV

TATTGGACAGCTCTGGAAATAC

FWD

CACTGGGAATCAGGAACAG

REV

GCTAGTCACACAGAAGAGAAG

Rotarod:
WT and SOD1-G93A mice were trained on the apparatus for three days beginning at
~P35 (5 weeks of age) and then tested once weekly for 6 weeks. During the test,
acceleration was increased from 5-18 rpm over the course of 180 seconds and the
latency to fall was measured for two trials. Falls were detected automatically by a
sensor at the base of the apparatus.

Surgeries
CTB injections:
Animals were anesthetized via IP injection of 1% Ketamine/0.1% Xylazine (doses 1
mL/kg and 0.1 mL/kg respectively) in 0.9% saline. Following anesthesia, animals were
positioned on the stereotaxic apparatus and skin was incised above the skull.
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Coordinates (from bregma) for thalamus injections were AP -1.85 mm, ML +/- 1.5 mm,
DV -3.2 mm. Pons injections were made at AP -4.1 mm, ML +/-0.6 mm, DV -5.2 mm.
Holes were drilled in the skull at the target coordinates using a dental drill. Cholera toxin
beta (Alexa 555-conjugated CTB, Thermo Fisher) was injected using a Hamilton syringe
with a pulled glass capillary pipette at a rate of 0.1 µL/min to a total volume of 0.25 µL.
Incisions were closed using Vetbond (3M) For spinal cord injections, an incision was
made from the base of the neck down between the shoulder blades to target the
cervical vertebrae. Back and shoulder muscles were separated by cutting connective
ligaments with a scalpel. Once the spinal column was exposed, connective tissue was
pushed aside slowly using the scalpel blade. Using forceps and surgical scissors, the
C6 vertebrae was cut away to reveal the dura and spinal tissue. After carefully cutting a
hole in the dura using forceps and scalpel, CTB was injected at a rate of 0.1 µL/min to a
total of 0.15-0.20 µL at the following coordinates: AP C6, ML +/-0.4 mm, DV ~ -1.1 mm.
Sutures were used to reposition back and shoulder muscles before suturing the incision.
Animals were allowed to recover in clean cages over a warming plate, and were given
low dose ibuprofen in drinking water during recovery. Animals were perfused after at
least 48 hrs following surgery to allow tracer to fully travel the length of the axons.

AAV Injections:
Animals were anesthetized via IP injection of 1% Ketamine/0.1% Xylazine (doses 1
mL/kg and 0.1mL/kg respectively) in 0.9% saline. Mice were then head-fixed into
stereotaxic apparatus, and the scalp was resected before drilling small bores over target
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injection sites. For labeling LL5b terminals in the spinal cord, AAV.DIO.EYFP was
injected at a rate of 0.1 µL/min to a total of 0.15-0.25 µL into the motor cortex of Gng7Cre mice at AP +0.5 mm, ML +/-1.3 mm, DV -0.75 mm from bregma. Mice were allowed
to recover post-operatively before being placed back into the colony room. The virus
was allowed to express for 4-5 weeks before collecting tissues, with weekly checks of
mouse health being performed throughout. For mitochondrial labeling and Pgc1a
overexpression

experiments,

AAV9.Ef1a.DIO.mitoGFP.WPRE.hGH,

SL1.Ef1a.TOM20.mCherry, or SL1.CMV.FLAG.Pgc1a.6XHis was injected into the pons
of mice via angled injection to AP -4.15, ML +/-2.01, DV -5.05, 15° from vertical. After
suturing was completed, mice were allowed to recover in clean cages over a warming
plate, and were given low dose ibuprofen in drinking water for up to one week following
the surgery. Viral expression was allowed to continue for 4-5 weeks before collecting
tissues, with periodic health checks performed during this time.

PRV injections:
HA-mCherry-expressing Pseudorabies virus (PRV) 298 was generously provided by
Lisa Pomeranz in the lab of Jeffery Friedman at The Rockefeller University. Mice were
anesthetized as described above. The dorsal face of left upper forelimb muscles were
exposed by a cutaneous incision extending from the lateral shoulder to just medial to
the elbow. 1µl injections of PRV were made at a rate of 0.25 µL/min into bicep, tricep,
trapezius, and deltoideus using a Hamilton syringe with a pulled glass capillary pipette
for a total of ~5 µl total. Incision was sutured and mice were allowed to recover post-op
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in BSL-2 quarantine. Mice were given low dose ibuprofen in drinking water during
recovery. Mice were closely monitored twice daily for 5 days, at which point they were
perfused and spinal and brain tissues were collected.

RA Injections
A 40 ml stock solution of 2.5 mg/ml all-trans retinoic acid (RA) in corn oil (100 mg in 40
ml) was made and stored at -20°C. 0.25 mg/ml working solutions in corn oil were made
fresh before injections, and animals were injected to a total of 1 mg/kg animal weight,
twice the dose described in (Kwok et al., 2012). Control mice were injected with corn oil
vehicle at a dose of 4 µl/g animal weight. IP injections of either RA or vehicle were
performed three times per week starting from ~P85 until end stage euthanasia. Overt
symptoms were recorded and a subjective score was assigned post-hoc, blind to
condition.

Tissue collection
Mouse tissue collection:
Mice received an IP injection of 1% Ketamine/0.1% Xylazine (lethal doses 2 mL/kg and
0.2 mL/kg respectively). The animals were then perfused transcardially first with
approximately 40 mL of sterile phosphate buffered saline (PBS) pH 7.4, followed by
approximately 30 mL of 4% paraformaldehyde (PFA) in PBS. Brain and spinal cord
were removed and placed in 4% PFA overnight at 4°C with shaking. Tissues were then
transferred to 30% w/v sucrose in PBS and stored at 4°C. Brain and spinal cord tissues
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were sectioned on freezing microtome at a thickness of 40 µm. To section spinal cord
tissue on the microtome, tissue was first embedded in Richard Allen Scientific Neg-50
(Thermo Fisher) over a slurry of 100% EtOH and dry ice. Sections were stored in nonfreezing storage media (25% w/v ethylene glycol, 25% glycerol, 50% PBS) at -20°C until
further processing. Before staining or mounting, sections were washed 3 x 5 min with
PBS.

Human brain tissue:
Human cortex tissue samples were received from the Miami Brain Bank, as well at the
University of Maryland Brain Bank (operating under NIH Neurobio Bank licensing).
Lateral motor cortex brain tissues were acquired from the University of Maryland Brain
Bank as formalin-fixed tissue blocks. Blocks were embedded in paraffin and sectioned
to ~15 µm by the Weill Cornell Medicine Imaging Core. Slides of medial motor cortex
sections were sent to our lab from the Miami Brain Bank.

Primate brain tissues:
Primate brain sections were collected in collaboration with colleagues in the Friewald
lab at the Rockefeller University. The left hemisphere of a rhesus macaque brain was
immediately immersed into a solution of 3.75% acrolein/2% PFA in phosphate buffer
(PB). Tissue was then washed in PB before shipping to Neuroscience Associates
(Knoxville, TN), where it was embedded in a gelatin-based matrix for serial sectioning.
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40 µm sections were collected and immersed in a preservation solution before being
returned to our lab.

Staining and Histology
Immunostaining:
The following antibodies were used in study:
Antigen

Species

Vendor

Catalog #

Application

Dilution

GFP

Chicken

Abcam

ab13970

IF, IHC

1:2000

RFP

Rabbit

Abcam

ab62341

IF

1:1000

NeuN

Mouse

Millipore

MAB377

IF

1:1000

GFAP

Rabbit

Thermo F.

Ab-4

IF

1:500

ChAT

Goat

Millipore

AB144P

IF

1:100

CTB

Rabbit

Abcam

ab34992

IF

1:1000

SMI-32

Mouse

Millipore

NE-1023

IF

1:250

SMI-32

Rabbit

Abcam

ab8135

IF

1:1000

Crym

Rabbit

Santa Cruz

sc-366780

IF

1:100

Crym

Mouse

Abcam

ab54669

IF

1:500

Pcp4

Rabbit

Santa Cruz

sc-74816

IF

1:100

Secondaries

Donkey

Jackson Immuno.

IF

1:500

All fluorescent antibody staining experiments were performed on free-floating tissue as
follows: sections were washed in PBS pH 7.4, 3 x 5 min to remove anti-freezing storage
solution. Sections were incubated with 2.5% Normal Donkey serum (NDS, Jackson
Immuno) and 2.5% TritonX-100 for approximately 30 mins. Sections were then
incubated in 1% NDS and 1% TritonX-100 with primary antibodies overnight at room
temperature with shaking. Sections were washed with PBS 3 x 5 min before incubating
149

in 1% NDS with fluorescent secondary antibodies for approximately 1 hour. Sections
were washed with PBS 3 x 5 min before being mounted on slides and coverslipped with
Prolong Gold with DAPI (Thermo). Sections were then visualized using a confocal
microscope. On-slide staining was performed in largely the same way, with antibody
incubations being carried out in a humidified chamber.
For non-fluorescent immunohistochemistry, a 10 min incubation in 0.3% hydrogen
peroxide in PBS and 3 x 5 min PBS washes preceded the blocking/permeabilization
step. A biotinylated secondary antibody was used, followed by a 1 hr incubation in ABC
solution (Vector Labs). DAB (Vector Labs) was then used to deposit the stain at the site
of antigen. Sections were then visualized using a brightfield microscope.

Primate tissue staining:
Because primate sections that were used in this study were made from acrolein-fixed
tissue, Schiff bases needed to be reduced prior to staining to quench auto-fluorescence
caused by fixation. For this, we adapted the protocol from (Luquin et al., 2010). Briefly,
prior to staining, free-floating primate sections were washed 3 x 5 min 0.1M phosphate
buffer (PB), pH 7.4. They were then incubated in a freshly-made solution of 1% sodium
borohydride (NaBH4) in 0.1M PB for 30 min at RT with agitation. Sections were then
washed 3 x 5 min in 0.1M PB, followed by 3 x 5 min PBS pH 7.4. Sections were
incubated for 30 min in a solution of 50% EtOH/0.3% H2O2 in PBS at RT with agitation.
Sections were washed 3 x 5 min in PBS and mounted onto charged slides. Sections
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were dried on a 60°C heat block, re-submerged briefly in PBS and dried again. On-slide
staining was performed as described above for free-floating sections.

Human tissue staining:
All human sections were stained on slides, as tissue was collected from FFPE blocks.
Immediately before staining, slides were deparaffinized by first submerging the sections
in Xylenes for 6 min, and subsequently washing in descending concentrations of EtOH
in water (100%, 100%, 95%, 70%, 50%) for 3 min each. Slides were then rinsed twice in
water before being submerged in PBS. Antigen unmasking was performed before
immunostaining. A solution of 0.1M sodium citrate, pH 6.0 with 0.5% TritonX-100 was
brought to 90°C using a microwave, and sections were immersed in this solution for 10
min. Solution was maintained at 90°C as needed during incubation with low power
microwave heating. The solution with submerged slides was allowed to come to room
temperature before the slides were removed and washed with PBS. Concentrations for
serums, Triton, and antibodies, as well as incubation times, were identical to freefloating protocol.

Fluorescence In-situ hybridization (FISH):
Cryostat sections (14 µm) for FISH experiments were made from PFA perfusion-fixed
and 30% sucrose cryopreserved brains that we were embedded in OTC freezing media.
On-slide labeling was performed using RNAscope ISH technology and its associated
kits. Probes against Crym (ACD Biotech, #466131) and Nefh (ACD Biotech, #443671)
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were used to label L5b cells in Colgalt2 and Gprin3 sections using the RNAscope
Multiplex Fluorescent Reagent Kit v2 (ACD Biotech, #323100). All steps were carried
out according to manufacturer recommendations in protocol #323100-USM, available
on the manufacturer website. Immunostaining after ISH was performed on-slide as
described above.

Confocal fluorescence and brightfield microscopy
A Zeiss Axio Observer.Z1 with LSM 700 confocal microscope equipped with 50 mW,
400-640 nm lasers was used for all fluorescent visualizations. Zen software (Zeiss) was
used for acquisition of images. For brightness and contrast adjustments, as well as
image analysis, FIJI was used (ImageJ, SciJava; Rueden et al., 2017; Schindelin et al.,
2012; Schneider et al., 2012). For acquisition of brightfield images of DAB-stained
sections, a Zeiss Axio Imager.M2 was used. Neurolucida was used to acquire tiled
images of whole sections.

Electron Microscopy (EM)
Immunostaining:
EM experiments were performed in collaboration with the Electron Microscopy
Resource Center at The Rockefeller University, and the following procedure was
adapted from the protocol written by K. Uryu. “Base buffer” below refers to either 75 mM
Na-cacodylate buffer pH 7.4, used for immunostaining in WT Colgalt2 sample
preparations, or 100 mM Tris buffer, pH 7.4 at 4°C used in immunostaining of WT vs
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SOD Gprin3 samples. Animal tissues were perfuse-fixed in 4% PFA (Electron
Microscopy Sciences) in 75 mM Na-cacodylate buffer. 50 µm sections were collected in
cold base buffer using a vibratome (Leica). Sections were washed in 0.5% H2O2 in base
buffer to quench endogenous peroxidase activity. After washing in base buffer 4 x 15
min, sections were washed in a blocking solution of 3% Bovine Serum Albumin (BSA),
and 0.1% saponin in base buffer. Anti-GFP primary antibody incubations were done in a
solution of 3% BSA with 0.1% saponin in base buffer for 48 hrs at 4°C. Sections were
washed 4 x 15 min in base buffer, and were then incubated with biotinylated secondary
antibody in base buffer containing 3% BSA and 0.1% saponin for 2 hrs at 4°C. Sections
were washed in base buffer 4 x 15 min, then incubated in ABC complex solution (1 µL
solution A + 1 µL solution B per 1 mL of base buffer; Vector Science Labs) with 3% BSA
and 0.1% saponin for 1 hr. Sections were washed 3 x 15 min before being incubated in
a solution of DAB (Vector Science Labs) + Urea H2O2 in base buffer for several minutes
until proper tissue contrast was achieved. Sections were rinsed in base buffer and fixed
in 2.5% gluteraldehyde in 75 mM Na-Cacodylate buffer overnight at 4°C.

Silver enhancement:
Fixed sections were washed with 75 mM Na-cacodylate buffer before being rinsed with
2% sodium acetate in H2O for 10 min. Sections were then incubated in a developer
solution of 3% Methenamine, 5% silver nitrate, and 1% sodium tetraborate for 15 min at
60°C. Sections were then washed once again in 2% sodium acetate, followed by an
incubation in 3% sodium thiosulfate. Gold toning was performed by incubating sections
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in 0.1% gold chloride for 5 min. Sections were then washed in 2% sodium acetate for 10
min, 3% sodium tetraborate for 5 min, and 2% sodium acetate again for 10 min. After
rinsing in 75 mM Na-cacodylate buffer, sections were fixed with 2.5% gluteraldehyde in
75 mM Na-cacodylate overnight at 4°C.

Osmication and Eponate infiltration:
Sections were washed in 75 mM Na-cacodylate before Osmication for ultra-structure
preservation. Sections were then incubated in a solution of 1% osmium tetra-oxide with
1% potassium ferrocyanide in cacodylate buffer for 30 min on ice. Sections were then
washed 3 x 5 min in Na-cacodylate buffer. They were then treated with a 2% solution of
uranium acetate in H2O for 30 min. Sections were then progressively dehydrated in
increasing concentrations of ethanol (50%, 70%, 95%, 100% x 2) 5 min each using a
microwave oven. Resin was then infiltrated into the sections by first immersing in a 1:1
solution of acetone and resin mixture (25 mL EPON812, 18 mL NMA, 7 mL DDSA, and
0.60 mL DMP-30) in a microwave under vacuum. Sections were immersed in 100%
resin mixture for further infiltration 2 x, then left in fresh resin in a 70°C incubator to
polymerize overnight. Sections were immersed one last time in 100% resin under
vacuum for 4 hrs. Resin-embedded sections were placed between two sheets of aclar
plastic to embed at 60°C for 48 hrs. Ultra-thin sections were made by staff at the EMRC.
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Image analyses
Multi-channel signal co-localization:
For co-localization analyses, position markers were placed in FIJI over any cells that
appeared subjectively positive for a marker. The position markers were saved as ROIs
in the ROI manager and placed over the next channel image of interest. The number of
points that were positive in this second channel was counted as being double-positive.
This analysis framework was used for CTB/GFP and PRV-mCherry/GFP co-localization
in retrograde tracing, and for L5b marker co-localization in mouse and human tissues.

Cell counts:
For determining loss of GFP+ cells in SOD1-G93A mice, a 3 x 2 x 3 (w x h x z) z-stack
tile scan of 20X fields was acquired on the confocal microscope. Every 6th section
between +1.00 mm and +0.00 mm to Bregma was imaged (one section every ~240
µm), with each hemisphere being imaged separately. The z-stacks were collapsed in
FIJI using the maximum intensity projection. Cells were then counted only if apical
dendrite was clearly visible. All counting was performed blind to disease condition.

Cell depth analyses:
Cell depths were determined using a custom script (github.com/mvmoya) written for
FIJI/ImageJ that calculates the percentage depth from pia and white matter. The pial
and white matter surfaces are manually delineated, and the points are placed on the
image to mark the locations of the cells. The algorithm then draws a reference line that
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is perpendicular to the pial line and intersects the cell’s point and terminates at the
intersection with the white matter line. The cell’s percent distance from the pial line
along the reference line is then calculated reported and as a percentage depth from pia.

Terminal densities in spinal cord:
Terminal densities for Gng7-Cre EYFP+ axon terminals were measured by thresholding
the EYFP channel image until terminals were exclusively visible in the image. The
ventral horn ROI was generated by outlining the area that contained ChAT+ alpha motor
neurons in the ChAT channel, and overlaying the resulting ROI onto the EYFP channel.
The density of thresholded terminals was returned by the built-in “Area Fraction” tool
found in FIJI/ImageJ. The density of terminals in the intermediate lamina was measured
by drawing a representative rectangular ROI over these regions and returning the same
measurement as described above.

Mitochondrial signal quantification:
Images of fluorescently-labeled mitochondria following mitoGFP or TOM20-mCherry
viral expression and immunostaining were collected at 63X-100X magnification and
analyzed in FIJI/ImageJ. Cytoplasmic space (excluding the nucleus) was outlined for
each neuronal cell body for which an apical dendrite could be observed. The area within
this cytoplasmic region was thresholded so as to only include the upper 25% of values
in the pixel depth distribution. This proportional thresholding strategy was chosen over
setting a fixed value for upper thresholding in order to normalize across cells located at
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different depths in the section that presumably were exposed to different levels of
antibody penetration. The thresholded image was then run through the “Particle
Analyzer” built into FIJI/ImageJ, to assess size, total area, number, and density of
discrete “particles” containing mitochondrial signal.

Cristae width measurements:
Electron micrographs were analyzed in FIJI/ImageJ. After importing the image, the
spatial resolution of the image was set in FIJI according to the magnification settings
and resolution used for acquiring the image. The width was measured in the narrowest
dimension for all cristae where both apposing membranes could be readily seen. All
mitochondria found in each micrograph were scanned for detectable cristae, regardless
of size, shape or subcellular location.

TRAP and RNA-Seq analyses
TRAP:
TRAP experiments from cortical cell types were performed as previously described
(Heiman et al., 2008). For cell type characterizations, ~P40 animals were sacrificed, and
whole cortex dissected in ice-chilled HBSS containing 2.5 mM HEPES-KOH (pH 7.4),
35 mM glucose, 4 mM NaHCO3, and 100 μg/ml cycloheximide. Cortices from 3 animals
were pooled per biological replicate, with 3 replicates per cell type being prepared in
total (9 animals). Samples were homogenized in extraction buffer containing 10 mM
HEPES-KOH (pH 7.4), 150 mM KCl, 5 mM MgCl2, 0.5 mM DTT, 100 μg/ml
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cycloheximide, RNasin (Promega) and SUPERas-In (Life Technologies) RNase
inhibitors, and Complete-EDTA-free protease inhibitors (Roche), and then centrifuged at
2000 x g to clear lysate debris. IGEPAL CA- 630 (NP-40, Sigma) and DHPC (Avanti
Polar Lipids, Alabaster, AL) were added to the resulting supernatant to a concentration
of 1% each, followed by 20,000 x g centrifugation. Polysomes were immunoprecipitated
(IP’ed) using 100 µg custom monoclonal anti-GFP antibodies (50 µg of clone 19C8 with
50 µg of clone 19F7) bound to biotinylated Protein L (Pierce, Thermo Fisher) coated
streptavidin-coated magnetic beads (Thermo Fisher), and washed with high salt buffer
containing 10 mM HEPES-KOH (pH 7.4), 350 mM KCl, 5 mM MgCl2, 1% IGEPAL CA630, 0.5 mM DTT, 100 μg/ml cycloheximide, and RNasin RNase inhibitors (Promega).
Overnight IP’s were eluted and purified using Absolutely RNA Nanoprep kit (Agilent).
RNA quality was assessed using Nanodrop spectrophotometer and Agilent 2100
Bioanalyzer. Samples with RNA integrity values > 7 were used to prepare libraries for
sequencing.
RNAs from TRAP IPs (15 ng per sample) were converted to cDNA using the Nugen
Ovation RNA-Seq System V2 kit. cDNAs were then fractionated by sonication and
libraries were made using the Illumina TrueSeq RNA Sample Preparation kit v2,
following manufacturer’s instructions. Sequencing was run on a machine at The
Rockefeller University Genomics core using the Illumina HiSeq 2500 platform (Illumina).
For disease TRAP cohorts, whole cortices from ~P70 (pre-symptomatic) and ~P110
(symptomatic) timepoints were collected from healthy and SOD1-G93A-crossed
Colgalt2 and Gprin3 animals and homogenized, and polysomes were IP’ed also as
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described above. At this point, Gprin3 RNA was sent to Dr. Hemali Phatnani at the New
York Genome Center (NYGC) for cDNA conversion, library sample preparation, and
sequencing. Colgalt2 cDNA libraries were instead prepared in our lab as described
above. Prepared libraries were multiplexed to 6 samples and sent to the NYGC for
sequencing.

Sequencing analyses:
Returned sequences in FASTQ files were first aligned to mm10 annotated mouse
genome using STAR aligner (Dobin et al., 2013) version 2.0.0e_r291. Whole gene
counts from exon-mapping aligned reads were quantified using HTSeq (Anders et al.,
2015) version 0.6.0, and the htseq-count module. Differential expression analysis on
whole gene counts was performed in DESeq2 version 1.22.2 in RStudio version 1.1.463
(Love et al., 2014), RStudio Team (2015). RStudio: Integrated Development for R.
RStudio, Inc., Boston, MA, URL http://www.rstudio.com/) using all default parameters.
Additional analysis packages can be found in the analysis source code, available on
github.com/mvmoya. For determining significantly enriched genes in Colgalt2, Gprin3,
and whole cortex cell type characterizations, adjusted p-values were used to determine
statistically significant relevant genes (p < 0.05). Because very few genes showed
adjusted p-values below 0.05 when comparing the same cell type across healthy and
disease conditions, un-adjusted p-values were used in disease analyses so as to
increase the number of genes available for gene ontology enrichment. Gene ontology
enrichment analyses were performed using Metascape (metascape,org; Zhou et al.,
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2019) with default parameters. Transcription factor motif enrichment analysis were
performed using HOMER (Heinz et al., 2010), searching -1500 upstream of the
transcription start site to 500 bases downstream of the transcription start site.
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